Citations

Citations to this article as recorded by  

• Differential Infiltration of T-Cell Populations in Tumor and Liver Tissues Predicts Recurrence-Free Survival in Surgically Resected Hepatocellular Carcinoma
  Eun Ji Jang, Ho Joong Choi, Young Kyoung You, Deok Hwa Seo, Mi Hyun Kwon, Keungmo Yang, Jaejun Lee, Jeong Won Jang, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
  Cancers.2025; 17(9): 1548.     CrossRef
• Metabolic Dysfunction-Associated Steatotic Liver Disease, Recent Revision of Terminology and Its Implications
  Hyo Young Lee, Eileen L. Yoon
  The Korean Journal of Gastroenterology.2025; 85(2): 126.     CrossRef
• Advances in identifying risk factors of metabolic dysfunction-associated alcohol-related liver disease
  Rui-Qi Ye, Yi-Fan Chen, Chang Ma, Xi Cheng, Wei Guo, Sha Li
  Biomedicine & Pharmacotherapy.2025; 188: 118191.     CrossRef
• A Case Report of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) with Improved Cardiometabolic Risk Factors Following Treatment with Saenggangunbi-tang
  Eun Kyung Lee, Min Jeong Park, Youngchul Kim, Jang-Hoon Lee
  The Journal of Internal Korean Medicine.2025; 46(2): 303.     CrossRef
• Food Nutrients and Bioactive Compounds for Managing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review
  Erdenetsogt Dungubat, Kohei Fujikura, Masahiko Kuroda, Toshio Fukusato, Yoshihisa Takahashi
  Nutrients.2025; 17(13): 2211.     CrossRef
• Associations between steatotic liver disease subtypes and incident atrial fibrillation in young adults: a nationwide cohort study
  Jeayeon Park, Goh Eun Chung, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Eun Ju Cho
  Cardiovascular Diabetology.2025;[Epub]     CrossRef
• Second-line antidiabetic drugs: friend or foe of the liver
  Jiwon Yang, Gunho Kim, Ju Hyun Shim, Jihyun An
  Journal of Liver Cancer.2025; 25(2): 187.     CrossRef
• Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease
  Anoushka Shenoy, Aijaz Ahmed, Donghee Kim
  Metabolism and Target Organ Damage.2025;[Epub]     CrossRef
• 2025 Clinical Practice Guidelines for Diabetes: Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
  Jaehyun Bae
  The Journal of Korean Diabetes.2025; 26(3): 172.     CrossRef
• Paired snRNA-seq and scRNA-seq analysis of MASLD patients to identify early-stage markers for disease progression
  Suebin Park, Su-Hyeon Lee, Se-eun Han, Beom Kyung Kim, Byungjin Hwang
  Hepatology Communications.2025;[Epub]     CrossRef
• Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease
  Ralf Weiskirchen, Amedeo Lonardo
  International Journal of Molecular Sciences.2025; 26(19): 9594.     CrossRef
• Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis
  Huiru Jin, Mengfan Jiao, Chengxiao Yu, Tingting Ren, Qingling Chen, Zixing Dai, Erfu Xie, Longfeng Jiang, Yuwen Li
  European Journal of Medical Research.2025;[Epub]     CrossRef
• Risk of Esophageal and Gastric Cancer by Histologic Subtype in Steatotic Liver Disease: A UK Biobank Study
  Donghoon Kang, Ji Won Han, Kenneth R. Muir, Artitaya Lophatananon, Jongin Lee
  Cancers.2025; 17(21): 3416.     CrossRef
• Metabolic dysfunction-associated steatotic liver disease and adverse pregnancy outcomes: a nationwide cohort study
  Young Mi Jung, Taesu Kim, Min-Jeong Oh, Dong Hyeon Lee, Geum Joon Cho, Won Kim
  Hepatology International.2025;[Epub]     CrossRef
• Implication of the Androgen Receptor in Muscle–Liver Crosstalk: An Overlooked Mechanistic Link in Lean-MASLD
  Eleni Myrto Trifylli, Christiana Charalambous, Nikolaos Spiliotopoulos, Nikolaos Papadopoulos, Anastasia Oikonomou, Spilios Manolakopoulos, Melanie Deutsch
  Livers.2025; 5(4): 65.     CrossRef
• Time-updated FIB-4 index predicts coronary artery calcification progression in individuals with metabolic dysfunction–associated steatotic liver disease
  Yesung Lee, Woncheol Lee
  Scientific Reports.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Haiyu Wang, Jinjun Chen
  Clinical and Molecular Hepatology.2026; 32(1): e58.     CrossRef
• Refining portal hypertension assessment: The clinical significance of spleen stiffness measurement in the Baveno VII Era: Editorial on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
  Do Seon Song
  Clinical and Molecular Hepatology.2026; 32(1): 400.     CrossRef
• Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
  Hee Yeon Kim, Miyoung Choi, Dae Won Jun
  Clinical and Molecular Hepatology.2025; 31(1): e48.     CrossRef
• Non-Invasive Liver Fibrosis Test Using Shear Wave Elastography
  Ji Won Han
  The Korean Journal of Medicine.2025; 100(1): 26.     CrossRef
• Influence of Sex in the Development of Liver Diseases
  Jie-Wen Zhang, Nan Zhang, Yi Lyu, Xu-Feng Zhang
  Seminars in Liver Disease.2025; 45(01): 015.     CrossRef
• KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
  Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang
  Clinical and Molecular Hepatology.2025; 31(Suppl): S1.     CrossRef
• Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study
  G. Craig Wood, Anthony Hoovler, Rakesh Luthra, Christopher D. Still, Hamzah Shariff, Matthew Still, Jonathan Hayes, Peter Benotti, Chioma Uzoigwe
  Expert Review of Gastroenterology & Hepatology.2025; 19(4): 427.     CrossRef
• Age serves as the silent architect of FIB-4’s precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on “Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liv
  Ji Won Han, Dae Won Jun
  Clinical and Molecular Hepatology.2025; 31(2): e152.     CrossRef
• The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study
  Yanjun Guo, Wei Su, Lulong Tao, Guoxin Zhang, Kun Wang
  BMC Gastroenterology.2025;[Epub]     CrossRef
• Future Perspectives of Liver Research in the Asia‐Pacific Region: Focus on Hepatitis B and C
  Beom Kyung Kim
  Journal of Gastroenterology and Hepatology.2025; 40(8): 1855.     CrossRef
• Novel Insights into Noninvasive Assessment of Liver Fibrosis in Chronic Hepatitis C Patients
  Guanlan Liu, Li Liu, Xing Yang, Qihao Wang, Mingqin Qian
  Journal of Clinical and Experimental Hepatology.2025; 15(6): 102610.     CrossRef
• A Case Report of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) with Improved Cardiometabolic Risk Factors Following Treatment with Saenggangunbi-tang
  Eun Kyung Lee, Min Jeong Park, Youngchul Kim, Jang-Hoon Lee
  The Journal of Internal Korean Medicine.2025; 46(2): 303.     CrossRef
• Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
  Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Clinical and Molecular Hepatology.2025; 31(3): 1018.     CrossRef
• Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population
  Jean-Bonny Nsumbu, Jean-Robert Makulo, Trésor Mutombo Tshiswaka, Christian Kisoka Lusunsi, Charles Nlombi Mbendi
  Hepatic Medicine: Evidence and Research.2025; Volume 17: 27.     CrossRef
• Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis
  Toshikazu Kohira, Satoshi Oeda, Erina Eto, Yoshihito Kubotsu, Misa Norita, Kaori Inoue, Nagisa Hara, Shotaro Noge, Kenichi Tanaka, Shigenobu Yoshimura, Noriko Oza, Keizo Anzai, Yuichiro Eguchi, Cheng Han Ng, Daniel Q. Huang, Mark D. Muthiah, Atsushi Kawag
  Scientific Reports.2025;[Epub]     CrossRef
• Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study
  Jung Hee Kim, Jae Hyun Yoon, Sung-Eun Kim, Ji-Won Park, Yewan Park, Gi-Ae Kim, Seong Kyun Na, Young-Sun Lee, Jeong Han Kim
  Medicina.2025; 61(9): 1601.     CrossRef
• Comment on ‘Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank’ by T. S. Lim et al.—Authors' Reply
  Tae Seop Lim, Sujin Kwon, Sung A Bae, Hye Yeon Chon, Seol A. Jang, Ja Kyung Kim, Chul Sik Kim, Seok Won Park, Kyoung Min Kim
  Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub]     CrossRef
• Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis
  Mi Na Kim, Geun U. Park, Seng Chan You, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn
  Journal of Gastroenterology and Hepatology.2025; 40(11): 2750.     CrossRef
• Prospects of late-stage development agents in the treatment of metabolic dysfunction-associated steatohepatitis
  Brian Lee, Ussama Ghumman, Lisa D. Pedicone, Andres Gomez Aldana, Eric Lawitz
  Clinical and Molecular Hepatology.2025; 31(4): 1167.     CrossRef
• Discovery of ultrasound-derived fat fraction as a non-invasive tool for MASLD diagnosis
  Huiru Jin, Mengfan Jiao, Chengxiao Yu, Tingting Ren, Qingling Chen, Zixing Dai, Erfu Xie, Longfeng Jiang, Yuwen Li
  European Journal of Medical Research.2025;[Epub]     CrossRef
• Mistakes in the utilization of vibration-controlled transient elastography in the evaluation of liver fibrosis: a narrative review
  Madunil Anuk Niriella, Uditha Bandara Dassanayake, Charith Priyanga Madurapperuma, Indeewari Prathibha Wijesingha, Arjuna Priyadarshin De Silva, Hithnadura Janaka de Silva
  Expert Review of Gastroenterology & Hepatology.2025; 19(12): 1299.     CrossRef
• Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
  Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• A Novel Deep Learning Framework for Liver Fibrosis Staging and Etiology Diagnosis Using Integrated Liver–Spleen Elastography
  Kai Yang, Fei Chen, Aiping Tian, Long Deng, Xiaorong Mao
  Diagnostics.2025; 15(23): 2986.     CrossRef
• Shear-Wave Elastography: Principles, Techniques, and Clinical Considerations
  Jae Seung Lee
  Clinical Ultrasound.2025; 10(2): 53.     CrossRef
• Vibration-Controlled Transient Elastography in Chronic Liver Disease: Current Research Insights
  Ho Soo Chun
  Clinical Ultrasound.2025; 10(2): 69.     CrossRef
• Recent Trends in Noninvasive Tests for Assessing Hepatic Fibrosis in Patients with Chronic Liver Disease
  Jung Hwan Yu
  The Korean Journal of Medicine.2024; 99(5): 232.     CrossRef
• Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography
  Mi Na Kim
  The Korean Journal of Gastroenterology.2024; 84(5): 201.     CrossRef
• Non-Invasive Test for Assessment of Liver Fibrosis in Chronic Hepatitis B
  Ye Ji Jun, Minjong Lee, Ho Soo Chun, Tae Hun Kim
  The Korean Journal of Gastroenterology.2024; 84(5): 206.     CrossRef
• Serological Markers to Assess Liver Fibrosis and Their Roles
  Beom Kyung Kim
  The Korean Journal of Gastroenterology.2024; 84(5): 195.     CrossRef
• Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography
  Han Ah Lee
  Clinical Ultrasound.2024; 9(2): 70.     CrossRef

Citations

Citations to this article as recorded by  

• Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
  Yuqi Feng, Letian Fang, Guangwen Cao
  Hepatoma Research.2025;[Epub]     CrossRef
• Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
  Moon Haeng Hur, Yoon Jun Kim
  Clinical and Molecular Hepatology.2025; 31(1): e93.     CrossRef
• A nationwide investigation on imaging follow-up after Locoregional therapy for hepatocellular carcinoma in China: Current practices and challenges
  Shuwei Zhou, Chenxin Song, Pei Liu, Shenghong Ju, Yuan-Cheng Wang
  European Journal of Radiology.2025; 186: 112057.     CrossRef
• The role of TACE in the era of immune-targeted therapy for hepatocellular carcinoma: a meta-analysis based on PSM
  Jiahao Li, Lei Xian, Xinsen Wang, Yingnan Liu, Jiarui Li
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Hepatic arterial infusion chemotherapy versus transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study
  Yi Zhang, Ze Zhang, Xiaoxv Yin, Anhui Xu, Yonghong Hao, Nan Jiang, Ruibing Zhou, Ketao Mu
  European Radiology.2025; 35(10): 6564.     CrossRef
• A risk prediction model for nausea and vomiting after TACE: a cross-sectional study
  Yali Dai, Mengting Zeng, Hong He, Miao Cai
  BMC Gastroenterology.2025;[Epub]     CrossRef
• Optimizing TACE for Hepatocellular Carcinoma: The Impact of Intra-Arterial Contrast Enhanced Ultrasound
  Linda Galasso, Jacopo Iaccarino, Giorgio Esposto, Gabriele Giansanti, Irene Mignini, Raffaele Borriello, Gianpaolo Vidili, Antonio Gasbarrini, Maria Elena Ainora, Maria Assunta Zocco
  Diagnostics.2025; 15(11): 1380.     CrossRef
• Optimizing Yttrium-90 Radioembolization Dosimetry for Hepatocellular Carcinoma: A Korean Perspective
  In Joon Lee, Hyo-Cheol Kim
  Korean Journal of Radiology.2025; 26(7): 688.     CrossRef
• Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
  Ramanpreet Singh, Mina S. Makary
  Journal of Gastrointestinal Cancer.2025;[Epub]     CrossRef
• Prognostic Role of Short-Chain Fatty Acid-Producing Gut Microbiota and Gut Microbial Dynamics in Patients with Hepatocellular Carcinoma Receiving Chemoembolization: A Prospective Study
  Jiwon Yang, Jihye Lim, Eun Hye Kim, Jihyun An, Danbi Lee, Han Chu Lee, Jin-Yong Jeong, Ju Hyun Shim
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 1991.     CrossRef
• Fucoidan Improves Tumour Control and Liver Function in TACE for Unresectable Hepatocellular Carcinoma: A Randomised Trial
  Yanting Zou, Szu‐Yuan Wu, Wanqin Zhang, Wei Zhang, Xizhong Shen, Xudong Qu, Qunyan Yao
  Liver International.2025;[Epub]     CrossRef
• Embolic efficacy and safety profile of UniPearls® microspheres for hepatic artery embolization in domestic pigs
  Junqing Xi, Kai Liu, Min Xu, Li Dai, Zhengqiang Yang, Baosheng Ren
  Journal of Materials Science: Materials in Medicine.2025;[Epub]     CrossRef
• Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC
  Rui Li, Jianxin Liu, Feilong Ye, Siqin He, Jingjun Huang, Mengdan Zhou, Qifeng Xie, Zhile Liu, Wei Cheng, Guodong Wang, Wei Deng, Xiaobin Wang, Tingqi Yang, Zhengyang Liang, Feiyan Hu, Wensou Huang, Mingyue Cai, Lulu Xie, Wen Zhang, Shenhai Gong, Yun Chen
  Journal of Hepatology.2025;[Epub]     CrossRef
• Nomogram for predicting post-transarterial chemoembolization survival in recurrent patients with hepatitis B virus-associated hepatocellular carcinoma
  Zhang-you Guo, Mu-yang Tu, Yin-shan Yang, Ling-xiang Xu, Dan-dan Fan
  Scientific Reports.2025;[Epub]     CrossRef
• Reassessing the L. reuteri/ indole-3-lactic acid pathway in TACE-related liver injury
  Xiang Zhang, Hui gong, Datian Chen
  Journal of Hepatology.2025;[Epub]     CrossRef
• Targeting lactic acidosis in the tumor microenvironment: Enhancing TACE efficacy in hepatocellular carcinoma
  Shuyi Hao, Hong Yao, Haojie Yu, Lijun Wang, Tingdong Yu, Hongping Xia, Yong Zha
  Liver Research.2025; 9(4): 273.     CrossRef
• Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure
  Jiahao Li, Yingnan Liu, Ruipeng Zheng, Chao Qu, Jiarui Li
  Life Sciences.2024; 342: 122540.     CrossRef
• Rhein‐based Pickering emulsion for hepatocellular carcinoma: Shaping the metabolic signaling and immunoactivation in transarterial chemoembolization
  Xiaoliu Liang, Hui Liu, Hu Chen, Xuqi Peng, Zhenjie Li, Minglei Teng, Yisheng Peng, Jiwei Li, Linyu Ding, Jingsong Mao, Chengchao Chu, Hongwei Cheng, Gang Liu
  Aggregate.2024;[Epub]     CrossRef
• Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
  Jungnam Lee, Young‐Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Jung Hwan Yu, Jin‐Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
  Journal of Gastroenterology and Hepatology.2024; 39(9): 1924.     CrossRef
• Modular multimodal hospital-home chain physical activity rehabilitation programme (3M2H-PARP) in liver cancer: a protocol for a randomised controlled trial
  Haiyan Chen, Hanxiao Lu, Huimin Zhou, Bo Wu, Zhixia Dong, Shuo Zhang, Yuanlong Gu, Guangwen Zhou, Jie Xiang, Jun Yang
  BMJ Open.2024; 14(5): e083228.     CrossRef
• Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
  Yuri Cho, Bo Hyun Kim, Young-Suk Lim
  Digestive Disease Interventions.2024; 08(03): 169.     CrossRef
• Immune-targeted therapy with transarterial chemo(embolization) for unresectable HCC: a systematic review and meta-analysis
  Huipeng Fang, Qiao Ke, Shiji Wu, Qiang Tu, Lei Wang
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Dexamethasone and N-acetylcysteine before transarterial chemoembolization in hepatocellular carcinoma: A Western perspective
  Marco Biolato, Maurizio Pompili
  World Journal of Gastroenterology.2024; 30(31): 3635.     CrossRef
• Research progress on machine algorithm prediction of liver cancer prognosis after intervention therapy
  Feng Guo
  American Journal of Cancer Research.2024; 14(9): 4580.     CrossRef
• Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
  Hyo-Cheol Kim
  Clinical and Molecular Hepatology.2023; 29(4): 984.     CrossRef
• Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion
  Dan Yang, Jiaojiao Du, Weijie Nie, Chaozhi Wang, Zhufang Ma
  Medicine.2023; 102(45): e35713.     CrossRef

Citations

Citations to this article as recorded by  

• Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study
  Sung Won Chung, Ye-Jee Kim, Jihye Lim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Sehee Kim, Won-Mook Choi
  American Journal of Gastroenterology.2025; 120(10): 2302.     CrossRef
• Transient elastography for assessing liver fibrosis in autoimmune liver diseases: Excellent performance but limited details: Editorial on “Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver di
  Kyung-Ah Kim
  Clinical and Molecular Hepatology.2025; 31(1): 275.     CrossRef
• Hard-to-treat autoimmune hepatitis and primary biliary cholangitis: The dawn of a new era of pharmacological treatment
  Atsumasa Komori, Yuki Kugiyama
  Clinical and Molecular Hepatology.2025; 31(1): 90.     CrossRef
• Comment on “Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis”
  Bilal Ahmad, Ayesha Arshad, Niqab Muhammad
  Digestive Diseases and Sciences.2025; 70(11): 3977.     CrossRef
• Autoimmune hepatitis. Clinical case
  Anna Usachova, Lyudmila Onyshchuk
  The Ukrainian Scientific Medical Youth Journal.2025; 154(2): 35.     CrossRef
• Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis
  Jihye Lim, Ye-Jee Kim, Sehee Kim, Ju Hyun Shim, Ashraf Elbahrawy
  PLOS One.2025; 20(7): e0325066.     CrossRef
• Incidence and risk factors of hepatocellular carcinoma in patients with autoimmune hepatitis in Asia
  Jiwon Yang, Sun Young Yim, Kunhee Kim, Hye Won Lee, Jonggi Choi
  JHEP Reports.2025; 7(10): 101524.     CrossRef
• Difficult to treat and refractory autoimmune hepatitis: Recent advances in pharmacological management
  Sayan Malakar, Umair Shamsul Hoda, Suprabhat Giri, Arghya Samanta, Akash Roy, Rajat Gupta, S Rakesh Kumar, Mayank Agarwal, Anubhav Pawar, Sumit Rungta, Uday C Ghoshal
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Mechanistic optimization of inavolisib combined with CDK4/6 inhibitors in the treatment of PIK3CA-mutated breast tumors
  Rongyu Zhu, Haixin Zhang, Fuli Zhang
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025
  Atsushi Tanaka, Sombat Treeprasertsuk, Ming-Ling Chang, Soek-Siam Tan, Cumali Efe, Sook-Hyang Jeong, Xiong Ma, Martin Weltman, Hiroyuki Isayama, Jidong Jia
  Hepatology International.2025;[Epub]     CrossRef
• Autoimmune hepatitis: current concepts in epidemiology, diagnosis, and management
  Brian J. Wentworth, Kwang Il Seo
  Kosin Medical Journal.2025; 40(4): 249.     CrossRef
• Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
  Atsumasa Komori
  Clinical and Molecular Hepatology.2024; 30(2): 157.     CrossRef
• Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database
  Jihye Lim, Hwa Jung Kim
  Orphanet Journal of Rare Diseases.2024;[Epub]     CrossRef
• The Impact of Histologic Portal T-Cell Density on the Clinical Outcomes in Hepatic Graft-versus-Host Disease and Autoimmune Liver Diseases
  Soon Kyu Lee, Sung-Soo Park, Silvia Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Seok Lee, Younghoon Kim, Ji Won Han, Hyun Yang, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Ke
  Diagnostics.2024; 14(16): 1745.     CrossRef
• Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis
  Jihyun An, Young Eun Chon, Gunho Kim, Mi Na Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Miyoung Choi, Dae Won Jun, Seung Up Kim, Ji Won Han, Young-Joo Jin
  Clinical and Molecular Hepatology.2024; 30(Suppl): S134.     CrossRef
• Analysis of Azathioprine Metabolites in Autoimmune Hepatitis Patient Blood—Method Development and Validation
  Andrea Guba, Patrícia Kováts, Zoltán A. Mezei, Mária Papp, Éva Csősz, Gergő Kalló
  International Journal of Molecular Sciences.2024; 25(20): 11233.     CrossRef
• AUTOIMMUNE HEPATITIS AND THE COMPLEXITY OF ITS MANAGEMENT: A CLINICAL CASE
  V. N. Zhdan, O. A. Kyrian, M. Yu. Babanina, I. V. Ivanytskyi, M. V. Tkachenko, V. G. Lebid
  Bulletin of Problems Biology and Medicine.2023; 1(2): 179.     CrossRef
• Comparison of four histological scoring systems for autoimmune hepatitis to improve diagnostic sensitivity
  Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim
  Clinical and Molecular Hepatology.2023; 30(1): 37.     CrossRef

Citations

Citations to this article as recorded by  

• Factors Influencing Overall Survival Period of Stage IV Cancer Patients
  Wen Pei Chang, Yen Kuang Lin, Shashank Kaushik
  European Journal of Cancer Care.2025;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
  Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235.     CrossRef

Citations

Citations to this article as recorded by  

• A case study of a patient with platelet transfusion refractoriness (PTR) combined with human leucocyte antigen (HLA) antibody positivity during hepatic arterial infusion chemotherapy in conjunction with the ‘atezolizumab plus bevacizumab’ regimen
  Yawen Xie, Yanxia Huang, Shuyue Liu
  Nursing in Critical Care.2025;[Epub]     CrossRef
• Exploring the association between air pollution and the incidence of liver cancers
  Xin Wu, Xin Zhang, Xiaopeng Yu, Hongyuan Liang, Shaoshan Tang, Yao Wang
  Ecotoxicology and Environmental Safety.2025; 290: 117437.     CrossRef
• Dual-Functional Micelles for Codelivery of Sorafenib and Dehydrodiisoeugenol in Treatment of Hepatocellular Carcinoma
  Su-Yu Yang, Shu-Tong Li, Tian-Hua Li, De-Jin Ma, Jun-Jie Yu, Yang Liu, Yang Yu, Xue-Tao Li, Juan Zang, Zi-Min Yuan, Liang Kong
  ACS Applied Nano Materials.2025; 8(11): 5355.     CrossRef
• Preparation and Evaluation of Hepatoma-Targeting Glycyrrhetinic Acid Composite Micelles Loaded with Curcumin
  Xueli Guo, Zhongyan Liu, Lina Wu, Pan Guo
  Pharmaceuticals.2025; 18(4): 448.     CrossRef
• SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming
  Xin Jin, Xigan He, Runze Huang, Qinyu Liu, Lei Wang, Xuanci Bai, Yibin Wu, Yixiu Wang, Ziting Jiang, Yi Shi, Gautam Sethi, Lu Wang, Weiping Zhu
  Journal of Experimental & Clinical Cancer Research.2025;[Epub]     CrossRef
• Refining Prognosis and Treatment Strategies Beyond the Barcelona Clinic Liver Cancer Stage in Hepatocellular Carcinoma with Lung Metastases: A Multicenter Cohort Study
  Feng Xia, Qian Chen, Chenyang Li, Huifang Liang, Qiao Zhang, Zhiyuan Huang, Zhenheng Wu, Huaxuan Yin, Liping Liu, Jun Zheng, Hengyi Gao, Guobing Xia, Li Ren, Wanguang Zhang, Xiaoping Chen, Jing Yan, Bixiang Zhang, Huilan Zhang, Zhao Huang
  MedComm.2025;[Epub]     CrossRef
• Long noncoding RNA RHPN1-AS1 promotes hepatocellular carcinoma progression under hypoxia through interaction with RPS15A protein
  Qin Peng, Yu-Ting Cai, Qi Ding, Xiang-Yun Qian, Cong Xu, Hang-Cheng Zhou, Hao Chen, Heng Li, Wei Wang
  Medical Oncology.2025;[Epub]     CrossRef
• MRI-based 2.5D deep learning and radiomics effectively predicted microvascular invasion and Ki-67 expression in hepatocellular carcinoma
  Hongmei Yu, Depeng Kong, Xiaojun Mo, Ju Huang, Jie Wu, Yang Wang, Feizhou Du, Nima Broomand Lomer,
  PLOS One.2025; 20(11): e0336579.     CrossRef
• LASSO-empowered nomogram integrating nutritional-inflammatory-tumor characteristics predicts immunotherapy outcomes in advanced HCC: Large retrospective cohort
  Shuifang Hu, Mingcong Xu, Shuping Li, Wei Chen, Zhenwei Peng
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Effect of External Oblique Intercostal Block on Postoperative Analgesia and Early Recovery in Patients Undergoing Open Liver Resection for Hepatocellular Carcinoma or Intrahepatic Bile Duct Stones: A Randomized Controlled Clinical Trial
  Qilu Ying, Manhua Zhu, Song Zhang, Lingzhi Wang, Ruifen Zhou, Kaiyun Xie
  Local and Regional Anesthesia.2025; Volume 18: 131.     CrossRef
• How Possible Is the Elimination of Viral Hepatitis? An Analysis Based on the Global Burden of Disease from Hepatitis B and C, 1990–2019
  Nelson Alvis-Guzman, Nelson J. Alvis-Zakzuk, Fernando De la Hoz Restrepo
  Microorganisms.2024; 12(2): 388.     CrossRef
• β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression
  Ruoyu Wang, Dan Tang, Longyun Ou, Jiacheng Jiang, Yu-nan Wu, Xuefei Tian
  Human Cell.2024; 37(4): 1156.     CrossRef
• Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma
  Deming Li, Ting Zhang, Ye Guo, Cong Bi, Ming Liu, Gang Wang
  Cell Death & Disease.2024;[Epub]     CrossRef
• Tumor burden score and alpha-fetoprotein level predict prognosis of patients with unresectable hepatocellular carcinoma treated with tyrosine kinase inhibitor and anti-PD-1 antibody
  Shichuan Tang, Tingfeng Huang, Cong Luo, Jun Fu, Kailing Zhang, Qingjing Chen, Jie Kong, Jianxi Zhang, Zhenghong Sun, Yongkang Diao, Kongying Lin, Yongyi Zeng
  iLIVER.2024; 3(3): 100109.     CrossRef
• Camrelizumab plus rivoceranib compared sorafenib as first-line therapeutic options for advanced hepatocellular carcinoma in China: a cost-effectiveness analysis
  Hongfu Cai, Jingwen Lin, Huide Zhu, Zhiwei Zheng
  BMJ Open.2024; 14(12): e079603.     CrossRef

Citations

Citations to this article as recorded by  

• Clinical outcomes of carbon-ion radiotherapy for residual or recurrent hepatocellular carcinoma after transarterial chemoembolization
  Y. Sekiguchi, K. Shibuya, S. Tomogane, Y. Miyasaka, S. Kakizaki, M. Okamoto, K. Araki, K. Shirabe, T. Ohno
  ESMO Gastrointestinal Oncology.2026; 11: 100280.     CrossRef
• Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis
  Young Seob Shin, Jae Kwang Yun, Jinhong Jung, Jin-hong Park, Si Yeol Song, Eun Kyung Choi, Sehoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Geun Dong Lee, Sang Min Yoon
  International Journal of Radiation Oncology*Biology*Physics.2025; 121(2): 432.     CrossRef
• Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
  Bruno Sangro, Masatoshi Kudo, Joseph P Erinjeri, Shukui Qin, Zhenggang Ren, Stephen L Chan, Yasuaki Arai, Jeong Heo, Anh Mai, Jose Escobar, Yamil Alonso Lopez Chuken, Jung-Hwan Yoon, Won Young Tak, Valeriy V Breder, Tanita Suttichaimongkol, Mohamed Bouatt
  The Lancet.2025; 405(10474): 216.     CrossRef
• Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
  Moon Haeng Hur, Yoon Jun Kim
  Clinical and Molecular Hepatology.2025; 31(1): e93.     CrossRef
• APAGE Position Statements on Green and Sustainability in Gastroenterology, Hepatology, and Gastrointestinal Endoscopy
  Tiing Leong Ang, Dao Viet Hang, James Weiquan Li, Jacky Chiu Leung Ho, Marianne Linley Sy‐Janairo, Raja Affendi Raja Ali, Govind K. Makharia, Sridhar Sundaram, Tanyaporn Chantarojanasiri, Hyun‐Gun Kim, Hiroyuki Isayama, Nonthalee Pausawasdi, Kaichun Wu, A
  Journal of Gastroenterology and Hepatology.2025; 40(4): 821.     CrossRef
• Transarterial chemoembolization in hepatocellular carcinoma: exploring its role in vascular invasion and extrahepatic metastasis: A systematic review
  Muhammad Usman Younas, Abdullah Saeed, Muhammad Ramzan, Muhammad Junaid Tahir, Khabab Abbasher Hussien Mohamed Ahmed, Ali Ahmed
  Medicine.2025; 104(8): e41570.     CrossRef
• Plasma protein levels and hepatocellular carcinoma: a Mendelian randomization study with drug screening implications
  Longhui Xie, Dekun Song, Jianwei Lan, Pengpeng Liu, Shuang Qin, Yinkuan Ning, Quanyan Liu
  Discover Oncology.2025;[Epub]     CrossRef
• Quantitative Ablation Confirmation Methods in Percutaneous Thermal Ablation of Malignant Liver Tumors: Technical Insights, Clinical Evidence, and Future Outlook
  Iwan Paolucci, Jessica Albuquerque Marques Silva, Yuan-Mao Lin, Alexander Shieh, Anna Maria Ierardi, Gianpaolo Caraffiello, Carlo Gazzera, Kyle A. Jones, Paolo Fonio, Reto Bale, Kristy K. Brock, Marco Calandri, Bruno C. Odisio
  Radiology: Imaging Cancer.2025;[Epub]     CrossRef
• Long‐Term Survival and Prognostic Factors of Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Hepatocellular Carcinoma
  Hoang Dong Duc, Mai Binh Thanh, Mai Bang Hong, Nguyen Thinh Tien, Nguyen Thai Van, Bui Bieu Quang, Nguyen Chau Dinh, Thai Ky Doan
  Cancer Reports.2025;[Epub]     CrossRef
• Association between early job loss and prognosis among hepatocellular carcinoma survivors
  B Yun, J Oh, S H Ahn, B K Kim, J-H Yoon
  Occupational Medicine.2025; 75(2): 113.     CrossRef
• Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report
  Tho Tran Dinh, Sy Than Van, Vinh Chu Van, Phuc Chu Minh
  Cureus.2025;[Epub]     CrossRef
• Imaging-based diagnosis of hepatocellular carcinoma: Liver Imaging Reporting and Data System and beyond
  Maryam Haghshomar, Andrea S Kierans, Laura Kulik, Frank H Miller, Amir A Borhani
  British Journal of Radiology.2025; 98(1173): 1344.     CrossRef
• Tumor size larger than 6.5 cm and microvascular invasion are comparable prognosticators for hepatocellular carcinoma: a multi-institutional observational study
  Hsing-Yu Chen, Hsin-I Tsai, Ming-Chin Yu, Wei-Chen Lee, Chih-Chi Wang, Jason Chia-Hsun Hsieh, Chiao-En Wu, Po-Ting Lin, Bo-Huan Chen, Sheng-Fu Wang, Chao-Wei Lee
  Clinical and Translational Oncology.2025; 28(1): 215.     CrossRef
• Outcome of hepatic resection for HCC in ideal and non-ideal candidates
  Lorenzo Lani, Laura Bucci, Valentina Santi, Benedetta Stefanini, Bernardo Stefanini, Angelo Sangiovanni, Sara Grasselli, Giorgia Ghittoni, Carlo Saitta, Filomena Morisco, Giuseppe Cabibbo, Fabio Marra, Gianpaolo Vidili, Maurizia Rossana Brunetto, Francesc
  Hepatology Communications.2025;[Epub]     CrossRef
• The construction and evaluation of a prognostic risk score model for HCC based on MPT-related lncRNAs
  Zerun Lin, Jianda Yu, Zhijian Chen, Jingyi Chen, Xiaobin Chi, Honghuan Lin, Yongbiao Chen
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Serum Level of Glypican-3 in Patients with Hepatocellular Carcinoma and Advanced Chronic Liver Disease: A Pilot Study
  Irina Ivanova, Sonya Banova-Chakyrova, Pavlina Boykova-Vylcheva, Yana Bocheva
  Livers.2025; 5(3): 36.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Annals of Surgical Treatment and Research.2025; 109(3): 123.     CrossRef
• Machine Learning–Based Selection of Resection vs Transplant and Survival in Hepatocellular Carcinoma
  Hyun Uk Kim, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Ho Joong Choi, Young Kyoung You
  JAMA Network Open.2025; 8(9): e2532353.     CrossRef
• Public health strategies for hepatocellular carcinoma: from risk factors to prevention and control
  Mei-Hsuan Lee
  Journal of Liver Cancer.2025; 25(2): 204.     CrossRef
• Hepatocellular carcinoma: Epidemiology, diagnosis and treatment
  Ezequiel Mauro, Tiago de Castro, Marcus Zeitlhoefler, Max W. Sung, Augusto Villanueva, Vincenzo Mazzaferro, Josep M. Llovet
  JHEP Reports.2025; 7(12): 101571.     CrossRef
• A Patient Charter to Improve Care for Hepatocellular Carcinoma
  Yasmine Hassan, Achim Kautz, Cary James, Dee Lee, Diane Langenbacher, Eric Bouffet, Jade Chakowa, Jessica Hicks, John Ward, Lili Kuschnereit, Manon Allaire, Tingting Zhang, Zeena Huang Chi
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 1849.     CrossRef
• Prognostic Role of Short-Chain Fatty Acid-Producing Gut Microbiota and Gut Microbial Dynamics in Patients with Hepatocellular Carcinoma Receiving Chemoembolization: A Prospective Study
  Jiwon Yang, Jihye Lim, Eun Hye Kim, Jihyun An, Danbi Lee, Han Chu Lee, Jin-Yong Jeong, Ju Hyun Shim
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 1991.     CrossRef
• Immune Checkpoint Inhibitor Use in Advanced Hepatocellular Carcinoma: A Real-World Analysis of Efficacy and Toxicity
  Fode Tounkara, Deepak Sherpally, Khalid Mumtaz, Mina S. Makary, Russell F. Palm, Ashish Manne
  Cancers.2025; 17(18): 3034.     CrossRef
• Impact of Add‐On Hepatobiliary Abbreviated Magnetic Resonance Imaging on Ultrasound Hepatoma Surveillance for Liver Cirrhosis‐ a Randomized Study
  Jing‐Houng Wang, Hsin‐You Ou, Yi‐Hao Yen, Chao‐Hung Hung, Sheng‐Nan Lu
  The Kaohsiung Journal of Medical Sciences.2025;[Epub]     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Journal of Liver Cancer.2025; 25(2): 140.     CrossRef
• GALAD score accuracy in detection of hepatocellular carcinoma in cirrhotic patients: a single-center study
  Mina Tharwat, Yosra Yosry, Islam Nakeeb, Sahar Hassany
  The Egyptian Journal of Internal Medicine.2025;[Epub]     CrossRef
• Dynamic Muscle Atrophy Predicts Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Lenvatinib: A Retrospective Study in Taiwan
  Hsing-Yun Lee, Ching-Di Chang, Yen-Hao Chen, Ming-Chao Tsai, Jing-Houng Wang, Sheng-Nan Lu, Tsung-Hui Hu, Chao-Hung Hung, Chien-Hung Chen, Yuan-Hung Kuo
  Gut and Liver.2025; 19(6): 878.     CrossRef
• Decoding the epigenetic landscape: ctDNA methylation as a game-changer in hepatocellular carcinoma management
  Dexin Yang, Yueru Yao, Fenfang Gui, Wuxuan Mei, Changchun Zeng
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2025; 1880(6): 189497.     CrossRef
• Investigating Alternative Treatment Options Unfeasible for Local Ablation Therapy in Patients with Small Solitary Hepatocellular Carcinomas
  Chang Hun Lee, In Hee Kim
  Gut and Liver.2024; 18(1): 5.     CrossRef
• RNA 5-methylcytosine writer NSUN5 promotes hepatocellular carcinoma cell proliferation via a ZBED3-dependent mechanism
  Xinyu Gu, Penghui Li, Xiaohui Gao, Yi Ru, Chen Xue, Shujun Zhang, Yafeng Liu, Xinjun Hu
  Oncogene.2024; 43(9): 624.     CrossRef
• Letter regarding “Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study”
  Jongman Kim
  Journal of Liver Cancer.2024; 24(1): 3.     CrossRef
• Liver cancer surveillance in people with hepatitis B in Africa
  Dennis A Ndububa
  The Lancet Gastroenterology & Hepatology.2024; 9(6): 491.     CrossRef
• SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea
  Hyo Jung Cho, Eunyoung Lee, Soon Sun Kim, Jae Youn Cheong
  Scientific Reports.2024;[Epub]     CrossRef
• Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC
  Jong Geun Park, Pu Reun Roh, Min Woo Kang, Sung Woo Cho, Suhyun Hwangbo, Hae Deok Jung, Hyun Uk Kim, Ji Hoon Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Young Kyoung You, Ho Joong Choi, Jae Yong Ryu, Pil Soo Sung
  Hepatology.2024; 80(5): 1074.     CrossRef
• Current perspectives of viral hepatitis
  Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou,
  World Journal of Gastroenterology.2024; 30(18): 2402.     CrossRef
• Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
  Yuri Cho, Bo Hyun Kim, Young-Suk Lim
  Digestive Disease Interventions.2024; 08(03): 169.     CrossRef
• Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma
  Jing Wang, Wenyue Gao, Hongbo Yu, Yuting Xu, Changchuan Bai, Qingwei Cong, Ying Zhu
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1143.     CrossRef
• Establishment of nomogram prediction model of contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for vessels encapsulating tumor clusters pattern of hepatocellular carcinoma
  Feiqian Wang, Kazushi Numata, Akihiro Funaoka, Xi Liu, Takafumi Kumamoto, Kazuhisa Takeda, Makoto Chuma, Akito Nozaki, Litao Ruan, Shin Maeda
  BioScience Trends.2024; 18(3): 277.     CrossRef
• Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
  Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235.     CrossRef
• Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma
  Ji Yeon Lee, Pil Soo Sung
  Gut and Liver.2024; 18(4): 558.     CrossRef
• Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
  Lung-Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, Kuo Chao Yew, Nobuharu Tamaki, Ruveena Bhavani Rajaram, Mara Teresa Panlilio, Rashid Lui, Hye Won Lee, Jimmy Che-To Lai, Anand V. Kulkarni, Madhumita Premkumar, Cosmas Rinaldi Adithya Lesmana, Yao Chun Hsu,
  Nature Reviews Gastroenterology & Hepatology.2024; 21(12): 834.     CrossRef
• Liver resection and transplantation in the era of checkpoint inhibitors
  Parissa Tabrizian, Rebecca Marino, Pierce K.H. Chow
  JHEP Reports.2024; 6(11): 101181.     CrossRef
• Global epidemiology of liver cancer 2022: An emphasis on geographic disparities
  Qianru Li, Chao Ding, Maomao Cao, Fan Yang, Xinxin Yan, Siyi He, Mengdi Cao, Shaoli Zhang, Yi Teng, Nuopei Tan, Jiachen Wang, Changfa Xia, Wanqing Chen
  Chinese Medical Journal.2024; 137(19): 2334.     CrossRef
• Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
  Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
  PLOS ONE.2024; 19(8): e0307712.     CrossRef
• Heavy smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment
  Jaejun Lee, Jong Young Choi, Soon Kyu Lee
  Journal of Liver Cancer.2024; 24(2): 253.     CrossRef
• A Nomogram Based on Features of Ultrasonography and Contrast-Enhanced CT to Predict Vessels Encapsulating Tumor Clusters Pattern of Hepatocellular Carcinoma
  Litao Ruan, Jingtong Yu, Xingqi Lu, Kazushi Numata, Dong Zhang, Xi Liu, Xiaojing Li, Mingwei Zhang, Feiqian Wang
  Ultrasound in Medicine & Biology.2024; 50(12): 1919.     CrossRef
• Prediction of PD-L1 expression in unresectable hepatocellular carcinoma with gadoxetic acid-enhanced MRI
  Jun Gu Kang, Kyunghwa Han, Taek Chung, Hyungjin Rhee
  European Journal of Radiology.2024; 181: 111772.     CrossRef
• Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma
  Wilhelm den Toom, Eva M. Negenman, Francois E.J.A. Willemssen, Erik van Werkhoven, Robert J. Porte, Roeland F. de Wilde, Dave Sprengers, Imogeen E. Antonisse, Ben J.M. Heijmen, Alejandra Méndez Romero
  Clinical and Translational Radiation Oncology.2024; 49: 100878.     CrossRef
• Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein throm
  Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon
  Clinical and Molecular Hepatology.2024; 30(4): 659.     CrossRef
• Combined Bone Mineral Density (BMD) and Monocyte-to-Lymphocyte Ratio (MLR) Predicts Recurrence and Prognosis in Hepatocellular Carcinoma Patients Following Liver Resection
  Ze-Jiao He, Tao Hu, Zi-Shu Zhang, Tian-Cheng Wang, Wei Huang
  Risk Management and Healthcare Policy.2024; Volume 17: 2741.     CrossRef
• Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances
  Gavin Wu, Nojan Bajestani, Nooruddin Pracha, Cindy Chen, Mina S. Makary
  Cancers.2024; 16(23): 3933.     CrossRef
• Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance
  Ali Gawi Ermi, Devanand Sarkar
  Cancers.2024; 16(23): 3944.     CrossRef
• Primary treatments for solitary hepatocellular carcinoma ≤ 3 cm: A systematic review and network meta-analysis
  Sang-Hoon Kim, Ki-Hun Kim, Byeong-Gon Na, Sung Min Kim, Rak-Kyun Oh
  Annals of Hepato-Biliary-Pancreatic Surgery.2024; 28(4): 397.     CrossRef
• TEAD2 Promotes Hepatocellular Carcinoma Development and Sorafenib Resistance via TAK1 Transcriptional Activation
  Yahui Zhang, Yidan Ren, Guoying Dong, Qinlian Jiao, Nan Guo, Ping Gao, Ya Li, Yunshan Wang, Wei Zhao
  Molecular Cancer Research.2024; 22(12): 1102.     CrossRef
• Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MRI improves diagnosis and efficacy evaluation of early-stage hepatocellular carcinoma
  Ya-Yun Wang
  American Journal of Cancer Research.2024; 14(10): 4855.     CrossRef
• Advances in systemic therapy leading to conversion surgery for advanced hepatocellular carcinoma
  Hiroyuki Hakoda, Akihiko Ichida, Kiyoshi Hasegawa
  BioScience Trends.2024; 18(6): 525.     CrossRef
• Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
  Roberto Iezzi, Alessandro Posa, Andrea Contegiacomo, In Joon Lee, Reto Bale, Alessandro Tanzilli, Lorenzo Tenore, Felice Giuliante, Antonio Gasbarrini, Shraga Nahum Goldberg, Tobias Jakobs, Maurizio Pompili, Irene Bargellini, Evis Sala, Hyo-Cheol Kim
  Cancers.2023; 15(15): 3988.     CrossRef
• A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
  Yun Bin Lee, Joon Yeul Nam, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Hyo-Cheol Kim, Jin Chul Paeng, Jung-Hwan Yoon, Yoon Jun Kim
  Clinical Cancer Research.2023; 29(18): 3650.     CrossRef
• Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
  Hyo-Cheol Kim
  Clinical and Molecular Hepatology.2023; 29(4): 984.     CrossRef
• The efficacy of treatment for hepatocellular carcinoma in elderly patients
  Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
  Journal of Liver Cancer.2023; 23(2): 362.     CrossRef
• Multiomics characterization of fatty acid metabolism for the clinical management of hepatocellular carcinoma
  Xin Huang, Benzhe Su, Mengjun Li, Yang Zhou, Xinyu He
  Scientific Reports.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Neutrophil count predicts the complete response after transarterial chemoembolization related to favorable outcome in hepatocellular carcinoma
  Young Mi Hong
  European Journal of Gastroenterology & Hepatology.2025; 37(1): 94.     CrossRef
• Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
  Yuqi Feng, Letian Fang, Guangwen Cao
  Hepatoma Research.2025;[Epub]     CrossRef
• A Prospective, Multicenter, Randomized, Noninferiority Trial of Stopad® Versus Tachosil® for Hemostasis After Liver Resection
  Seung Yeon Lim, Gi Hong Choi, Jin Hong Lim, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, Yeshong Park, MeeYoung Kang, Jinju Kim, Hyelim Joo, Jai Young Cho
  Cancers.2025; 17(5): 757.     CrossRef
• Reply: Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of hepatocellular carcinoma
  Deok Hwa Seo, Pil Soo Sung
  Hepatology.2025; 81(4): E123.     CrossRef
• The Association Between Hepatocellular Carcinoma and Gastrointestinal Adenocarcinoma: Is This a New Syndrome in Patients With Cirrhosis? A Case Series
  Fabrizio Bronte, Fabio D'Amato, Maria Rosa Barcellona, Giuseppe Bronte, Giuseppe Malizia, Salvatore Ialuna, Giorgio Fusco, Francesco Verderame, Enrico Bronte, Maria Grazia Bavetta
  Cancer Reports.2025;[Epub]     CrossRef
• Roadmap for HCC Surveillance and Management in the Asia Pacific
  Masatoshi Kudo, Bui Thi Oanh, Chien-Jen Chen, Do Thi Ngat, Jacob George, Do Young Kim, Luckxawan Pimsawadi, Pisit Tangkijvanich, Raoh-Fang Pwu, Rosmawati Mohamed, Sakarn Bunnag, Sheng-Nan Lu, Sirintip Kudtiyakarn, Tatsuya Kanto, Teerha Piratvisuth, Chao-C
  Cancers.2025; 17(12): 1928.     CrossRef
• TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects
  Wanting Zeng, Wei Zhu, Guosheng Yuan, Jinzhang Chen, Zhanhui Wang, Jinlin Hou, De-Ke Jiang
  Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
• Development and validation of a risk prediction model for patients with hepatocellular carcinoma receiving atezolizumab–bevacizumab
  Heechul Nam, Dong Yun Kim, Do Young Kim, Ji Hoon Kim, Chang Wook Kim, Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Soon Kyu Lee, Jung Hyun Kwon, Soon Woo Nam, Ahlim Lee, Do Seon Song, U Im Chang,
  Hepatology.2025;[Epub]     CrossRef
• Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab
  Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Ji Hoon Kim, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Myeong Jun Song, Soon Woo
  Clinical Cancer Research.2025; 31(20): 4323.     CrossRef
• Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis
  Jihoon Kim, Jin-Hyoung Kim, Byung Soo Im, Gun Ha Kim, Hee Ho Chu, Dong Il Gwon, Ji Hoon Shin, Ju Hyun Shim, Sang Min Yoon, Sehee Kim
  Cancers.2025; 18(1): 33.     CrossRef
• The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
  Beom Kyung Kim
  Gut and Liver.2024; 18(1): 3.     CrossRef
• Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
  Josep M. Llovet, Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron Schwartz, Eli Pikarsky, Masatoshi Kudo, Richard S. Finn
  Nature Reviews Clinical Oncology.2024; 21(4): 294.     CrossRef
• High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study
  Jun Sik Yoon, Ji Hoon Hong, Soo Young Park, Seung Up Kim, Hwi Young Kim, Ju Yeon Kim, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Han Ah Lee, Gi‐Ae Kim, Dong Hyun Sinn, Sung Jae Park, Youn Jae Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Jeong‐Hoon Lee
  Alimentary Pharmacology & Therapeutics.2024; 59(8): 973.     CrossRef
• Role of reimbursement and Physicians' awareness in the survival of sorafenib‐eligible advanced hepatocellular carcinoma patients
  Hui‐Ling Huang, Te‐Sheng Chang, Lariza Marie Canseco, Fan Wu, Sheng‐Nan Lu
  The Kaohsiung Journal of Medical Sciences.2024; 40(6): 589.     CrossRef
• Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
  Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235.     CrossRef
• Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
  Mi Na Kim, Beom Kyung Kim, Heejin Cho, Myung Ji Goh, Yun Ho Roh, Su Jong Yu, Dong Hyun Sinn, Soo Young Park, Seung Up Kim, Tyng-Yuan Jang
  PLOS ONE.2024; 19(8): e0307712.     CrossRef
• The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases
  Beom Kyung Kim
  Journal of Liver Cancer.2024; 24(2): 129.     CrossRef
• Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
  Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi
  Journal of Liver Cancer.2024; 24(2): 243.     CrossRef
• Primary treatments for solitary hepatocellular carcinoma ≤ 3 cm: A systematic review and network meta-analysis
  Sang-Hoon Kim, Ki-Hun Kim, Byeong-Gon Na, Sung Min Kim, Rak-Kyun Oh
  Annals of Hepato-Biliary-Pancreatic Surgery.2024; 28(4): 397.     CrossRef
• Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
  Yeshong Park, Ho-Seong Han, Seung Yeon Lim, Hyelim Joo, Jinju Kim, MeeYoung Kang, Boram Lee, Hae Won Lee, Yoo-Seok Yoon, Jai Young Cho
  Medicina.2024; 61(1): 12.     CrossRef
• A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
  Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, Hae Lim Lee, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U Im Chang, Jin Mo Yang, Soon Woo Nam, Seok-Hwan Kim, Myeong Jun Song, Ji Hoon Kim, Ahlim Lee, Hyun Yang, Si Hyun Bae, Ji Won Han, Heechul Nam, Pil Soo Su
  Cancers.2023; 15(17): 4423.     CrossRef
• What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
  Min Kyung Park, Yoon Jun Kim
  Clinical and Molecular Hepatology.2023; 29(2): 332.     CrossRef
• The current trends in the health burden of primary liver cancer across the globe
  Peter Konyn, Aijaz Ahmed, Donghee Kim
  Clinical and Molecular Hepatology.2023; 29(2): 358.     CrossRef
• Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
  Do Young Kim
  Clinical and Molecular Hepatology.2023; 29(2): 335.     CrossRef
• A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
  Yun Bin Lee, Joon Yeul Nam, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Hyo-Cheol Kim, Jin Chul Paeng, Jung-Hwan Yoon, Yoon Jun Kim
  Clinical Cancer Research.2023; 29(18): 3650.     CrossRef
• Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
  Yasunori Minami, Tomoko Aoki, Satoru Hagiwara, Masatoshi Kudo
  Cancers.2023; 15(19): 4763.     CrossRef

Citations

Citations to this article as recorded by  

• Prediction model of liver function through facial images using deep learning for liver cancer patients
  Ai-xian Zhang, Yang Yang, Bo Yang, Qing-lun Gao, Yu-xuan Wang, Di Jing, Han Li, Jia-rui Chen, Li-zhao Yu, Yan-peng Li, Tao Zeng, Bo-yuan Liu, Shuo Zhao, Xue-ling Zu, Xiu-ping Zhang, Zhen Lei, Ming-gen Hu
  Biomedical Signal Processing and Control.2026; 113: 108965.     CrossRef
• Molecular and cellular secrets revealed: How umbilical cord-derived mesenchymal stem cells can target hepatocellular carcinoma
  Mohammad Sadegh Izadi, Reza Arefnezhad, Amirmasoud Asadi, Aryan Rezaee, Leila Kalantari, Farzad Nasrpour Tahouneh, Mohammad Mehdi Shadravan, Seyyed Taher Seyyed Mahmoudi, Zahra GhaniBeygi, Fatemeh Rostamnezhad, Armin Razman, Fardad Ejtehadi, Fatemeh Rezae
  Tissue and Cell.2026; 98: 103200.     CrossRef
• Development and validation of machine learning-based model for predicting early recurrence for patients with HBV-associated hepatocellular carcinoma after curative hepatectomy
  Zi-Chen Yu, Zhe-Jin Shi, Zheng-Kang Fang, Si-Yu Liu, Yang Yu, Kai-Di Wang, Dong-Sheng Huang, Guo-Liang Shen, Cheng-Wu Zhang, Lei Liang
  The American Journal of Surgery.2026; 251: 116716.     CrossRef
• Comparison of repeat hepatectomy with radiofrequency ablation for the survival of hepatocellular carcinoma with solitary intrahepatic recurrence after hepatectomy
  Jialu Fu, Jiafeng Chen, Lei Jin, Junfeng Huang, Shengwei Mao, Xuhui Zhao, Weifeng Qu, Rui Yang, Yi Wang, Yichao Bu, Zhiqi Guan, Jun Gao, Xiaoling Wu, Qianfu Zhao, Tianhao Chu, Guiqi Zhu, Yuan Fang, Yinghong Shi, Weiren Liu
  Clinics and Research in Hepatology and Gastroenterology.2026; 50(2): 102750.     CrossRef
• Arterial-Washout Temporal Profiling in CEUS LI-RADS: A Diagnostic Algorithm for Reducing Hepatocellular Carcinoma Misclassification
  Yang Wang, Zhixian Zhu, Mengjiao Zhu, Size Wu
  Radiology: Imaging Cancer.2026;[Epub]     CrossRef
• Synergistic Strategies in Systemic Therapy for Advanced Hepatocellular Carcinoma
  Yongxin Yu, Yulang Jiang, Yipeng Yang, Christian Glandorff, Wenzheng Fang, Mingyu Sun
  Global Challenges.2026;[Epub]     CrossRef
• Comprehensive Bioinformatics Analysis and Machine Learning of TTK as a Transhepatic Arterial Chemoembolization Resistance Target in Hepatocellular Carcinoma
  Yangyang Xiao, Youwen Hu
  Molecular Biotechnology.2025; 67(7): 2720.     CrossRef
• Triterpenes from Ganoderma lucidum inhibit hepatocellular carcinoma by regulating enhancer-associated lncRNA in vivo
  Ruolin Zhao, Caiyun Zhang, Chenchen Tang, Xinxin Wu, Sheng Hu, Qingqiong Luo, Ning Jia, Lingzhi Fan, Yixing Wang, Wencheng Jiang, Qilong Chen
  Journal of Ethnopharmacology.2025; 336: 118706.     CrossRef
• Multi‐stage automatic and rapid ablation and needle trajectory planning method for CT‐guided percutaneous liver tumor ablation
  Shengwei Li, Fanyu Zhou, Yumeng Zhang, Sheng Xu, Yufeng Wang, Lin Cheng, Zhixin Bie, Bin Li, Xiao‐Guang Li
  Medical Physics.2025; 52(1): 113.     CrossRef
• Xiaoai Jiedu recipe reduces cell survival and induces apoptosis in hepatocellular carcinoma by stimulating autophagy via the AKT/mTOR pathway
  Yi Ji, Li Li, Wenting Li, Liu Li, Yanxia Ma, Qingfeng Li, Xi Chen, Wenyue Zhao, Hengzhou Zhu, Jiege Huo, Mianhua Wu
  Journal of Ethnopharmacology.2025; 339: 119135.     CrossRef
• AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
  Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
  Journal of Hepatology.2025; 82(6): 1080.     CrossRef
• Advancements in locoregional therapy for advanced hepatocellular carcinoma: Emerging perspectives on combined treatment strategies
  Qi Liu, Renjie Zhang, Weixi Shen
  European Journal of Surgical Oncology.2025; 51(2): 109502.     CrossRef
• Efficiency and safety of HAIC combined with lenvatinib and tislelizumab for advanced hepatocellular carcinoma with high tumor burden: a multicenter propensity score matching analysis
  Zhonghua Zhao, Xiongying Jiang, Shiping Wen, Yanzhang Hao
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Juglone induces ferroptotic effect on hepatocellular carcinoma and pan-cancer via the FOSL1-HMOX1 axis
  Chuyu Wang, Ying Zhao, Yingfei Peng, Wei Chen, Jie Zhu, Chenzheng Gu, Ran Huo, Lin Ding, Yu Liu, Te Liu, Chunyan Zhang, Wenjing Yang, Hao Wang, Wei Guo, Beili Wang
  Phytomedicine.2025; 139: 156417.     CrossRef
• PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
  Zhaoqian He, Hua Chen, Chen Liang, Xiang Tang, Lingmin Jiang, Feihu Xie, Qi Liu, Yun Zheng
  ImmunoTargets and Therapy.2025; Volume 14: 51.     CrossRef
• Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
  Mario Romeo, Marcello Dallio, Carmine Napolitano, Claudio Basile, Fiammetta Di Nardo, Paolo Vaia, Patrizia Iodice, Alessandro Federico
  Diagnostics.2025; 15(3): 252.     CrossRef
• Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
  Yuqi Feng, Letian Fang, Guangwen Cao
  Hepatoma Research.2025;[Epub]     CrossRef
• The XIAP inhibitor AZD5582 improves the treatment effect of microwave ablation on hepatocellular carcinoma
  Wenhui Wang, Fuyuan Wu, Zhe Wu, Mengfan Zhang, Qiang Lu
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Urgent need for education on hepatocellular carcinoma surveillance among high-risk population in China
  Lei Cai, Chao Li, Li-Yang Sun, Yong-Kang Diao, Ming-Da Wang, Tian Yang
  Clinical and Molecular Hepatology.2025; 31(1): e39.     CrossRef
• Single-cell transcriptomic analysis reveals efferocytosis signature predicting immunotherapy response in hepatocellular carcinoma
  Longhu Li, Guangyao Li, Wangfeng Zhai
  Digestive and Liver Disease.2025; 57(5): 1061.     CrossRef
• Machine Learning Prognostic Model for Post-Radical Resection Hepatocellular Carcinoma in Hepatitis B Patients
  Dalong Zhu, Alimu Tulahong, Abuduhaiwaier Abuduhelili, Chang Liu, Ayinuer Aierken, Yanze Lin, Tiemin Jiang, Renyong Lin, Yingmei Shao, Tuerganaili Aji
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 353.     CrossRef
• BAIAP2L2 facilitates hepatocellular carcinoma progression and immune evasion of via targeting JAK1-mediated pathway and PD-L1 expression
  Zhiyue Xie, Yanxia Wu, Nan Peng, Jing Wang, Hui Wang, Liang Zhao
  Cancer Gene Therapy.2025; 32(4): 464.     CrossRef
• Development and validation of an interpretable machine learning model for predicting the risk of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study
  Linghong Wu, Zengjing Liu, Hongyuan Huang, Dongmei Pan, Cuiping Fu, Yao Lu, Min Zhou, Kaiyong Huang, TianRen Huang, Li Yang
  BMC Gastroenterology.2025;[Epub]     CrossRef
• Case Report: Successful immune checkpoint inhibitor rechallenge after sintilimab-induced Guillain-Barré syndrome
  Lin Ye, Wan Rong Yue, Hao Shi, Jian Ren Li, Yu Ya Qun
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Microalgae-based biodegradable embolic agent for the treatment of hepatocellular carcinoma through transarterial embolization
  Kaiyue Wang, Danni Zhong, Lingxiao Yang, Cheng Zeng, Qitao Hu, Min Zhou, Zhe Tang
  Journal of Nanobiotechnology.2025;[Epub]     CrossRef
• Case Report: Posterior reversible encephalopathy syndrome after lenvatinib treatment for hepatocellular carcinoma
  Minchun Chen, Jing Shen, Rongrong Jia, Mingze Chang, Jingyi Zhang, Jie Zheng, Runqing Xue, Lulu Guo, Kangkang Yan
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• AEBP1 inhibition reduces cell growth and PI3K/AKT pathway while less regulates cell mobility in hepatocellular carcinoma
  Liyou Liu, Qingshan Cai, Dongyang Wu, Shudong Li, Dong Liu, Jianxing Zheng
  World Journal of Surgical Oncology.2025;[Epub]     CrossRef
• PD-1 inhibitors improve the efficacy of transcatheter arterial chemoembolization combined with apatinib in advanced hepatocellular carcinoma: a meta-analysis and trial sequential analysis
  Jiahui Yu, Jinxin Yu, Yimiao Chen, Yuting Yang, Pengsheng Yi
  BMC Cancer.2025;[Epub]     CrossRef
• Preparation and Evaluation of Hepatoma-Targeting Glycyrrhetinic Acid Composite Micelles Loaded with Curcumin
  Xueli Guo, Zhongyan Liu, Lina Wu, Pan Guo
  Pharmaceuticals.2025; 18(4): 448.     CrossRef
• BEND3 promotes hepatocellular carcinoma progression and metastasis by activating the PI3K/AKT/mTOR pathway and inducing epithelial-mesenchymal transition
  Liu-Lin Yang, Xing Chen, Kai-Ting Huang, Shao-Tong Tang, Gui-Yan Ye, Ji-Long Wang
  Clinics and Research in Hepatology and Gastroenterology.2025; 49(5): 102582.     CrossRef
• Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10
  Zhiwei Li, Chun Zhang, Guixiang Huang, Zixin Zhang, Qinghao Wang, Xiran Liu, Yanling Qin, Hao Zhou, Anyi Hou, Jun He, Limin Li, Xiang Hu, Xiaofeng Ding
  Cell Death & Disease.2025;[Epub]     CrossRef
• Prognostic nutritional index predicts survival in intermediate and advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with PD-(L)1 inhibitors and molecular targeted therapies
  Hao-Huan Tang, Ming-Qing Zhang, Zi-Chen Zhang, Chen Fan, Shu-Shu Li, Wei Chen, Wei-Dong Wang
  BMC Cancer.2025;[Epub]     CrossRef
• METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery
  Xie Weng, Yangyue Huang, Zhuoya Fu, Xingli Liu, Fuli Xie, Jiale Wang, Qiaohua Zhu, Dayong Zheng
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Building a Predictive Model for the Hemodynamic Effects of Regorafenib on Portal Vein in Patients with Advanced Hepatocellular Carcinoma Based on Machine Learning Algorithms
  建阁 曾
  Advances in Clinical Medicine.2025; 15(04): 3130.     CrossRef
• The application progress of PAMAM dendrimer in cancer imaging and treatment
  Cong-Ying Zhang, Kai Gu, Meng-Yi Chi, Xiao-Yan Gao, Ling Gao, Nan-Nan Zhang, Yu-Xi Liu, Tian-Zhu Li
  Journal of Biomaterials Science, Polymer Edition.2025; 36(11): 1638.     CrossRef
• Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)
  Wei Gao, Zhao-Long Pan, Xiao-Hui Zhao, Lu Yang, Jun-Bo Cao, Dong-Yang Li, Hai-Jing Zheng, Chen Liu, Guang-Tao Li, Xu Bao, Xiao-Meng Liu, Wei-Hao Zhang, Xiao-Lin Zhu, Bo-Han Xiao, Tian-Qiang Song, Qiang Li, Wei Lu, Wen-Ge Xing, Wei Zhang
  eClinicalMedicine.2025; 83: 103217.     CrossRef
• Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular carcinoma: a Systematic Review and meta-analysis
  Dongdong Wu, Ning Liu, Hao Dong, Kan Zhou, Lei Du, Ying Li, Yanjun Chao, Fuping Ma
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Sex disparities in hepatocellular carcinoma immunotherapy: hormonal and genetic influences on treatment efficacy
  Lei Song, Liyan Sun, Yuning Ren, Xiaodan Wang, Lei Xian
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Bibliometric analysis of hepatocellular carcinoma and tyrosine kinase inhibitors
  Wurihan Wu, Hejun Mao, Jian Song, Fan Yang
  Medicine.2025; 104(20): e42015.     CrossRef
• Clinical significance of cyclin‑dependent kinase inhibitor 3 in hepatocellular carcinoma
  Xing Liu, Kaiyuan Chang, Jian Liu
  Molecular and Clinical Oncology.2025; 23(1): 1.     CrossRef
• Indian National Association for the Study of the Liver Position Statements on Prevention, Diagnosis, and Management of Hepatitis B Virus Infection in India
  Anil Arora, Praveen Sharma, Radha K. Dhiman, Ajay Duseja, Vivek A. Saraswat, V.G. Mohan Prasad, Shiv K. Sarin, Subrat K. Acharya, Shivaram P. Singh, Padaki N. Rao, Ramesh R. Rai, Anil C. Anand, Manisha Dwivedi, S.P. Misra, Ashish Goel, Ashish Kumar, Satye
  Journal of Clinical and Experimental Hepatology.2025; 15(6): 102608.     CrossRef
• A non-invasive nomogram for the prediction of poor prognosis of hepatocellular carcinoma based on the novel marker Interleukin-41
  Zihan Mu, Jiaojiao Su, Jiuhua Yi, Rui Fan, Jiayuan Yin, Yazhao Li, Bowen Yao
  BMC Cancer.2025;[Epub]     CrossRef
• The microbiological features and risk factors for liver abscess after thermal ablation of liver cancer
  Xiurong Ding, Yanhua Yu, Ming Chen, Yanfang Kang, Jinli Lou
  Frontiers in Cellular and Infection Microbiology.2025;[Epub]     CrossRef
• Evaluation of the efficacy of laparoscopic hepatolobectomy for primary liver cancer with early combined enteral and parenteral nutritional support
  Zhouxia Wei, Yingxian Li, Suyan Jiang
  Discover Oncology.2025;[Epub]     CrossRef
• TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects
  Wanting Zeng, Wei Zhu, Guosheng Yuan, Jinzhang Chen, Zhanhui Wang, Jinlin Hou, De-Ke Jiang
  Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
• Prediction of the effect of Bupleurum chinensis DC. (Chaihu) on survival and its potential targets in hepatocellular carcinoma based on a prognostic model
  Hanhan Li, Shan Liu, Shang Xiang, Wei Guo, Jiayang Huang, Ling Yu, Zhuangzhong Chen, Yuan lin, Lizhu Lin, Hanrui Chen
  BMC Complementary Medicine and Therapies.2025;[Epub]     CrossRef
• Evaluating serum extra spindle pole bodies-like 1 protein vs p53 antibody for hepatitis B virus-related hepatocellular carcinoma diagnosis
  Yan-Fei Feng, Hui-Kun Zhou, Bo-Bin Hu, Hang Wang, Heng-Kai Liang, Lu Wei, Qing-Mei Li, Tu-Mei Su, Qian-Bing Yin, Ming-Hua Su, Jian-Ning Jiang
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Knowledge, attitudes, and practices of liver cancer screening among high-risk populations in China
  Ge-hui Feng, Min Liu, Yun-shan Chen, Yi-fei Wang, Ke-hao Zhao, Mao-ting Huang, Wen-ting Yi, Ling Zhao, Ying Zeng
  BMC Public Health.2025;[Epub]     CrossRef
• The diagnostic value of midkine as a novel serum biomarker in alpha-fetoprotein-negative hepatocellular carcinoma
  Liuyi Lu, Chunling Zhu, Liling Yi, Siting Li, Mengli Fan, Jiayao Lin, Qiliu Peng
  The International Journal of Biological Markers.2025; 40(3): 166.     CrossRef
• Hepatic artery infusion chemotherapy combined with lenvatinib and PD‑1 inhibitors in the treatment of intermediate and advanced unresectable hepatocellular carcinoma
  Peng Jiang, Fengfeng Li, Zhenyu Jiang, Yiling Sun, Fan Yang, Lisha Chu, Ya Gai, Hongjian Wang
  Oncology Letters.2025; 30(3): 1.     CrossRef
• Comparing neoadjuvant targeted therapy plus transarterial chemoembolization versus triple therapy including immunotherapy in hepatocellular carcinoma: a Chinese multicentre study
  Hao Yu, Quan Yuan, Rui Yu, Rongjie Ye, Shuqi Yang, Ming Niu, Yunyun Sun, Jingpeng Ke, Liuxing Feng, Ping Guo, Yujian Liu, Jingrui Yang, Zaifa Hong, Taozhu Ye, Weixiang Ni, Xin Wang, Zhenhao Xie, Jiahuan Xu, Chuncheng Lin, Lizhi Lv, Shuangjia Wang, Chao Zh
  Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
• EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell lines
  Bin Xu, Xiangnan Liang, Wuguang Liu, BaiTong Wu, Qiuxiang Wang, Gong Kai, Chun Han, Binwen Sun, Bing Dong, Chengyong Dong, Liming Wang
  Hereditas.2025;[Epub]     CrossRef
• A technological convergence in hepatobiliary oncology: Evolving roles of smart surgical systems
  Xuanci Bai, Runze Huang, Qinyu Liu, Xin Jin, Lu Wang, Wei Tang, Kenji Karako, Weiping Zhu
  BioScience Trends.2025; 19(4): 410.     CrossRef
• Heterogeneity in prognosis for early-stage hepatocellular carcinoma after hepatectomy: A multicenter analysis of 4,623 patients across five major staging systems
  Lan-Qing Yao, Hui-Xuan Fan, Fu-Jie Chen, Yu-Chen Li, Alfred Wei Chieh Kow, Yi-Fan Li, Ying-Jian Liang, Zi-Qiang Li, Yong-Yi Zeng, Qi-Xuan Zheng, Hong Wang, Ya-Hao Zhou, Ting-Hao Chen, Si-Yuan Wang, Hong-Wei Guo, Chao Li, Yong-Kang Diao, Jia-Hao Xu, Li-Hui
  European Journal of Surgical Oncology.2025; 51(10): 110383.     CrossRef
• Comparison of survival benefit and safety profile between lenvatinib and donafenib as conversion therapy in patients with hepatocellular carcinoma
  Yuehong Hou
  American Journal of Translational Research.2025; 17(5): 3496.     CrossRef
• Plumbagin Triggers Cuproptosis in Hepatocellular Carcinoma (HCC) via the DNA‐Methyltransferase 1 (DNMT1)/microRNA‐302a‐3p (miR‐302a‐3p)/ATPase Copper Transporting Beta (ATP7B) Axis
  Chuyu Wang, Hao Wang, Chong Wang, Tongtong Tian, Anli Jin, Yu Liu, Ran Huo, Te Liu, Baishen Pan, Wei Guo, Wenjing Yang, Beili Wang
  MedComm.2025;[Epub]     CrossRef
• Identification of a novel prognostic gene signature associated with therapeutic resistance in hepatocellular carcinoma
  Siliang wang, Shuangshuang Wang, Xu Wang, Yuxiang Sun, Xiao Du, Dan Han, Huanyu Ni, Yun Zhu, Huilian Shi, Zhaocong Yang
  Genes & Diseases.2025; : 101837.     CrossRef
• Mechanistic insights into FUNDC2P4 and HSF1 regulation of EMT in residual hepatocellular carcinoma following insufficient radiofrequency ablation
  Ni Tang, Liangxia Yang, Chengmou Huang, Lu Yang, Liangxing Yang, Haihang Zhang, Jiangzheng Zeng
  International Journal of Hyperthermia.2025;[Epub]     CrossRef
• Ursolic acid, a key anticancer compound derived from Prunella vulgaris L., induces apoptosis in HepG2 cells by directly targeting the STAT3 signaling pathway
  Hailing Pan, Jing Wang, Hanyin Shen, Ziyang Li, Keda Zhu, Fan Yang, Fusheng Jiang, Jinzu Yang, Meiya Li
  Journal of King Saud University – Science.2025; 37: 1422025.     CrossRef
• Evaluation of anti-liver cancer activity and anticancer mechanism of one novel small molecule compound (THY-10A62) targeting FAK pathway
  Wanqiu Huang, Rong Zou, Jie Xu, Yuliang Deng, Dongping Zhang, Yiguo Hu, Qian Zhang, Jian Huang, Zhaoqi Zhang
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Critical analysis of the liver cancer policies and programs in China: implications for international liver cancer control
  Xianwen Chen, Junnan Shi, Yan Xue, Yunfeng Lai, Menghuan Song, Carolina Oi Lam Ung, Hao Hu
  Global Health Research and Policy.2025;[Epub]     CrossRef
• Adjuvant TACE Improves Prognosis After Resection in Dual-Phenotype Hepatocellular Carcinoma: A Propensity Score-Matched Study
  Zijian Leng, Taifeng Zhu, Ziyue Huang, Xiaokun Chen, Yuce Lu, Yuehao Zhang, Xueshuai Wan, Xiaobo Yang, Lei Zhang, Haitao Zhao, Shunda Du, Zhonghai Zhao, Yongchang Zheng
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 2213.     CrossRef
• The causal relationship between platelet indices and liver cancer: a bidirectional two-sample Mendelian randomization study
  Xin He, Yuzhe Zhang, Zhengsheng Yi, Xiaohui Zhao, Yusheng Shi, Shengni Hua
  Discover Oncology.2025;[Epub]     CrossRef
• Predicting the outcome of transarterial chemoembolization combined with targeted immunotherapy for unresectable hepatocellular carcinoma based on MRI radiomics
  Jiaxuan Liu, Na Zhao, Yuxin Hang, Qiwen You, Yulong Tian, Haibo Shao
  Scientific Reports.2025;[Epub]     CrossRef
• Hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitors versus lenvatinib plus PD-1 inhibitors as first-line treatment for hepatocellular carcinoma with high tumour burden and portal vein tumour thrombus (CHANCE 2416): study protocol of
  Jiaxi Liu, Songnan Zhang, Haibo Shao
  BMJ Open.2025; 15(9): e099510.     CrossRef
• The effect of interval time of transcatheter arterial chemoembolization with drug-eluting beads on the efficacy and safety of unresectable hepatocellular carcinoma: a case-control study
  Guoyu Deng, Huaqing Zhang, Haotian Xue, Kaizhong Zheng, Chang Zhao
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Low Aggregate Index of Systemic Inflammation Values Correlate with Favorable Prognosis and High Abundance of Parabacteroides in Hepatocellular Carcinoma
  Wenju Sun, Fengqin Zhou, Chengyu Shi, Congcong Xu, Zhihai Wang, Xufeng Guo
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 2491.     CrossRef
• Clinical Implications and Novel Insights into Adolescent Primary Liver Cancer: A Nightmare for Adolescents?
  Huidong Guo, Xiaojun Chen, Rong Li, Jianzhen Shen, Donghui Gan, Yue Yin, Hehui Zhang, Jiachen Xie, Longfei Xie, Yanquan Liu
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 2513.     CrossRef
• Chemoresistance mitigation of dual drug-loaded nanoparticles with doxorubicin and curcumin
  Binhui Wang, Wanqian Li, Weiyong Hong, Jiabing Wang, Lingzhi Tao, Shujiao Shen
  Cytotechnology.2025;[Epub]     CrossRef
• Development of an UPLC-MS/MS method for quantification of donafenib and its metabolite in rat plasma: application to drug–drug interaction
  Yuxin Shen, Ruibin Li, Lu Cao, Jun Wu, Haoxin Fu, Peiqi Wang, Ren-ai Xu, Ling Ji
  Biochemical Pharmacology.2025; : 117540.     CrossRef
• CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After Hepatectomy
  Yu Lei, Yaowei Bai, Yang Su, Xiatong Bai, Yingliang Wang, Chuansheng Zheng
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 2585.     CrossRef
• 3D dynamic magnetic microfluidic chip for efficient plasma extracellular vesicle enrichment and machine learning–based multiparametric diagnosis of hepatocellular carcinoma
  Xiaodan Xi, Kezhen Yi, Lili Xu, Danfei Xu, Xin Hu, Menglu Gao, Junfeng Ren, Fei Long, Wei Zhong, Yue Hu, Si Wu, Xin He, Jiurong He, Weihua Huang, Yuan Rong, Min Xie, Fubing Wang, Wei Cui
  Journal of Nanobiotechnology.2025;[Epub]     CrossRef
• Diagnostic performance of serum origin recognition complex subunit 1 protein for hepatitis B virus-related hepatocellular carcinoma
  Yan-Fei Feng, Tu-Mei Su, Bo-Bin Hu, Hang Wang, Qing-Mei Li, Qian-Bing Yin, Long Huang, Hong-Qian Liang, Ao-Li Ren, Ming-Hua Su, Jian-Ning Jiang
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Application of laparoscopic liver surgery techniques in laparoscopic thermal ablation of liver tumors
  Yongkun Li, Chenhao Jiang, Zheng Wang, Lei Liu, Ke Wu, Lu Zheng, Nan You
  BMC Gastroenterology.2025;[Epub]     CrossRef
• Massive extrapancreatic solid pseudopapillary neoplasm misdiagnosed as hepatic tumor: a case report and literature review
  Jixu Guo, Qingjuan Zhao, Liting Qin, Shengjie Xie, Shiliu Lu, Baibei Li, Meilin He, Linhong Xie, Shuiping Yu
  Frontiers in Oncology.2024;[Epub]     CrossRef
• A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy
  Honghai Zhang, Shugui Sheng, Wenying Qiao, Ming Han, Ronghua Jin
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Novel insights into small open reading frame-encoded micropeptides in hepatocellular carcinoma: A potential breakthrough
  Qiangnu Zhang, Liping Liu
  Cancer Letters.2024; 587: 216691.     CrossRef
• Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
  Josep M. Llovet, Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron Schwartz, Eli Pikarsky, Masatoshi Kudo, Richard S. Finn
  Nature Reviews Clinical Oncology.2024; 21(4): 294.     CrossRef
• Nomogram for Predicting Postoperative Pulmonary Metastasis in Hepatocellular Carcinoma Based on Inflammatory Markers
  Huanjie Zhou, Haiping Zheng, Ying Wang, Ming Lao, Hong Shu, Meifang Huang, Chao Ou
  Cancer Control.2024;[Epub]     CrossRef
• KDM4A-AS1 Promotes Cell Proliferation, Migration, and Invasion via the miR-4306/STX6 Axis in Hepatocellular Carcinoma
  Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang
  Critical Reviews in Eukaryotic Gene Expression.2024; 34(4): 55.     CrossRef
• Development of Shark Single Domain Antibodies Specific for Human α-Fetoprotein and the Multimerization Strategy in Serum Detection
  Zheming Wang, Xiaoxia Xie, Zhenyun He, Zhichang Sun, Yongli Zhang, Fujing Mao, Hua Pei, Sihang Zhang, Bruce D. Hammock, Xing Liu
  Analytical Chemistry.2024; 96(10): 4242.     CrossRef
• The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma
  Qijuan Zang, Yalin Ju, Siyi Liu, Shaobo Wu, Chengbin Zhu, Liangru Liu, Weicheng Xu, Yingli He
  Human Cell.2024; 37(3): 752.     CrossRef
• Pre-operative enhanced magnetic resonance imaging combined with clinical features predict early recurrence of hepatocellular carcinoma after radical resection
  Jian-Ping Chen, Ri-Hui Yang, Tian-Hui Zhang, Li-An Liao, Yu-Ting Guan, Hai-Yang Dai
  World Journal of Gastrointestinal Oncology.2024; 16(4): 1192.     CrossRef
• Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB
  Shaowen Jiang, Simin Guo, Yan Huang, Jie Xu, Yi Li, Yilan Zeng, Yuan Guo, Lijuan Ouyang, Chuanwu Zhu, Weifeng Zhao, Qin Zhang, Qing Guo, Haiguang Xin, Qing Xie
  Antiviral Research.2024; 226: 105892.     CrossRef
• Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges
  Shunzhen Zheng, Siew Wee Chan, Fei Liu, Jun Liu, Pierce Kah Hoe Chow, Han Chong Toh, Wanjin Hong
  Cancers.2024; 16(8): 1582.     CrossRef
• Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
  YiFeng Liang, LiMing Gan, DeJin Zeng, LangHua Lin, ZheKun Xiong, FangLian Liao, ALing Wang
  Clinical and Translational Oncology.2024; 26(10): 2652.     CrossRef
• Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study
  Jae-Sung Yoo, Ji Hoon Kim, Hee Sun Cho, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Suho Kim, Jung Suk Oh, Ho Jong Chun, Pil Soo Sung
  Abdominal Radiology.2024; 49(9): 3127.     CrossRef
• Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities
  Ming‐Da Wang, Xue‐Jun Xu, Ke‐Chun Wang, Yong‐Kang Diao, Jia‐Hao Xu, Li‐Hui Gu, Lan‐Qing Yao, Chao Li, Guo‐Yue Lv, Tian Yang
  Cancer Science.2024; 115(7): 2159.     CrossRef
• Dual-molecular targeting nanomedicine upregulates synergistic therapeutic efficacy in preclinical hepatoma models
  Qilong Wang, Xiwei Sun, Xizhu Fang, Zhongying Wang, Haodong Wang, Siqiao Sun, Shuai Wang, Tingting Li, Ping Zhang, Zhihua Cheng
  Acta Biomaterialia.2024; 183: 306.     CrossRef
• Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma
  Jing Wang, Wenyue Gao, Hongbo Yu, Yuting Xu, Changchuan Bai, Qingwei Cong, Ying Zhu
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1143.     CrossRef
• TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis
  Wenjing Ji, Weibin Zhang, Xin Zhang, Yue Ke
  Cellular Signalling.2024; 121: 111268.     CrossRef
• Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment
  Sumit Roy, Vancha Harish, Sharfuddin Mohd, Sachin Kumar Singh
  Advanced Therapeutics.2024;[Epub]     CrossRef
• Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study
  Saikang Tang, Yingming Gao, Xue Yan, Weihua Zhi, Yue Han
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Efficacy and safety of apatinib plus immune checkpoint inhibitors and transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma
  Jianfei Wu, Xuefeng Bai, Guodong Yu, Quan Zhang, Xixi Tian, Yuan Wang
  Journal of Cancer Research and Clinical Oncology.2024;[Epub]     CrossRef
• The potential of lenvatinib in breast cancer therapy
  Yuefeng Shang, Tong Liu, Wenjing Wang
  Medical Oncology.2024;[Epub]     CrossRef
• Evaluating the impact of treatment sequencing on outcomes in hepatocellular carcinoma: a comparative analysis of TACE and systemic therapies
  XingRong Zheng, Xin Song, BoXiang Zhang, XiYao Chen, YeQiong Zhang, QiuMin Luo, ZhiPeng Li, ZheXuan Deng, RuiXuan Xu, Liang Peng, Chan Xie
  Clinical and Experimental Medicine.2024;[Epub]     CrossRef
• Development and validation of survival prediction models for patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus tyrosine kinase inhibitors
  Kun Huang, Haikuan Liu, Yanqin Wu, Wenzhe Fan, Yue Zhao, Miao Xue, Yiyang Tang, Shi-Ting Feng, Jiaping Li
  La radiologia medica.2024; 129(11): 1597.     CrossRef
• TAF15 inhibits p53 nucleus translocation and promotes HCC cell 5-FU resistance via post-transcriptional regulation of UBE2N
  Jiayan Fang, Mengqi Zou, Mei Yang, Yejia Cui, Rong Pu, Yufeng Yang
  Journal of Physiology and Biochemistry.2024; 80(4): 919.     CrossRef
• Low miR-936-mediated upregulation of Pim-3 drives sorafenib resistance in liver cancer through ferroptosis inhibition by activating the ANKRD18A/Src/NRF2 pathway
  Xiao Li, Mengna Cui, Long Xu, Qie Guo
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edior on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A sy
  Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li
  Clinical and Molecular Hepatology.2024; 30(4): 965.     CrossRef
• Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
  Yu-Tang Chen, Bo-Wen-Tao Chen, Jun-Ming Xu, Xiao-Cui You, Yi Tang, Shao-Jie Wu, Zhu-Ting Fang
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 2441.     CrossRef
• APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
  George Lau, Shuntaro Obi, Jian Zhou, Ryosuke Tateishi, Shukui Qin, Haitao Zhao, Motoyuki Otsuka, Sadahisa Ogasawara, Jacob George, Pierce K. H. Chow, Jianqiang Cai, Shuichiro Shiina, Naoya Kato, Osamu Yokosuka, Kyoko Oura, Thomas Yau, Stephen L. Chan, Min
  Hepatology International.2024; 18(6): 1661.     CrossRef
• Camrelizumab plus rivoceranib compared sorafenib as first-line therapeutic options for advanced hepatocellular carcinoma in China: a cost-effectiveness analysis
  Hongfu Cai, Jingwen Lin, Huide Zhu, Zhiwei Zheng
  BMJ Open.2024; 14(12): e079603.     CrossRef
• Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma
  Siqi Yang, Jinshuai Lan, Zhe Li, Ming Li, Ya Wu, Liyan Sun, Tong Zhang, Yue Ding
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Cost-effectiveness of camrelizumab plus rivoceranib for advanced hepatocellular carcinoma in the context of regional disparities in China
  Zhonghua Zhao, Xiongying Jiang, Shiping Wen, Yanzhang Hao
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Bavachin stimulates ferroptosis and reduces malignant phenotype progression of hepatocellular carcinoma cells by inducing lipid peroxidation by modulation of the Nrf2/HO-1 signaling pathway
  Haoyu Li
  American Journal of Translational Research.2024; 16(11): 6925.     CrossRef
• 5-Fluorouracil Sensitivity-Based Molecular Subtyping of Hepatocellular Carcinoma Reveals Three Clinically Distinct Subgroups with Differential Prognosis
  Diego Huaman, Mario Quispe, Cesar Flores, Luis Paredes
  Specialty Journal of Pharmacognosy, Phytochemistry, and Biotechnology.2024; 4(1): 157.     CrossRef
• Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
  Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
  Clinical and Molecular Hepatology.2023; 29(2): 342.     CrossRef
• The clinical management of hepatocellular carcinoma in China: Progress and challenges
  Shan Shan, Jidong Jia
  Clinical and Molecular Hepatology.2023; 29(2): 339.     CrossRef
• A bibliometric study on the utilization of lenvatinib in hepatocellular carcinoma (2014–2022)
  Cong-Cong Wang, Cai-Yan Yu, Jing Zhang, Rui Wang, Xiang-Shuo Kong
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy
  Liangdi Jiang, Xuerui Wang, Faisal Raza, Hongyu Zhong, Jing Su, Wei-En Yuan, Mingfeng Qiu
  Biomaterials Science.2023; 11(15): 5301.     CrossRef
• From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification
  Zhongqi Fan, Meishan Jin, Lei Zhang, Nanya Wang, Mingyue Li, Chuanlei Wang, Feng Wei, Ping Zhang, Xiaohong Du, Xiaodong Sun, Wei Qiu, Meng Wang, Hongbin Wang, Xiaoju Shi, Junfeng Ye, Chao Jiang, Jianpeng Zhou, Wengang Chai, Jun Qi, Ting Li, Ruoyan Zhang,
  Gut.2023; 72(11): 2149.     CrossRef
• Heterogeneity characterization of hepatocellular carcinoma based on the sensitivity to 5-fluorouracil and development of a prognostic regression model
  Xinyu Gu, Shuang Li, Xiao Ma, Di Huang, Penghui Li
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma
  Yasunori Minami, Tomoko Aoki, Satoru Hagiwara, Masatoshi Kudo
  Cancers.2023; 15(19): 4763.     CrossRef
• A novel signature of the ligand and receptor genes associated with disulfidoptosis for prediction of prognosis, immunologic therapy responses in hepatocellular carcinoma
  Chong Fu, Chang Cheng, Yanping Zhang
  Heliyon.2023; 9(9): e19502.     CrossRef
• Effect of intermittent Pringle maneuver on perioperative outcomes and long-term survival following liver resection in patients with hepatocellular carcinoma: a meta-analysis and systemic review
  Lingbo Hu, Aidong Wang, Yingli Qiao, Xiandan Huang
  World Journal of Surgical Oncology.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Risk-based selection of treatment strategies in hepatocellular carcinoma with macrovascular invasion
  Nalee Kim, Hyunki Park, Jeong Il Yu, Hee Chul Park, Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Dong Hyun Sinn, Moon Seok Choi, Jung Yong Hong, Minsuk Kwon, Sung Wook Shin, Sung Ki Cho, Dongho Hyun
  Radiotherapy and Oncology.2026; 214: 111260.     CrossRef
• A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
  Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
  Journal of Hepatology.2025; 82(2): 235.     CrossRef
• Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma
  Sung Won Chung, Hyun Jun Um, Won-Mook Choi, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee
  Clinical Gastroenterology and Hepatology.2025; 23(2): 300.     CrossRef
• A classification model for resectability in hepatocellular carcinoma patients
  Ikuo Nakamura, Tomoaki Yoh, Takashi Nishimura, Masayuki Okuno, Tomohiro Okamoto, Hideaki Sueoka, Kenjiro Iida, Masaharu Tada, Takamichi Ishii, Satoru Seo, Yasuhiro Fujimoto, Hiroko Iijima, Seiko Hirono, Etsuro Hatano
  Hepatology Research.2025; 55(1): 94.     CrossRef
• The Critical Role of Regulatory T Cells in Immune Tolerance and Rejection Following Liver Transplantation: Interactions With the Gut Microbiome
  Soon Kyu Lee, Jung Hyun Kwon, Jeong Won Jang, Si Hyun Bae, Seung Kew Yoon, Eun Sun Jung, Jong Young Choi
  Transplantation.2025; 109(5): 784.     CrossRef
• Hepatic Resection for Hepatocellular Carcinoma
  Parissa Tabrizian, Adriana Pero, Myron Schwartz
  Clinics in Liver Disease.2025; 29(1): 59.     CrossRef
• Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCC
  Jinyeong Lim, Myung Ji Goh, Byeong Geun Song, Dong Hyun Sinn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Dong Ik Cha, Kyowon Gu, Sang Yun Ha, Inwoo Hwang, Woong-Yang Park, Yong-Han Paik
  JHEP Reports.2025; 7(4): 101304.     CrossRef
• The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors
  Xiaoyu Huang, Gang Peng, Yaqing Kong, Xiaojing Cao, Xiang Zhou
  Journal of Inflammation Research.2025; Volume 18: 203.     CrossRef
• The Cancer Clinical Library Database (CCLD) from the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) Project
  Sangwon Lee, Yeon Ho Choi, Hak Min Kim, Min Ah Hong, Phillip Park, In Hae Kwak, Ye Ji Kang, Kui Son Choi, Hyun-Joo Kong, Hyosung Cha, Hyun-Jin Kim, Kwang Sun Ryu, Young Sang Jeon, Hwanhee Kim, Jip Min Jung, Jeong-Soo Im, Heejung Chae
  Cancer Research and Treatment.2025; 57(1): 19.     CrossRef
• A Call for Quality Assurance in Alpha-Fetoprotein Testing within the National Cancer Screening Program to Improve Hepatocellular Carcinoma Surveillance in Korea
  Hyorin Kim, Sollip Kim, Hyeongsu Kim, Hye Ryun Lee
  Laboratory Medicine Online.2025; 15(1): 84.     CrossRef
• Correspondence to editorial on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”
  Young-Joo Jin, Seung Up Kim
  Clinical and Molecular Hepatology.2025; 31(1): e55.     CrossRef
• Hepatocellular carcinoma surveillance after sustained virological response in chronic hepatitis C: Editorial on “Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-ana
  Ho Soo Chun, Minjong Lee
  Clinical and Molecular Hepatology.2025; 31(1): 261.     CrossRef
• Canadian Association of Radiologists Cancer Diagnostic Imaging Referral Guideline
  Candyce Hamel, Barb Avard, Howard Lim, Alex Mathieson, Alan Michaud, Kristoff Nelson, Devang Odedra, Jason Pantarotto, Anna Wilkinson, Karim Samji
  Canadian Association of Radiologists Journal.2025; 76(3): 427.     CrossRef
• Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma
  Kanghee Park, Hye Won Lee, Euichang Kim, Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Changhoon Yoo, Baek‐Yeol Ryoo, Seungbong Han, Jonggi Choi
  Alimentary Pharmacology & Therapeutics.2025; 61(8): 1310.     CrossRef
• Temporal trends of liver cancer burden, comparative analysis of risk factors and trend forecasts to 2024 in China, USA, the Republic of Korea, and Mongolia: an analysis based on multiple data sources from Global Burden of Disease 2019, the Global Cancer O
  Xing Yao, Xinchun Ling, Ziyi Zhu, Xiaolu Cao, Shaoliang Tang
  Journal of Global Health.2025;[Epub]     CrossRef
• Cytokine-Induced Killer Cell Immunotherapy Reduces Recurrence in Patients with Early-Stage Hepatocellular Carcinoma
  Dong Hyun Kim, Eun Min Kim, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Gi Hong Choi, Sang Hoon Ahn, Hye Won Lee, Do Young Kim
  Cancers.2025; 17(4): 566.     CrossRef
• A Case of Splenic Oligometastasis without Intrehepatic Recurrence Identified Six Years Following Hepatectomy for Hepatocellular Carcinoma
  Ji Won Han, Pil Soo Sung
  The Korean Journal of Gastroenterology.2025; 85(1): 89.     CrossRef
• AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
  Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
  Journal of Hepatology.2025; 82(6): 1080.     CrossRef
• Prognostic Value of Changes in Combined Child–Pugh Class and ALBI Grade in Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Plus Targeted Therapy and PD-(L)1 Inhibitors
  Xiaoyu Huang, Xiaojing Cao, Yaqing Kong, Fan Tang, Tianhao Cong, Xiang Zhou
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 481.     CrossRef
• Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: a multicenter, propensity score matching analysis
  Zi-Hui Ma, Xiao-Lu Lin, Feng-Hua Liu, Jing-Lei Zhang, Mao-Lin Yan, Xing-Chao Song, Lei Guo, Jie Xue, Chong-De Lu, Jie Shi, Yan Meng, Shu-Qun Cheng, Wei-Xing Guo
  BMC Cancer.2025;[Epub]     CrossRef
• Automated detection of small hepatocellular carcinoma in cirrhotic livers: applying deep learning to Gd-EOB-DTPA-enhanced MRI
  JunQiang Lei, YongSheng Xu, YuanHui Zhu, ShanShan Jiang, Song Tian, Yi Zhu
  Abdominal Radiology.2025; 50(9): 4087.     CrossRef
• Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?
  Lorenzo Lani, Giacomo Zaccherini, Edoardo G. Giannini, Franco Trevisani
  Hepatoma Research.2025;[Epub]     CrossRef
• Assessing the Validity of the AASLD Surgical Treatment Algorithm in Patients with Early-Stage Hepatocellular Carcinoma
  Aryoung Kim, Byeong Geun Song, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Myung Ji Goh, Dong Hyun Sinn
  Gut and Liver.2025; 19(2): 265.     CrossRef
• Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter study
  Qizhen Huang, Xiaohong Zhong, Shaoxing Chen, Wenhui Liu, Jing Yang, Qingjing Chen, Tingting Yang, Fuqun Wei, Juhui Chen, Yufei Zhou, Lijuan Zhan, Xiuhui Liang, Jianji Pan, Kongying Lin, Jinsheng Hong, Yongyi Zeng
  Hepatology International.2025; 19(4): 877.     CrossRef
• Effectiveness of noncontrast-abbreviated magnetic resonance imaging in a real-world hepatocellular carcinoma surveillance
  Hyun Kyung Yang, Sunyoung Lee, Min Young Lee, Myeong-Jin Kim
  European Radiology.2025; 35(9): 5792.     CrossRef
• A nationwide investigation on imaging follow-up after Locoregional therapy for hepatocellular carcinoma in China: Current practices and challenges
  Shuwei Zhou, Chenxin Song, Pei Liu, Shenghong Ju, Yuan-Cheng Wang
  European Journal of Radiology.2025; 186: 112057.     CrossRef
• Developing a novel predictive model for identifying risk factors associated with being lost to follow-up among high-risk patients for recurrence following radical resection of hepatocellular carcinoma: the first report
  Zichen Yu, Wenli Cao, Chengfei Du, Jie Liu, Liping Peng, Fangqiang Wei
  BMC Cancer.2025;[Epub]     CrossRef
• A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024
  Hyunjae Shin, Su Jong Yu
  Journal of Liver Cancer.2025; 25(1): 19.     CrossRef
• Microwave ablation vs. liver resection for patients with hepatocellular carcinomas
  Hyundam Gu, Yeonjoo Seo, Dong Jin Chung, Kwang Yeol Paik, Seung Kew Yoon, Jihye Lim
  Journal of Liver Cancer.2025; 25(1): 99.     CrossRef
• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  Han Ah. Lee, Hyun Woong Lee, Yeon Seok Seo, Dong Hyun Sinn, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2025; 40(7): 1675.     CrossRef
• Efficacy and safety of image-guided hypofractionated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective, multicenter study
  Sang Min Lee, Jin Hwa Choi, Jung-Hwan Yoon, Yoon Jun Kim, Su Jong Yu, Jeong-Hoon Lee, Hyun-Cheol Kang, Eui Kyu Chie, Kyung Su Kim
  BMC Cancer.2025;[Epub]     CrossRef
• A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B
  Jiwon Yang, Mark D. Muthiah, Won-Mook Choi
  Current Hepatology Reports.2025;[Epub]     CrossRef
• Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance
  Dong Ho Lee
  Journal of Liver Cancer.2025; 25(1): 31.     CrossRef
• Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry
  Jihyun An, Young Chang, Gwang Hyeon Choi, Won Sohn, Jeong Eun Song, Hyunjae Shin, Jae Hyun Yoon, Jun Sik Yoon, Hye Young Jang, Eun Ju Cho, Ji Won Han, Suk Kyun Hong, Ju-Yeon Cho, Kyu-Won Jung, Eun Hye Park, Eunyang Kim, Bo Hyun Kim
  Journal of Liver Cancer.2025; 25(1): 109.     CrossRef
• Letter: Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma—Authors' Reply
  Jiwon Yang, Won‐Mook Choi
  Alimentary Pharmacology & Therapeutics.2025; 61(12): 1975.     CrossRef
• Abbreviated MRI for Hepatocellular Carcinoma Screening: A Comprehensive Review
  Ji Hye Min, Young Kon Kim, Woo Kyoung Jeong, Bachir Taouli
  Current Hepatology Reports.2025;[Epub]     CrossRef
• Comparison of initial treatments for resectable hepatocellular carcinoma within Milan criteria: an observational study based on a nationwide survey
  Sang Jin Kim, Woo Kyoung Jeong, Hyung-Joon Han, Gyu-Seong Choi, Kyun-Hwan Kim, Jongman Kim
  Annals of Surgical Treatment and Research.2025; 108(5): 279.     CrossRef
• Differential Infiltration of T-Cell Populations in Tumor and Liver Tissues Predicts Recurrence-Free Survival in Surgically Resected Hepatocellular Carcinoma
  Eun Ji Jang, Ho Joong Choi, Young Kyoung You, Deok Hwa Seo, Mi Hyun Kwon, Keungmo Yang, Jaejun Lee, Jeong Won Jang, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
  Cancers.2025; 17(9): 1548.     CrossRef
• The effect of continuous infusion chemotherapy through femoral artery catheterization on GP73, AFP-L3, and safety efficacy in liver cancer patients
  Qiong Yan, Xinguo Sun, Yubo Wang, Shijiao Duan, Bo Wang
  Clinical and Experimental Medicine.2025;[Epub]     CrossRef
• Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma
  Sung Won Chung, Jin Sun Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Kang Mo Kim
  Clinical Cancer Research.2025; 31(10): 2046.     CrossRef
• Predictability of clinical outcomes after external beam radiotherapy for hepatocellular carcinoma according to tumor marker dynamics
  Sunmin Park, Chai Hong Rim, Young Kul Jung, Hyung Joon Yim, Hwan Hoon Chung, Won Sup Yoon, Gregory Tiao
  PLOS One.2025; 20(5): e0323450.     CrossRef
• Abbreviated MRI-Based Surveillance Strategies for Early Hepatocellular Carcinoma Detection
  Hyo Jung Park, Dong Wook Kim, Won-Mook Choi, So Yeon Kim
  Journal of the Korean Society of Radiology.2025; 86(3): 335.     CrossRef
• LI-RADS CT/MRI Treatment Response Assessment Update in 2024
  Jaeseung Shin, Kyowon Gu, Ji Hye Min
  Journal of the Korean Society of Radiology.2025; 86(3): 352.     CrossRef
• Hepatic Artery Infusion Chemotherapy for Hepatocellular Carcinoma: Clinical Advancements
  Wei Xu, Qing Li, Bin Liang
  Current Oncology.2025; 32(6): 313.     CrossRef
• Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation Study
  Jia‐Yong Su, De‐Jia Huang, Shao‐Ping Liu, Xiao‐Ling Xu, Shu‐Chang Chen, Jun‐Jie Ou, Jian‐Rong Li, Tai‐Xin Yang, Wen‐Yang Li, Yuan Fan, Zhao‐Chan Wen, Le Chen, Zhen Qin, Bei‐Bei Long, Da‐Zhi Li, Jiang‐Hong Huang, Yi‐Jia Lu, Jun‐Chi Zhong, Hai‐Qiang Zhu, Li
  Hepatology Research.2025; 55(9): 1263.     CrossRef
• The efficacy and safety of tislelizumab with or without tyrosine kinase inhibitor as adjuvant therapy in hepatocellular carcinoma with high-risk of recurrence after curative resection
  Ning Peng, Lin-Feng Mao, Jia-Yong Su, Shao-Ping Liu, Jun-Jie Ou, Shu-Chang Chen, Ze Su, Wen-Feng Li, Fu-Quan Yang, Yong-Heng Zhou, Le Li, Jian-Hong Zhong
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Optimizing Yttrium-90 Radioembolization Dosimetry for Hepatocellular Carcinoma: A Korean Perspective
  In Joon Lee, Hyo-Cheol Kim
  Korean Journal of Radiology.2025; 26(7): 688.     CrossRef
• Significant Improvement in Long-Term Survival after Liver Resection for Hepatocellular Carcinoma: Evolving Outcomes over 20 Years
  Na Reum Kim, Gi Hong Choi, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi
  Yonsei Medical Journal.2025; 66(10): 637.     CrossRef
• Role of imaging-guided biopsy for hepatocellular carcinoma
  Roberto Cannella, Zachary T. Berman, Nikhil V. Tirukkovalur, Samer T. Tohme, Marta I. Minervini, Alessandro Furlan
  European Journal of Radiology.2025; 191: 112271.     CrossRef
• Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
  Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
  Osteoporosis International.2025; 36(8): 1391.     CrossRef
• Outcome of hepatic resection for HCC in ideal and non-ideal candidates
  Lorenzo Lani, Laura Bucci, Valentina Santi, Benedetta Stefanini, Bernardo Stefanini, Angelo Sangiovanni, Sara Grasselli, Giorgia Ghittoni, Carlo Saitta, Filomena Morisco, Giuseppe Cabibbo, Fabio Marra, Gianpaolo Vidili, Maurizia Rossana Brunetto, Francesc
  Hepatology Communications.2025;[Epub]     CrossRef
• A technological convergence in hepatobiliary oncology: Evolving roles of smart surgical systems
  Xuanci Bai, Runze Huang, Qinyu Liu, Xin Jin, Lu Wang, Wei Tang, Kenji Karako, Weiping Zhu
  BioScience Trends.2025; 19(4): 410.     CrossRef
• Conversion therapy followed by surgery and adjuvant therapy improves survival in Barcelona C stage hepatocellular carcinoma ― A propensity score-matched analysis
  Yinbiao Cao, Liru Pan, Zikun Ran, Wenwen Zhang, Junfeng Li, Xuerui Li, Tianyu Jiao, Zhe Liu, Tao Wan, Haowen Tang, Shichun Lu
  BioScience Trends.2025; 19(4): 432.     CrossRef
• Enhancing TNM Stage Completeness Using the SEER Summary Stage: A Nationwide Study From Korea
  Chang Kyun Choi, Mina Suh, Kyu-Won Jung, E Hwa Yun
  Journal of Preventive Medicine and Public Health.2025; 58(4): 415.     CrossRef
• Pre- and postoperative predictors of extrahepatic recurrence after curative resection for hepatocellular carcinoma
  Chang Hun Lee, Yun Chae Lee, Seung Young Seo, Ga Ram You, Hoon Gil Jo, Sung Bum Cho, Eun Young Cho, In Hee Kim, Sung Kyu Choi, Jae Hyun Yoon
  BMC Cancer.2025;[Epub]     CrossRef
• Impact of an immediate short waiting period on ultrasound-based ablative margin assessment following radiofrequency ablation for hepatocellular carcinoma
  Seungchul Han, Min Woo Lee, Kyowon Gu, Hyunchul Rhim
  Ultrasonography.2025; 44(5): 354.     CrossRef
• Prognostic Role of Short-Chain Fatty Acid-Producing Gut Microbiota and Gut Microbial Dynamics in Patients with Hepatocellular Carcinoma Receiving Chemoembolization: A Prospective Study
  Jiwon Yang, Jihye Lim, Eun Hye Kim, Jihyun An, Danbi Lee, Han Chu Lee, Jin-Yong Jeong, Ju Hyun Shim
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 1991.     CrossRef
• Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular Carcinoma
  Gwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, Alexander Kuo, Walid S. Ayoub, Hirsh Trivedi, Yun Wang, Aarshi Vipani, Pin-Jung Chen, Steven A. Miles, Emily A. Kaymen, Andrew Hendifar, Tsuyoshi Todo, Todd V. Brennan, Georgios Voidonikolas, Steven A. Wisel,
  Liver Cancer.2025; : 1.     CrossRef
• Spectrum of therapeutic options in hepatocellular carcinoma
  Hyun Phil Shin, Moonhyung Lee, Jung Won Jeon
  Journal of Exercise Rehabilitation.2025; 21(4): 190.     CrossRef
• Precision Strategy for Hepatocellular Carcinoma Surveillance after Hepatitis C Cure: Debates across Guidelines
  Masaaki Mino, Eiji Kakazu, Tatsuya Kanto
  Gut and Liver.2025; 19(5): 651.     CrossRef
• Alternative Surveillance Improves Outcomes by Detecting Early-Stage Hepatocellular Carcinoma in Chronic Hepatitis B Patients
  Dong Ho Lee, Heejin Cho, Su Jong Yu, Min Kyung Park, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon
  Gut and Liver.2025; 19(5): 770.     CrossRef
• 15-Year Trends in Hepatocellular Carcinoma: Epidemiology, Treatment, and Outcomes from a Hospital-Based Registry
  Songgyung Kim, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Ki-Hun Kim, Jonggi Choi
  Gut and Liver.2025; 19(5): 746.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Annals of Surgical Treatment and Research.2025; 109(3): 123.     CrossRef
• Re-evaluating surgical strategies in Barcelona Clinic Liver Cancer-B hepatocellular carcinoma
  Ioannis Liapis, Ioannis A Ziogas, Charalampos Theocharopoulos, Dimitrios P Moris, Trevor L Nydam, Ana L Gleisner, Richard D Schulick, Georgios Tsoulfas
  World Journal of Hepatology.2025;[Epub]     CrossRef
• Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis
  Youngsu Park, Yuri Cho, Seung Up Kim, Aryoung Kim, Hyunjae Shin, Hyo-Cheol Kim, In Joon Lee, Gyoung Min Kim, Dongho Hyun, Yunmi Ko, Jeayeon Park, Jae Woong Yoon, Gyung Sun Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan
  Diagnostic and Interventional Imaging.2025;[Epub]     CrossRef
• Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria
  Hyun Yang, Soon Sun Kim, Seong Hee Kang, Jieun Kwon, Do Young Kim, Eunju Kim, Hyun Phil Shin, Jeong Il Yu, Jeong-Ju Yoo, Eileen L. Yoon, Sangheun Lee, Young Eun Chon, Janghan Jung, Jaekyung Cheon, Woosun Choi, Seul Ki Han, Ji Eun Han, Moon Haeng Hur, Hyun
  Journal of Liver Cancer.2025; 25(2): 160.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Journal of Liver Cancer.2025; 25(2): 140.     CrossRef
• Predicting the outcome of transarterial chemoembolization combined with targeted immunotherapy for unresectable hepatocellular carcinoma based on MRI radiomics
  Jiaxuan Liu, Na Zhao, Yuxin Hang, Qiwen You, Yulong Tian, Haibo Shao
  Scientific Reports.2025;[Epub]     CrossRef
• Magnetic resonance imaging-guided radiotherapy for portal vein tumor thrombus in hepatocellular carcinoma: outcomes and prognostic factors
  So Jung Lee, Myungsoo Kim
  Radiation Oncology.2025;[Epub]     CrossRef
• Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab
  Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Ji Hoon Kim, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Myeong Jun Song, Soon Woo
  Clinical Cancer Research.2025; 31(20): 4323.     CrossRef
• Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography
  Dong Wook Kim, Won Chang, So Yeon Kim, Young-Suk Lim, Jonggi Choi, Jungheum Cho, Jin-Wook Kim, Jai Young Cho, Sun Kyung Jeon, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Kyung-Suk Suh, Kwang-Woong Lee, Dong Ho Lee
  Clinical and Molecular Hepatology.2025; 31(4): 1285.     CrossRef
• Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
  Zheng Wang, Jia Fan, Shaolai Zhou, Yunfan Sun, Fei Liang, Yuan Ji, Fangming Gu, Tao Li, Li Peng, Tao Peng, Xiaolun Huang, Zhenbin Ding, Dousheng Bai, Bangde Xiang, Guang Tan, Tianfu Wen, Yongyi Zeng, Feng Han, Yu Zhang, Shengdong Wu, Haitao Zhao, Yi Chen,
  The Lancet.2025; 406(10515): 2089.     CrossRef
• Overview of the multidisciplinary team activity in patients with hepatocellular carcinoma and their survival outcomes
  V. Guarini, C. Garzòn, D. Casado, M. Casanova, P. Villarejo, I. Azinovic, E. Crespo, I. Fernandez, M. Lopez, M.M. de Bourio, M. Moran, M. Jimenez, G. Medrano, V. Castellano, A. Lamarca
  ESMO Gastrointestinal Oncology.2025; 10: 100263.     CrossRef
• Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
  Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• Adverse Event Monitoring with Imaging: Prognostic Significance in Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma
  Jeayeon Park, Dong Ho Lee, Yunmi Ko, Hyunjae Shin, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Su Jong Yu
  Liver Cancer.2025; : 1.     CrossRef
• Deep learning approach for discrimination of liver lesions using nine time-phase images of contrast-enhanced ultrasound
  Naohisa KAMIYAMA, Katsutoshi SUGIMOTO, Ryuichi NAKAHARA, Tatsuya KAKEGAWA, Takao ITOI
  Choonpa Igaku.2025;[Epub]     CrossRef
• Improving surgical treatments for hepatocellular carcinoma
  Abdullah K. Malik, Daniel Geh, Thomas R. Jeffry Evans, Pierce K. H. Chow, Derek A. Mann, Steven A. White
  Nature Reviews Gastroenterology & Hepatology.2025;[Epub]     CrossRef
• External beam radiation for HCC: Ready for incorporation into guidelines?
  Michael Buckstein, Laura A. Dawson
  JHEP Reports.2025; : 101683.     CrossRef
• Real-World Comparison of Lenvatinib and Sorafenib as First-Line Treatments for Hepatocellular Carcinoma: A Multicenter Study
  Mira Kang, Won Chul Cha, Dong Hyun Sinn, Woo Kyoung Jeong, Do Young Kim, Min Ji Lee, Subin Lim, DongKyu Kim, Kyu-Pyo Kim, Baek-Yeol Ryoo, Won-Mook Choi, Kang Mo Kim, Ki-Hun Kim, Doik Lee, Eui Jun Choi, Choungwon Jung, Joohyun Kim, Jung Yong Hong
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 2611.     CrossRef
• Navigating the Therapeutic Pathway and Optimal First-Line Systemic Therapy for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors
  Hyun Phil Shin, Moonhyung Lee
  Medicina.2025; 61(12): 2164.     CrossRef
• Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance
  Jie Gao, Nan Bai, Mingyu Liu, Ninghua Yao, Zhangzhi Tang, Banglong Xu, Weiting Chen, Xuyang He, Jiayu Shao, Saiyan Bian, Hui Zhao, Wenjie Zheng
  Oncogenesis.2025;[Epub]     CrossRef
• Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines
  Sun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, Eunji Kim, Jin-Kyu Kang, Won Il Jang, Ji Eun Moon, Isaure Roquette, Xavier Mirabel, Tomoki Kimura, Masayuki Ueno, Ting-Shi Su, Alison C. Tree, Matthias Guckenberger, Simon S. Lo, Marta Scorsetti, Ben J. Slotman
  International Journal of Radiation Oncology*Biology*Physics.2024; 118(2): 337.     CrossRef
• Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection
  Na Reum Kim, Heejin Bae, Hyeo Seong Hwang, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Mi-Suk Park, Gi Hong Choi
  Liver Cancer.2024; 13(2): 181.     CrossRef
• Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations
  Ming Zhao, Zhi Guo, Ying-Hua Zou, Xiao Li, Zhi-Ping Yan, Min-Shan Chen, Wei-Jun Fan, Hai-Liang Li, Ji-Jin Yang, Xiao-Ming Chen, Lin-Feng Xu, Yue-Wei Zhang, Kang-Shun Zhu, Jun-Hui Sun, Jia-Ping Li, Yong Jin, Hai-Peng Yu, Feng Duan, Bin Xiong, Guo-Wen Yin,
  Hepatology International.2024; 18(1): 4.     CrossRef
• Comparative Performance of 2018 LI‐RADS versus Modified LIRADS (mLI‐RADS): An Individual Participant Data Meta‐Analysis
  Stacy M. Goins, Hanyu Jiang, Christian B. van der Pol, Jean‐Paul Salameh, Eric Lam, Robert G. Adamo, Matthew D.F. McInnes, Andreu F. Costa, Christopher Clarke, Sang Hyun Choi, Tyler J. Fraum, Daniel R. Ludwig, Bin Song, Ijin Joo, Andrea S. Kierans, So Yeo
  Journal of Magnetic Resonance Imaging.2024; 60(3): 1082.     CrossRef
• Deep learning approach for discrimination of liver lesions using nine time-phase images of contrast-enhanced ultrasound
  Naohisa Kamiyama, Katsutoshi Sugimoto, Ryuichi Nakahara, Tatsuya Kakegawa, Takao Itoi
  Journal of Medical Ultrasonics.2024; 51(1): 83.     CrossRef
• Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study
  Bo Hyun Kim, Hee Chul Park, Tae Hyun Kim, Young-Hwan Koh, Jung Yong Hong, Yuri Cho, Dong Hyun Sinn, Boram Park, Joong-Won Park
  JHEP Reports.2024; 6(4): 100991.     CrossRef
• The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma
  Li-Yue Sun, Wen-Jian Cen, Xin-Xin Zeng, Yu-Yun Zhong, Ling Deng, Jiao-Jiao Yang, Ming Li, Fang Wang
  The American Surgeon™.2024; 90(6): 1240.     CrossRef
• Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
  Sojung Han, Do Young Kim, Ho Yeong Lim, Jung-Hwan Yoon, Baek-Yeol Ryoo, Yujeong Kim, Kookhee Kim, Bo Yeon Kim, So Young Yi, Dong-Sook Kim, Do-Yeon Cho, Jina Yu, Suhyun Kim, Joong-Won Park
  Gut and Liver.2024; 18(1): 116.     CrossRef
• The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
  Beom Kyung Kim
  Gut and Liver.2024; 18(1): 3.     CrossRef
• Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real‐world study
  Jun‐Zhe Yi, Zhi‐Jian Zhu, Gong‐Wei Liu, Yi‐Min Zhang, Jie Xu, Xin‐Tong Wu, Ke Ding, Jian‐Chao Liu, Ke‐Fei Zhang, Xiong‐Ying Jiang, Qi‐Feng Chen, Yue Hu, Song Chen, Sui‐Xing Zhong, Jiong‐Liang Wang, Ning Lyu, Ming Zhao
  Hepatology Research.2024; 54(6): 575.     CrossRef
• Clinical course of patients with hepatocellular carcinoma who experienced radiologic complete response after radioembolization
  Sungmo Moon, Gyoung Min Kim, Jong Yun Won, Joon Ho Kwon, Juil Park, Kichang Han, Man-Deuk Kim, Hyung Cheol Kim, Dong Kyu Kim, Jin Young Choi
  Frontiers in Oncology.2024;[Epub]     CrossRef
• A Prospective Analysis of the Effects of a Powder-Type Hemostatic Agent on the Short-Term Outcomes after Liver Resection
  MeeYoung Kang, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, Yeshong Park, Jinju Kim
  Medicina.2024; 60(2): 278.     CrossRef
• Image Quality and Diagnostic Performance of Low-Dose Liver CT with Deep Learning Reconstruction versus Standard-Dose CT
  Dong Ho Lee, Jeong Min Lee, Chang Hee Lee, Saif Afat, Ahmed Othman
  Radiology: Artificial Intelligence.2024;[Epub]     CrossRef
• Identification of patients with favorable prognosis after resection in intermediate-stage-hepatocellular carcinoma
  Han Ah Lee, Minjong Lee, Jeong-Ju Yoo, Ho Soo Chun, Yewan Park, Hwi Young Kim, Tae Hun Kim, Yeon Seok Seo, Dong Hyun Sinn
  International Journal of Surgery.2024; 110(2): 1008.     CrossRef
• Treatment options for solitary hepatocellular carcinoma ≤5 cm: surgery vs. ablation: a multicenter retrospective study
  Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Hidenori Toyoda, Toshifumi Tada, Kunihiko Tsuji, Toru Ishikawa, Takeshi Hatanaka, Ei Itobayashi, Koichi Takaguchi, Akemi Tsutsui, Atsushi Naganuma, Satoshi Yasuda, Satoru Kakizaki, Akiko Wakuta, Shohei Shi
  Journal of Liver Cancer.2024; 24(1): 71.     CrossRef
• ESR Essentials: diagnosis of hepatocellular carcinoma—practice recommendations by ESGAR
  Roberto Cannella, Marc Zins, Giuseppe Brancatelli
  European Radiology.2024; 34(4): 2127.     CrossRef
• Association between Unplanned Conversion and Patient Survival after Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Propensity Score Matched Analysis
  Boram Lee, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, MeeYoung Kang, Yeshong Park, Jinju Kim
  Journal of Clinical Medicine.2024; 13(4): 1116.     CrossRef
• Achieving Textbook Outcomes after Laparoscopic Resection in Posterosuperior Segments of the Liver: The Impact of the Learning Curve
  Mizelle D’Silva, Jai-Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae-Won Lee, Bo-Ram Lee, Mee-Young Kang, Ye-Shong Park, Jin-Ju Kim
  Cancers.2024; 16(5): 930.     CrossRef
• Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
  Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
  Diagnostics.2024; 14(5): 495.     CrossRef
• Comparison between laparoscopic liver resection and open liver resection in patients with hepatocellular carcinoma with portal vein tumor thrombosis
  Kyeong Sik Kim, Gyu-Seong Choi, Jinsoo Rhu, Jongman Kim
  Surgical Endoscopy.2024; 38(4): 2116.     CrossRef
• Usefulness of contrast-enhanced ultrasound-guided biopsy for suspected viable hepatocellular carcinoma after treatment: a single-arm prospective study
  Jeongin Yoo, Dong Ho Lee
  Ultrasonography.2024; 43(2): 88.     CrossRef
• Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis
  Manuel Lim, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
  Journal of Liver Cancer.2024; 24(1): 102.     CrossRef
• Radiofrequency for hepatocellular carcinoma larger than 3 cm: potential for applications in daily practice
  Ji Hoon Kim, Pil Soo Sung
  Journal of Liver Cancer.2024; 24(1): 1.     CrossRef
• A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
  Hae Lim Lee, Seok Hwan Kim, Hee Yeon Kim, Sung Won Lee, Myeong Jun Song
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy
  Diyang Xie, Zhongchen Li, Jia Yuan, Xin Yin, Rongxin Chen, Lan Zhang, Zhenggang Ren
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 693.     CrossRef
• Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
  Jungnam Lee, Young‐Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Jung Hwan Yu, Jin‐Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
  Journal of Gastroenterology and Hepatology.2024; 39(9): 1924.     CrossRef
• A multi-parametric prognostic model based on clinicopathologic features: vessels encapsulating tumor clusters and hepatic plates predict overall survival in hepatocellular carcinoma patients
  Si-Ping Xiong, Chun-Hua Wang, Mei-fang Zhang, Xia Yang, Jing-Ping Yun, Li-Li Liu
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
  Yuri Cho, Bo Hyun Kim, Young-Suk Lim
  Digestive Disease Interventions.2024; 08(03): 169.     CrossRef
• Real-World Effectiveness of First Line Lenvatinib Therapy in Advanced Hepatocellular Carcinoma: Current Insights
  Tiago Biachi de Castria, Richard Kim
  Pragmatic and Observational Research.2024; Volume 15: 79.     CrossRef
• Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
  Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
  Clinical and Molecular Hepatology.2024; 30(3): 360.     CrossRef
• A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
  Ji W. Han, Soon K. Lee, Jung H. Kwon, Soon W. Nam, Hyun Yang, Si H. Bae, Ji H. Kim, Heechul Nam, Chang W. Kim, Hae L. Lee, Hee Y. Kim, Sung W. Lee, Ahlim Lee, U I. Chang, Do S. Song, Seok-Hwan Kim, Myeong J. Song, Pil S. Sung, Jong Y. Choi, Seung K. Yoon,
  Clinical Cancer Research.2024; 30(13): 2812.     CrossRef
• Consistent efficacy of hepatic artery infusion chemotherapy irrespective of PD‑L1 positivity in unresectable hepatocellular carcinoma
  Ji Kim, Young Kim, Hee-Chul Nam, Chang-Wook Kim, Jae-Sung Yoo, Ji Han, Jeong Jang, Jong Choi, Seung Yoon, Ho Jong Chun, Jung Oh, Suho Kim, Sung Lee, Pil Sung
  Oncology Letters.2024;[Epub]     CrossRef
• Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
  Ye Rim Kim, Sung Won Chung, Min-Ju Kim, Won-Mook Choi, Jonggi Choi, Danbi Lee, Han Chu Lee, Ju Hyun Shim
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 1235.     CrossRef
• Medios de contraste específicos para el estudio del hígado en resonancia magnética
  A. Perez-Girbes, J.M. Lee, L. Martí-Bonmatí
  Radiología.2024; 66: S75.     CrossRef
• Cost-effectiveness of immune checkpoint inhibitors as a first-line therapy for advanced hepatocellular carcinoma: a systematic review
  Hongyu Gong, Siew Chin Ong, Fan Li, Yan Shen, Zhiying Weng, Keying Zhao, Zhengyou Jiang, Meng Wang
  Health Economics Review.2024;[Epub]     CrossRef
• Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment
  Rosmawati Mohamed, Wendy Wang, Tawesak Tanwandee, Irsan Hasan, Cam Phuong Pham, Young-Suk Lim, Sheng-Nan Lu, Murallitharan Munisamy, Thi Thanh Huong Tran, Evy Ratnawati, Wattana Sukeepaisarnjaroen, Mahir Karababa, Chee-Kiat Tan
  Journal of Gastrointestinal Cancer.2024; 55(3): 1333.     CrossRef
• Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study
  Kyu-Pyo Kim, Kang Mo Kim, Baek-Yeol Ryoo, Won-Mook Choi, Won Chul Cha, Mira Kang, Dong Hyun Sinn, Myung Ji Goh, Do Young Kim, Min Ji Lee, Subin Lim, DongKyu Kim, Kyoungdae Baek, Joohyun Kim, Eui Jun Choi, Doik Lee, Jung-Ae Kim, Ki-Hun Kim
  Liver Cancer.2024; : 1.     CrossRef
• Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma
  Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Yong-Han Paik
  Gut and Liver.2024; 18(4): 709.     CrossRef
• Glycemic Burden and Clinical Outcomes of Early Stage Hepatocellular Carcinoma after Curative Treatment
  Hyun Joo Lee, Moon Seok Choi, Byeong Geun Song, Won Seok Kang, Geum Youn Gwak, Myung Ji Goh, Yong Han Paik, Joon Hyeok Lee, Dong Hyun Sinn
  Cancers.2024; 16(15): 2652.     CrossRef
• Modified Albumin-Bilirubin Grade After Curative Treatment: Predicting the Risk of Late Intrahepatic Recurrence of Hepatocellular Carcinoma
  Myung Ji Goh, Hee Chul Park, Nalee Kim, Bong Kyung Bae, Moon Seok Choi, Jinsoo Rhu, Min Woo Lee, Woo Kyoung Jeong, Minji Kim, Kyunga Kim, Jeong Il Yu
  Journal of Korean Medical Science.2024;[Epub]     CrossRef
• Liver resection and transplantation in the era of checkpoint inhibitors
  Parissa Tabrizian, Rebecca Marino, Pierce K.H. Chow
  JHEP Reports.2024; 6(11): 101181.     CrossRef
• Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
  Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
  Gut and Liver.2024; 18(5): 789.     CrossRef
• Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendation of the Korean Liver Cancer Association
  Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
  Journal of Liver Cancer.2024; 24(2): 131.     CrossRef
• Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
  Jiwon Yang, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Deok-Bog Moon, Dong-Hwan Jung, Jonggi Choi
  Journal of Liver Cancer.2024; 24(2): 178.     CrossRef
• The position of loco-regional therapy in the management of hepatocellular carcinoma with extrahepatic metastases
  Beom Kyung Kim
  Journal of Liver Cancer.2024; 24(2): 129.     CrossRef
• Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
  Seungchul Han, Pil Soo Sung, Soo Young Park, Jin Woong Kim, Hyun Pyo Hong, Jung-Hee Yoon, Dong Jin Chung, Joon Ho Kwon, Sanghyeok Lim, Jae Hyun Kim, Seung Kak Shin, Tae Hyung Kim, Dong Ho Lee, Jong Young Choi
  Korean Journal of Radiology.2024; 25(9): 773.     CrossRef
• Heavy smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment
  Jaejun Lee, Jong Young Choi, Soon Kyu Lee
  Journal of Liver Cancer.2024; 24(2): 253.     CrossRef
• Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
  Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Moon Seok Choi
  Journal of Liver Cancer.2024; 24(2): 243.     CrossRef
• Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging
  Jae Seok Bae, Jeong Min Lee, Bo Yun Hur, Jeongin Yoo, Sae-Jin Park
  Journal of Liver Cancer.2024; 24(2): 206.     CrossRef
• Superselective ablative chemo-ethanol embolization for recurrent single hepatocellular carcinoma: a 6-month outcome analysis
  Jae Hwan Lee, Kun Yung Kim, Chong-ho Lee, Minuk Kim, Chang Jin Yoon
  Journal of Liver Cancer.2024; 24(2): 217.     CrossRef
• Dynamic Peripheral T-Cell Analysis Identifies On-Treatment Prognostic Biomarkers of Atezolizumab plus Bevacizumab in Hepatocellular Carcinoma
  Ji Won Han, Min Woo Kang, Soon Kyu Lee, Hyun Yang, Ji Hoon Kim, Jae-Sung Yoo, Hee Sun Cho, Eun Ji Jang, Deok Hwa Seo, Jung Hyun Kwon, Soon Woo Nam, Si Hyun Bae, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Liver Cancer.2024; : 1.     CrossRef
• Evolving trends in treatment patterns for hepatocellular carcinoma in Korea from 2008 to 2022: a nationwide population-based study
  Ji Won Han, Won Sohn, Gwang Hyeon Choi, Jeong Won Jang, Gi Hyeon Seo, Bo Hyun Kim, Jong Young Choi
  Journal of Liver Cancer.2024; 24(2): 274.     CrossRef
• Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis
  Young-Joo Jin, Hee Yeon Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun, Miyoung Choi, Seung Up Kim
  Clinical and Molecular Hepatology.2024; 30(Suppl): S159.     CrossRef
• Clinical and Radiologic Predictors of Response to Atezolizumab-Bevacizumab in Advanced Hepatocellular Carcinoma
  Se Jin Choi, Sung Won Chung, Jonggi Choi, Kang Mo Kim, Hyung-Don Kim, Changhoon Yoo, Baek-Yeol Ryoo, Seung Soo Lee, Won-Mook Choi, Sang Hyun Choi
  Cancer Research and Treatment.2024; 56(4): 1219.     CrossRef
• Hepatobiliary contrast agents for Liver Magnetic Resonance Imaging
  A. Perez-Girbes, J.M. Lee, L. Martí-Bonmatí
  Radiología (English Edition).2024; 66: S75.     CrossRef
• Clinical Significance of Biliary Invasion at Diagnosis in Barcelona Clinic Liver Cancer Stage B–C Hepatocellular Carcinoma: A Nationwide Cohort Analysis in South Korea
  Chai Hong Rim, Won Sup Yoon, Sunmin Park
  Oncology.2024; : 1.     CrossRef
• Diagnostic performance of Sonazoid-enhanced CEUS in identifying definitive hepatocellular carcinoma in cirrhotic patients according to KLCA-NCC 2022 and APASL 2017 guidelines
  Zhe Huang, Rong-Hua Zhu, Shan-shan Li, Hong-Chang Luo, Kai-Yan Li
  Insights into Imaging.2024;[Epub]     CrossRef
• Stage dependent microbial dynamics in hepatocellular carcinoma and adjacent normal liver tissues
  Hee Eun Jo, Sophallika Khom, Sumi Lee, Su Hyeon Cho, Shin Young Park, Ga Ram You, Hyosin Kim, Nah Ihm Kim, Jae-Ho Jeong, Jae Hyun Yoon, Misun Yun
  Scientific Reports.2024;[Epub]     CrossRef
• Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein throm
  Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon
  Clinical and Molecular Hepatology.2024; 30(4): 659.     CrossRef
• Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma
  Jiwon Yang, Won-Mook Choi, Hyung-Don Kim, Jonggi Choi, Changhoon Yoo, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee
  Liver Cancer.2024; : 1.     CrossRef
• Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review
  Jiahao Li, Yingnan Liu, Yuqi Qiu, Chao Qu, Jiarui Li
  Frontiers in Immunology.2024;[Epub]     CrossRef
• New strategy of LI-RADS v2018 to improve the sensitivity for small hepatocellular carcinoma ≤ 3.0 cm on extracellular-contrast enhanced MRI
  Jinhui Zhou, Yao Zhang, Jing Zhang, Jingbiao Chen, Hang Jiang, Linqi Zhang, Xi Zhong, Tianhui Zhang, Lichun Chen, Yufeng Wang, Yikai Xu, Jin Wang
  European Journal of Radiology.2024; 181: 111830.     CrossRef
• A Case of Hepatic Epithelioid Hemangioendothelioma Treated with Radiofrequency Ablation
  Yu Rim Lee, Jae Young Jang
  Clinical Ultrasound.2024; 9(2): 96.     CrossRef
• Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography
  Han Ah Lee
  Clinical Ultrasound.2024; 9(2): 70.     CrossRef
• Albumin–Bilirubin Grade as a Valuable Predictor of Recurrence and Prognosis in Patients with Hepatocellular Carcinoma Following Radiofrequency Ablation
  Chang Hun Lee, Ga Ram You, Hoon Gil Jo, Chung Hwan Jun, Eun Young Cho, In Hee Kim, Sung Kyu Choi, Jae Hyun Yoon
  Cancers.2024; 16(24): 4167.     CrossRef
• Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
  Ji Yeon Lee, Jaejun Lee, Suho Kim, Jae-sung Yoo, Ji Hoon Kim, Keungmo Yang, Ji Won Han, Jeong Won Jang, Jong Yong Choi, Seung Kew Yoon, Ho Jong Chun, Jung Suk Oh, Pil Soo Sung
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Noninvasive identification of proliferative hepatocellular carcinoma on multiphase dynamic CT: quantitative and LI-RADS lexicon-based evaluation
  Wanli Zhang, Nan Li, Jiamin Li, Yue Zhao, Yi Long, Chutong He, Chuanxian Zhang, Bo Li, Yandong Zhao, Shengsheng Lai, Wenshuang Ding, Mingyong Gao, Lilian Tan, Xinhua Wei, Ruimeng Yang, Xinqing Jiang
  European Radiology.2024; 35(6): 3460.     CrossRef
• Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
  Yu-Tang Chen, Bo-Wen-Tao Chen, Jun-Ming Xu, Xiao-Cui You, Yi Tang, Shao-Jie Wu, Zhu-Ting Fang
  Journal of Hepatocellular Carcinoma.2024; Volume 11: 2441.     CrossRef
• APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
  George Lau, Shuntaro Obi, Jian Zhou, Ryosuke Tateishi, Shukui Qin, Haitao Zhao, Motoyuki Otsuka, Sadahisa Ogasawara, Jacob George, Pierce K. H. Chow, Jianqiang Cai, Shuichiro Shiina, Naoya Kato, Osamu Yokosuka, Kyoko Oura, Thomas Yau, Stephen L. Chan, Min
  Hepatology International.2024; 18(6): 1661.     CrossRef
• International perspectives on LI-RADS
  Andrea S. Kierans, Diego A. Aguirre, Sonal Krishan, Jeong Min Lee, Maxime Ronot, Jin Wang, Elizabeth M. Hecht
  Abdominal Radiology.2024; 50(7): 2917.     CrossRef
• Identification of macrotrabecular‐massive hepatocellular carcinoma through multiphasic CT‐based representation learning method
  Zhenyang Zhang, Wanli Zhang, Chutong He, Jincheng Xie, Fangrong Liang, Yandong Zhao, Lilian Tan, Shengsheng Lai, Xinqing Jiang, Xinhua Wei, Xin Zhen, Ruimeng Yang
  Medical Physics.2024; 51(12): 9017.     CrossRef
• The Pretreatment Neutrophil-to-Lymphocyte Ratio as a Near-Term Prognostic Indicator in Patients with Locally Advanced Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy: A Propensity Score Matching Cohort Study
  Weifu Liu, Kongzhi Zhang, Shiguang Chen, Xiaolong Wang, Wenchang Yu
  British Journal of Hospital Medicine.2024; 85(11): 1.     CrossRef
• Repeat laparoscopic hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: A multicenter, propensity score matching analysis
  Zihui Ma, Xiaolu Lin, Jinglei Zhang, Xingchao Song, Maolin Yan, Lei Guo, Jie Xue, Chongde Lu, Jie Shi, Shuqun Cheng, Weixing Guo
  BioScience Trends.2024; 18(6): 563.     CrossRef
• Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
  Jaejun Lee, Jae-Sung Yoo, Ji Hoon Kim, Dong Yeup Lee, Keungmo Yang, Bohyun Kim, Joon-Il Choi, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ji Won Han, Pil Soo Sung
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Prognostic Evaluation of Conversion Therapy following Hepatic Arterial Infusion Chemotherapy or Immunotherapy in Patients with Advanced or Transarterial Chemoembolization Unsuitable Intermediate-Stage Hepatocellular Carcinoma: A Retrospective Cohort Study
  Li-Fu Kuo, Wen-Chun Liu, Ming-Feng Li, Fu-Huan Huang, Chu-Kuang Chou, Tsung-Hsien Chen, Yi-Tseng Tsai, Ping-I. Hsu, Chao-Jen Li, I.-Ting Wu, Kun-Feng Tsai
  Oncology.2024; 103(7): 549.     CrossRef
• A comprehensive study on the feasibility and diagnostic potential of fluctuation imaging in liver tumor assessment
  Dong Ho Lee, Jae Young Lee
  Scientific Reports.2024;[Epub]     CrossRef
• Emerging Prospects for Combining Immune Checkpoint Inhibitors with Loco-regional Therapy in Hepatocellular Carcinoma
  Eun Young Cho, Chang Hun Lee, In Hee Kim
  Journal of Digestive Cancer Research.2024; 12(3): 229.     CrossRef
• Treatment Duration of Adjuvant Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Patients at High Risk of Recurrence after Resection: A Prospective, Multicentric Cohort Study
  Jia-Yong Su, Shao-Ping Liu, Xiao-Ling Xu, Jun-Jie Ou, Po-Hua Ye, Bin-Tong Zhao, Jia-Song Chen, Qiu-Mei Luo, Jin-Rong Liu, Fei-Min Tang, Jian-Rong Li, Da-Long Yang, Zhu-Jian Deng, Li-Xin Pan, Yao-Jie Li, Le Li, Zhen-Ming Qin, Xiu-Mei Liang, Yi-Li Ma, Liang
  Liver Cancer.2024; 14(4): 378.     CrossRef
• Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
  European Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
  Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
  Infectious Agents and Cancer.2023;[Epub]     CrossRef
• A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
  Chih-Lang Lin, Kung-Hao Liang, Ching-Chih Hu, Cheng-Hung Chien, Li-Wei Chen, Rong-Nan Chien, Yang-Hsiang Lin, Chau-Ting Yeh
  International Journal of Molecular Sciences.2023; 24(2): 1681.     CrossRef
• Barriers to palliative care in hepatocellular carcinoma: A review of the literature
  Mostafa Abasseri, Shakira Hoque, BA Slavica Kochovska, Kim Caldwell, Linda Sheahan, Amany Zekry
  Journal of Gastroenterology and Hepatology.2023; 38(7): 1047.     CrossRef
• Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis
  Su Jong Yu, Jeong-Ju Yoo, Dong Ho Lee, Su Jin Kim, Eun Ju Cho, Se Hyung Kim, Jeong-Hoon Lee, Yoon Jun Kim, Jeong Min Lee, Jae Young Lee, Jung-Hwan Yoon
  Biomedicines.2023; 11(2): 382.     CrossRef
• Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis
  Yinbiao Cao, Haowen Tang, Bingyang Hu, Wenwen Zhang, Tao Wan, Jun Han, Tianyu Jiao, Junfeng Li, Xuerui Li, Zhanyu Yang, Zhe Liu, Minggen Hu, Weidong Duan, Chenggang Li, Zhiming Zhao, Shichun Lu
  HPB.2023; 25(7): 775.     CrossRef
• Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
  Sung Won Chung, Heejin Cho, Hyunjae Shin, Jeayeon Park, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Myungsu Lee, Yoon Jun Kim, Jin Chul Paeng, Jung-Hwan Yoon, Jin Wook Chung, Jeong-Hoon Lee, Hyo-Cheol Kim
  Frontiers in Oncology.2023;[Epub]     CrossRef
• A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment
  Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
  Journal of Liver Cancer.2023; 23(1): 206.     CrossRef
• Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
  Ja Kyung Yoon, Sunyoung Lee, Jeong Ah Hwang, Ji Eun Lee, Seung-seob Kim, Myeong-Jin Kim
  Journal of Liver Cancer.2023; 23(1): 157.     CrossRef
• How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
  Beom Kyung Kim
  Journal of Liver Cancer.2023; 23(1): 121.     CrossRef
• Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
  Yuri Cho, Bo Hyun Kim, Joong-Won Park
  Clinical and Molecular Hepatology.2023; 29(2): 252.     CrossRef
• What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
  Min Kyung Park, Yoon Jun Kim
  Clinical and Molecular Hepatology.2023; 29(2): 332.     CrossRef
• Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
  Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
  Clinical and Molecular Hepatology.2023; 29(2): 206.     CrossRef
• Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
  Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
  Clinical and Molecular Hepatology.2023; 29(2): 197.     CrossRef
• The current trends in the health burden of primary liver cancer across the globe
  Peter Konyn, Aijaz Ahmed, Donghee Kim
  Clinical and Molecular Hepatology.2023; 29(2): 358.     CrossRef
• Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
  Shen-Yung Wang
  Clinical and Molecular Hepatology.2023; 29(2): 349.     CrossRef
• Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
  Do Young Kim
  Clinical and Molecular Hepatology.2023; 29(2): 335.     CrossRef
• Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
  Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
  Clinical and Molecular Hepatology.2023; 29(2): 242.     CrossRef
• Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
  Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
  Clinical and Molecular Hepatology.2023; 29(2): 230.     CrossRef
• Higher Number of Tumor-Infiltrating PD-L1+ Cells Is Related to Better Response to Multikinase Inhibitors in Hepatocellular Carcinoma
  Ji Won Han, Ji Hoon Kim, Dong Hyun Kim, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jaegyoon Ahn, Hyun Yang, Pil Soo Sung
  Diagnostics.2023; 13(8): 1453.     CrossRef
• Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC
  Wang Yao, Ran Wei, Jia Jia, Wang Li, Mengxuan Zuo, Shuqing Zhuo, Ge Shi, Peihong Wu, Chao An
  Therapeutic Advances in Medical Oncology.2023;[Epub]     CrossRef
• Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
  Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
  Diagnostics.2023; 13(9): 1537.     CrossRef
• Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation
  Carlo Bosi, Margherita Rimini, andrea Casadei-Gardini, Giorgio Ercolani
  Expert Review of Anticancer Therapy.2023; 23(5): 503.     CrossRef
• Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy
  Stergios A. Polyzos, Lampros Chrysavgis, Ilias D. Vachliotis, Evangelos Chartampilas, Evangelos Cholongitas
  Seminars in Cancer Biology.2023; 93: 20.     CrossRef
• Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
  Hui Liu, Cheng-Long Han, Bao-Wen Tian, Zi-Niu Ding, Ya-Fei Yang, Yun-Long Ma, Chun-Cheng Yang, Guang-Xiao Meng, Jun-Shuai Xue, Dong-Xu Wang, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
  Expert Review of Gastroenterology & Hepatology.2023; 17(6): 623.     CrossRef
• Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection
  Yue Xu, Xiaoqin Yao, Jinmei Li, Guoyuan Zhang, Guangcheng Luo, Qiang Wang
  Cancer Medicine.2023; 12(12): 13329.     CrossRef
• Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes
  Ji Hoon Kim, Jin Hyoung Kim, Hyun-Ki Yoon, Gi-Young Ko, Ji Hoon Shin, Dong Il Gwon, Heung-Kyu Ko, Hee Ho Chu, Seong Ho Kim, Gun Ha Kim, Yonghun Kim, Shakir Aljerdah
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score
  Min Kyung Park, Dong Ho Lee, Bo Yun Hur, Hyung-Chul Lee, Yun Bin Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee
  Radiology.2023;[Epub]     CrossRef
• Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology
  Woo Kyoung Jeong, Hyo-Jin Kang, Sang Hyun Choi, Mi-Suk Park, Mi Hye Yu, Bohyun Kim, Myung-Won You, Sanghyeok Lim, Young Seo Cho, Min Woo Lee, Jeong Ah Hwang, Jae Young Lee, Jung Hoon Kim, Ijin Joo, Jae Seok Bae, So Yeon Kim, Yong Eun Chung, Dong Hwan Kim,
  Korean Journal of Radiology.2023; 24(6): 482.     CrossRef
• Transarterial Chemoembolization for Hepatocellular Carcinoma: 2023 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association
  Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
  Korean Journal of Radiology.2023; 24(7): 606.     CrossRef
• Comparative Study of Long-Term Outcomes of Laparoscopic Liver Resection versus Radiofrequency Ablation for Single Small Hepatocellular Carcinoma Located in Left Lateral Segments of the Liver
  MeeYoung Kang, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, Yeshong Park, Jinju Kim, Chang Jin Yoon
  Medicina.2023; 59(6): 1063.     CrossRef
• Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
  Beom Kyung Kim, Sang Hoon Ahn
  Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
• Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
  Bong Kyung Bae, Jeong Il Yu, Hee Chul Park, Myung Ji Goh, Yong-Han Paik
  Radiation Oncology Journal.2023; 41(2): 98.     CrossRef
• Magnetic Resonance Imaging-Based Surveillance of Hepatocellular Carcinoma: Current Status and Future Perspectives
  Hyo Jung Park, So Yeon Kim, Young-Suk Lim
  Current Hepatology Reports.2023; 22(3): 83.     CrossRef
• Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association–National Cancer Center 2022 Criteria
  Ja Kyung Yoon, Dai Hoon Han, Sunyoung Lee, Jin-Young Choi, Gi Hong Choi, Do Young Kim, Myeong-Jin Kim
  Cancer Research and Treatment.2023; 55(3): 939.     CrossRef
• Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
  Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang
  BMC Cancer.2023;[Epub]     CrossRef
• Comparison of Open versus Laparoscopic Approaches in Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation
  Yeshong Park, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Boram Lee, MeeYoung Kang, Jinju Kim
  Medicina.2023; 59(7): 1243.     CrossRef
• Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study
  Le Li, Pei-Sheng Wu, Xiu-Mei Liang, Kang Chen, Guan-Lan Zhang, Qi-Bin Su, Rong-Rui Huo, Rong-Wei Xie, Shan Huang, Liang Ma, Jian-Hong Zhong
  Journal of Gastroenterology.2023; 58(10): 1043.     CrossRef
• Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
  Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim
  Clinical and Molecular Hepatology.2023; 29(3): 763.     CrossRef
• Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association
  Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
  Clinical and Molecular Hepatology.2023; 29(3): 521.     CrossRef
• Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging
  Yoon Jung Hwang, Jae Seok Bae, Youngeun Lee, Bo Yun Hur, Dong Ho Lee, Haeryoung Kim
  Clinical and Molecular Hepatology.2023; 29(3): 733.     CrossRef
• Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods
  Seungchul Han, Se Woo Kim, Sungeun Park, Jeong Hee Yoon, Hyo-Jin Kang, Jeongin Yoo, Ijin Joo, Jae Seok Bae, Jeong Min Lee
  Ultrasound in Medicine & Biology.2023; 49(10): 2256.     CrossRef
• Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
  Jongman Kim, Dong-Jin Joo, Shin Hwang, Jeong-Moo Lee, Je-Ho Ryu, Yang-Won Nah, Dong-Sik Kim, Doo-Jin Kim, Young-Kyoung You, Hee-Chul Yu
  World Journal of Gastrointestinal Surgery.2023; 15(7): 1340.     CrossRef
• Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
  Yuri Cho, Jin Woo Choi, Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun, In Joon Lee, Hyunchul Rhim
  Journal of Liver Cancer.2023; 23(2): 241.     CrossRef
• A Case of Transverse Myelitis Following Treatment with Atezolizumab for Advanced Hepatocellular Carcinoma
  Kyung Han Kim, Yang-Hyun Baek, Yeo Wool Kang, Byeol-A Yoon, Sang Yi Moon
  The Korean Journal of Gastroenterology.2023; 82(1): 35.     CrossRef
• Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines from the Korean Society of Radiology and the Korean Society of Abdominal Radiology
  Woo Kyoung Jeong, Hyo-Jin Kang, Sang Hyun Choi, Mi-Suk Park, Mi Hye Yu, Bohyun Kim, Myung-Won You, Sanghyeok Lim, Young Seo Cho, Min Woo Lee, Jeong Ah Hwang, Jae Young Lee, Jung Hoon Kim, Ijin Joo, Jae Seok Bae, So Yeon Kim, Yong Eun Chung, Dong Hwan Kim,
  Korean Journal of Abdominal Radiology.2023; 7(1): 1.     CrossRef
• Suboptimal performance of LI-RADS v2018 on gadoxetic acid–enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates
  Na Eun Oh, Sang Hyun Choi, Sehee Kim, Habeen Lee, Hyeon Ji Jang, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin
  European Radiology.2023; 34(1): 465.     CrossRef
• External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion
  Jeong Il Yu, Hee Chul Park, Hyunju Shin, Hyunki Park, Sung Wook Shin, Sung Ki Cho, Dongho Hyun, Jaeseung Shin, Myung Ji Goh, Moon Seok Choi, Boram Park, Sang Min Yoon, Jinhong Jung
  Radiotherapy and Oncology.2023; 187: 109841.     CrossRef
• Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study
  Jae-Hyun Yoon, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, Jeong-Han Kim
  Medicina.2023; 59(8): 1436.     CrossRef
• Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab
  Kazuhiro Nouso, Shohei Shiota, Rio Fujita, Akiko Wakuta, Kazuya Kariyama, Atsushi Hiraoka, Masanori Atsukawa, Joji Tani, Toshifumi Tada, Shinichiro Nakamura, Kazuto Tajiri, Masaki Kaibori, Masashi Hirooka, Ei Itobayashi, Satoru Kakizaki, Atsushi Naganuma,
  Cancer Medicine.2023; 12(17): 17849.     CrossRef
• Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
  Hyo-Jin Kang, Jeong Min Lee, Se Woo Kim
  Ultrasonography.2023; 42(4): 479.     CrossRef
• The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
  Matthew Man Pok Lee, Landon Long Chan, Stephen Lam Chan
  Journal of Liver Cancer.2023; 23(2): 262.     CrossRef
• A Real-World Comparative Analysis of Atezolizumab Plus Bevacizumab and Transarterial Chemoembolization Plus Radiotherapy in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
  Soon Kyu Lee, Jung Hyun Kwon, Sung Won Lee, Hae Lim Lee, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U Im Chang, Jin Mo Yang, Soon Woo Nam, Seok-Hwan Kim, Myeong Jun Song, Ji Hoon Kim, Ahlim Lee, Hyun Yang, Si Hyun Bae, Ji Won Han, Heechul Nam, Pil Soo Su
  Cancers.2023; 15(17): 4423.     CrossRef
• Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma
  Kazuhiro Nouso, Shohei Shiota, Rio Fujita, Akiko Wakuta, Kazuya Kariyama, Atsushi Hiraoka, Masanori Atsukawa, Joji Tani, Toshifumi Tada, Yu Matsuo, Shinichiro Nakamura, Kazuto Tajiri, Masaki Kaibori, Masashi Hirooka, Ei Itobayashi, Satoru Kakizaki, Atsush
  Liver Cancer International.2023; 4(3-4): 101.     CrossRef
• Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea
  Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han
  Infectious Diseases and Therapy.2023; 12(10): 2387.     CrossRef
• A Phase I/IIa Trial of Yttrium-90 Radioembolization in Combination with Durvalumab for Locally Advanced Unresectable Hepatocellular Carcinoma
  Yun Bin Lee, Joon Yeul Nam, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Hyo-Cheol Kim, Jin Chul Paeng, Jung-Hwan Yoon, Yoon Jun Kim
  Clinical Cancer Research.2023; 29(18): 3650.     CrossRef
• Has the growing evidence of radiotherapy for hepatocellular carcinoma increased the use of radiotherapy in elderly patients?
  Tae Hyun Kim
  Radiation Oncology Journal.2023; 41(3): 141.     CrossRef
• Salvage Hepatectomy for Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation: A Retrospective Cohort Study with Propensity Score-Matched Analysis
  Yeshong Park, Ho-Seong Han, Yoo-Seok Yoon, Chang Jin Yoon, Hae Won Lee, Boram Lee, MeeYoung Kang, Jinju Kim, Jai Young Cho
  Cancers.2023; 15(19): 4745.     CrossRef
• Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis
  Myung Ji Goh, Jihye Kim, Won Hyuk Chang, Dong Hyun Sinn, Geum-Yeon Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jong Man Kim, Wonseok Kang
  Gut and Liver.2023; 17(5): 786.     CrossRef
• Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
  Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon
  Clinical and Molecular Hepatology.2023; 29(4): 1029.     CrossRef
• Management of early-stage hepatocellular carcinoma: challenges and strategies for optimal outcomes
  Jae Hyun Yoon, Sung Kyu Choi
  Journal of Liver Cancer.2023; 23(2): 300.     CrossRef
• Diagnostic performance of magnetic resonance imaging and contrast-enhanced ultrasound in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma: a meta-analysis
  Yingyi Wu, Chunchao Xia, Jie Chen, Qin Qin, Zheng Ye, Bin Song
  Abdominal Radiology.2023; 49(1): 34.     CrossRef
• Novel paradigm in the treatment of hepatocellular carcinoma: Anticipating breakthroughs with particle therapy
  Sang Min Yoon
  Clinical and Molecular Hepatology.2023; 29(4): 977.     CrossRef
• Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
  Hyo-Cheol Kim
  Clinical and Molecular Hepatology.2023; 29(4): 984.     CrossRef
• Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
  Hyeon-Jong Kim, Seung Hyuk Lee, Hyun Jeong Shim, Hyun Jin Bang, Sang Hee Cho, Ik-Joo Chung, Eu Chang Hwang, Jun Eul Hwang, Woo Kyun Bae
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
  Sung Uk Lee, Tae Hyun Kim
  Clinical and Molecular Hepatology.2023; 29(4): 958.     CrossRef
• Nomogram for predicting overall survival in patients with large (>5 cm) hepatocellular carcinoma based on real-world practice
  Nalee Kim, Jeong Il Yu, Hee Chul Park, Jung Yong Hong, Ho Yeong Lim, Myung Ji Goh, Yong-Han Paik
  Journal of Liver Cancer.2023; 23(2): 350.     CrossRef
• Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis
  Ha Il Kim, Jihyun An, Seungbong Han, Ju Hyun Shim
  Clinical and Molecular Hepatology.2023; 29(4): 1013.     CrossRef
• The efficacy of treatment for hepatocellular carcinoma in elderly patients
  Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
  Journal of Liver Cancer.2023; 23(2): 362.     CrossRef
• Does threshold growth benefit imaging criteria when used as a major diagnostic imaging feature for hepatocellular carcinoma?
  Ji Young Choi, Rohee Park, Sang Hyun Choi, Hyeon Ji Jang, Se Jin Choi, Subin Heo
  European Journal of Radiology.2023; 169: 111188.     CrossRef
• Predicting the risk of early bleeding following endoscopic variceal ligation in cirrhotic patients with computed tomography
  Hwaseong Ryu, Tae Un Kim, Ki Tae Yoon, Young Mi Hong
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Hepatocellular Carcinoma: Optimal Radiological Evaluation before Liver Transplantation
  Marco Dioguardi Burgio, Lorenzo Garzelli, Roberto Cannella, Maxime Ronot, Valérie Vilgrain
  Life.2023; 13(12): 2267.     CrossRef
• Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study
  Jonathan Abdelmalak, Simone I. Strasser, Natalie Ngu, Claude Dennis, Marie Sinclair, Avik Majumdar, Kate Collins, Katherine Bateman, Anouk Dev, Joshua H. Abasszade, Zina Valaydon, Daniel Saitta, Kathryn Gazelakis, Susan Byers, Jacinta Holmes, Alexander J.
  Cancers.2023; 15(24): 5741.     CrossRef
• Survival Prediction Model for Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis Based on XGBoost Algorithm
  Jihye Lim, Hyeon-Gi Jeon, Yeonjoo Seo, Moonjin Kim, Ja Un Moon, Se Hyun Cho
  Journal of Hepatocellular Carcinoma.2023; Volume 10: 2251.     CrossRef
• Sequential regorafenib or nivolumab therapy in recurrent hepatocellular carcinoma with sorafenib failure in liver transplant patients does not improve prognosis
  Jieun Kwon, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
  Annals of Liver Transplantation.2023; 3(2): 104.     CrossRef
• Thermal ablation of hepatocellular carcinoma
  Laura Crocetti, Paola Scalise, Elena Bozzi, Gianvito Candita, Roberto Cioni
  Journal of Medical Imaging and Radiation Oncology.2023; 67(8): 817.     CrossRef
• Development and Validation of a Difficulty Scoring System for Laparoscopic Liver Resection to Treat Hepatolithiasis
  Yeongsoo Jo, Jai Young Cho, Ho-Seong Han, Yoo-Seok Yoon, Hae Won Lee, Jun Suh Lee, Boram Lee, Eunhye Lee, Yeshong Park, MeeYoung Kang, Junghyun Lee
  Medicina.2022; 58(12): 1847.     CrossRef
• Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
  Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
  Diagnostics.2022; 13(1): 3.     CrossRef

Citations

Citations to this article as recorded by  

• Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases
  Jongman Kim, Sang Jin Kim, Boram Park, Kyunga Kim, YoungRok Choi, Geun Hong, Jun Yong Park, Young Seok Han, Nam-Joon Yi, Seung Heui Hong, Soon-Young Kim, Jungbun Park, Youngwon Hwang, Dong-Hwan Jung
  Journal of Korean Medical Science.2026;[Epub]     CrossRef
• Chronic comorbidities, concomitant medications, and treatment patterns of chronic hepatitis B patients receiving nucleos(t)ide analogue therapy: a hospital claims database study in Japan
  Daisuke Nakamoto, Emi Ohata, Mayumi Yuda, Nobuyuki Fukui, Nao Makino, Rie Kanamori, Nozomi Aoki, Akio Kanazawa, Hirotake Mori, Yuji Nishizaki, Hirohide Yokokawa, Yuichiro Yano, Toshio Naito
  BMC Infectious Diseases.2026;[Epub]     CrossRef
• A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
  Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo
  Journal of Hepatology.2025; 82(2): 235.     CrossRef
• Impact of Maternal Hepatitis B Virus Infection on Congenital Heart Disease Risk in Offspring: A National Cohort Study
  Yewan Park, Jihye Heo, Danbee Kang, Geum‐Youn Gwak
  Journal of Viral Hepatitis.2025;[Epub]     CrossRef
• A Machine Learning Model to Predict De Novo Hepatocellular Carcinoma Beyond Year 5 of Antiviral Therapy in Patients With Chronic Hepatitis B
  Yeonjung Ha, Seungseok Lee, Jihye Lim, Kwanjoo Lee, Young Eun Chon, Joo Ho Lee, Kwan Sik Lee, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Dong Keon Yon, Jinseok Lee, Han Chu Lee
  Liver International.2025;[Epub]     CrossRef
• AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
  Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se
  Journal of Hepatology.2025; 82(6): 1080.     CrossRef
• Accelerating the momentum to achieve global elimination of hepatitis B infection: a scoping review of hepatitis B guidelines to reduce mother to child transmission
  Ka Wang Cheung, Ying Rong Li, Ms Tiffany Sin-Tung Au, Mimi Tin Yan Seto
  eClinicalMedicine.2025; 80: 103038.     CrossRef
• Effect of invasive tests during pregnancy on perinatal transmission of hepatitis B infection: a scoping review
  Ka Wang Cheung, Tiffany Sin-Tung Au, Ying Rong Li, Zhenyan Han, Zhu Zhang, Mimi Tin Yan Seto
  eClinicalMedicine.2025; 80: 103039.     CrossRef
• Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
  Soon Kyu Lee, Ho Joong Choi, Young Kyoung You, Pil Soo Sung, Seung Kew Yoon, Jeong Won Jang, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(1): 131.     CrossRef
• Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
  Log Young Kim, Jae Young Kim, Jeong‐Ju Yoo, Sang Gyune Kim, Young‐Seok Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study
  Jung Hee Kim, Sung-Eun Kim, Do Seon Song, Hee Yeon Kim, Eileen L. Yoon, Ji Won Park, Tae Hyung Kim, Young-Kul Jung, Ki Tae Suk, Hyung Joon Yim, Jung Hyun Kwon, Sung Won Lee, Seong Hee Kang, Moon Young Kim, Soung Won Jeong, Jae-Young Jang, Jeong Ju Yoo, Sa
  Annals of Medicine.2025;[Epub]     CrossRef
• The sV184A Variant in HBsAg Specific to HBV Subgenotype C2 Leads to Enhanced Viral Replication and Apoptotic Cell Death Induced by PERK‐eIF2α‐CHOP‐Mediated ER Stress
  Yu‐Min Choi, Dong Hyun Kim, Eun Ju Cho, Ziyun Kim, Junghwa Jang, Hyunsoo Kim, Su Jong Yu, Bum‐Joon Kim
  Journal of Medical Virology.2025;[Epub]     CrossRef
• Comparison of hepatocellular carcinoma incidence after long-term treatment with besifovir vs. tenofovir AF
  Hyuk Kim, Jae-Young Kim, Yoon E. Shin, Hye-Jin Yoo, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Prediction of long-term HBsAg seroclearance in patients with HBeAg-negative chronic hepatitis B
  Hae Lim Lee, Soon Kyu Lee, Ji Won Han, Hyun Yang, Heechul Nam, Pil Soo Sung, Hee Yeon Kim, Sung Won Lee, Do Seon Song, Jung Hyun Kwon, Chang Wook Kim, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  JHEP Reports.2025; 7(7): 101391.     CrossRef
• Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
  Tyng‐Yuan Jang, Chia‐Yen Dai
  Advances in Digestive Medicine.2025;[Epub]     CrossRef
• Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
  Soon Kyu Lee, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(2): e161.     CrossRef
• Reconsidering treatment indications for chronic hepatitis B: Insights from the TORCH-B roll-over study: Editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”
  Chih-Wen Wang, Ming-Lung Yu
  Clinical and Molecular Hepatology.2025; 31(2): 606.     CrossRef
• Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
  Soon Kyu Lee, Jong Young Choi
  Clinical and Molecular Hepatology.2025; 31(2): e212.     CrossRef
• Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
  Jihye Lim, Hyundam Gu, Hyunji Sang, Su Jin Jeong, Ha Il Kim
  Alzheimer's Research & Therapy.2025;[Epub]     CrossRef
• Unraveling Demographic Patterns in Hepatitis B Clinical and Laboratory Profiles: Insights From a Ghanaian Cohort: A Retrospective Study
  Napoleon Bellua Sam, Saeed Folorunsho Majeed, Adams Dramani
  Health Science Reports.2025;[Epub]     CrossRef
• A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B
  Jiwon Yang, Mark D. Muthiah, Won-Mook Choi
  Current Hepatology Reports.2025;[Epub]     CrossRef
• A greater frequency of circulating CCR7loPD-1hi follicular helper T cells indicates a durable clinical cure after Peg IFN-α therapy in chronic hepatitis B patients
  Shan Ren, Xiao Lin, Wenjing Wang, Wang Xiaoxiao, Lina Ma, Yanhong Zheng, Sujun Zheng, Xinyue Chen
  Hepatology Communications.2025;[Epub]     CrossRef
• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  Han Ah. Lee, Hyun Woong Lee, Yeon Seok Seo, Dong Hyun Sinn, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2025; 40(7): 1675.     CrossRef
• Head‐to‐Head Comparison of Long‐Term HCC Risk of Antivirals‐Treated Versus Untreated Low‐Level Viremia in HBV‐Compensated Cirrhosis
  Nobuharu Tamaki, Daniel Q. Huang, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Dong Hyun Sinn, Tae Seop Lim, Hiroyuki Marusawa, Seng Gee Lim, Hironori Ochi, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Masayuki Kurosaki, Beom Kyung K
  Journal of Gastroenterology and Hepatology.2025; 40(6): 1595.     CrossRef
• Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients
  Jihye Lim, Hyo Young Lee, Hyunji Sang, Su Jin Jeong, Ha Il Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis B
  Tyng-Yuan Jang, Yu-ting Zeng, Po-Cheng Liang, Chih-Da Wu, Yu-Ju Wei, Pei-Chien Tsai, Po-Yao Hsu, Yi-Shan Tsai, Ming-Yen Hsieh, Yi-Hung Lin, Meng-Hsuan Hsieh, Chih-Wen Wang, Jeng-Fu Yang, Ming-Lun Yeh, Chung-Feng Huang, Wan-Long Chuang, Jee-Fu Huang, Batbo
  Journal of the Chinese Medical Association.2025; 88(5): 361.     CrossRef
• Concise Commentary: Gray Area—Underappreciated HCC Risk in Untreated “Gray Zone” and Immune-Tolerant CHB Patients
  Won-Mook Choi
  Digestive Diseases and Sciences.2025; 70(9): 2910.     CrossRef
• Immunizations in adult liver transplant candidates and recipients
  Dongwook Kim, Pyoeng Gyun Choe
  Annals of Liver Transplantation.2025; 5(1): 19.     CrossRef
• Emergency living donor liver transplantation
  Jongman Kim
  Annals of Liver Transplantation.2025; 5(1): 27.     CrossRef
• Association between maternal chronic hepatitis B virus infection and the neurodevelopment of children: A comprehensive Korean cohort study
  Yewan Park, Jihye Heo, Danbee Kang, Geum-Youn Gwak
  Preventive Medicine Reports.2025; 55: 103116.     CrossRef
• Letter on ‘Association Between Viral Replication Activity and Postoperative Recurrence of HBV‐Related Hepatocellular Carcinoma’. Authors' Reply
  Jiwon Yang, Won‐Mook Choi
  Alimentary Pharmacology & Therapeutics.2025; 62(2): 238.     CrossRef
• Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study
  Young Joo Park, Ki Youn Yi, Hyun Young Woo, Jeong Heo, Geun Am Song, Riccardo Nevola
  PLOS One.2025; 20(5): e0324019.     CrossRef
• Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates
  Liang Wang, Shipeng Ma, Lajpat Rai Malhi, Xiaoping Wu, Liping Liu, Xin Wan, Yuliang Zhang, Xiaopeng Li, Shanfei Ge
  Annals of Hepatology.2025; 30(2): 101925.     CrossRef
• Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study
  Young Eun Chon, Jonghyun Lee, Eileen L. Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
  European Journal of Gastroenterology & Hepatology.2025;[Epub]     CrossRef
• Metabolic effects and cardiovascular disease risks of TDF or TAF in patients with chronic hepatitis B: a systematic review and meta-analysis
  Yuan-Hai Zhou, Nan Cai, Yu-Xin Chen, Yong-Lu Su, Peng Hu
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• A Case of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis B Who was Not Under Surveillance Following the Loss of HBsAg
  Myeong Jun Song
  The Korean Journal of Gastroenterology.2025; 85(3): 425.     CrossRef
• Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
  Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
  Osteoporosis International.2025; 36(8): 1391.     CrossRef
• Longitudinal changes in estimated glomerular filtration rates in chronic hepatitis B patients treated with Tenofovir Alafenamide vs Entecavir
  Xuan Li, Qiang Wu, Fang Huang, Changxiang Lai, Fengjuan Chen, Juan Meng, Fang Wang, Hui Zeng, Lina Zhang
  PeerJ.2025; 13: e19901.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Ki, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Annals of Surgical Treatment and Research.2025; 109(3): 123.     CrossRef
• Chronic hepatitis B: Is it time for expanded antiviral treatment?
  Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra
  World Journal of Virology.2025;[Epub]     CrossRef
• Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Tenofovir Alafenamide or Tenofovir Disoproxil Fumarate
  Jiwon Yang, Jihye Lim, Ye‐Jee Kim, Hwa Jung Kim, Jonggi Choi
  Liver International.2025;[Epub]     CrossRef
• Aspirin Use and Risk of HCC and Gastrointestinal Bleeding in Patients With HBV‐Related Cirrhosis: A Landmark Analysis
  Mi Na Kim, Geun U. Park, Seng Chan You, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn
  Journal of Gastroenterology and Hepatology.2025; 40(11): 2750.     CrossRef
• Surgical treatment of hepatocellular carcinoma: an expert consensus-based practical recommendation from the Korean Liver Cancer Association
  Min-Su Park, Jai Young Cho, Eunju Kim, Hee Young Na, YoungRok Choi, Na Reum Kim, Young-In Yoon, Boram Lee, Eun Sun Jang, Yun Kyung Jung, Kyung Sik Kim
  Journal of Liver Cancer.2025; 25(2): 140.     CrossRef
• Comparative Renal Safety of Besifovir Dipivoxil Maleate and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients: Insights From a Nationwide Cohort Study
  Hyun Bin Choi, Jae Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
  Journal of Korean Medical Science.2025;[Epub]     CrossRef
• Distinguishing True Immune Tolerant Hepatitis B Patients: Insights From Long‐Term Clinical Outcomes
  Jung Hyun Kwon, Sung Won Lee, Hee‐Yeon Kim, Do Seon Song, Soon Kyu Lee, Heechul Nam, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  Journal of Viral Hepatitis.2025;[Epub]     CrossRef
• Enhanced Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma Using Age-male-albumin-bilirubin-platelet (aMAP) and Liver Stiffness Assessed by Vibration-controlled Transient Elastography
  Hye Yeon Chon, Hyung Joon Yim, Seok-Jae Heo, Su Jong Yu, Ja Kyung Kim, Sang Hoon Ahn, Grace Lai-Hung Wong, Jimmy Che-To Lai, Terry Cheuk-Fung Yip, Sang Gyune Kim, Yeon Seok Seo, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2025;[Epub]     CrossRef
• Disease burden of chronic hepatitis B and C patients in South Korea: a population-based 16-year cohort study
  Oeuk Jeong, Changhee Chu, Jungyeon Kim, Jae Seung Lee, Jun Yong Park, Kyung Eun Lee, Jaehyun Seong, Min Jin Go
  BMC Infectious Diseases.2025;[Epub]     CrossRef
• Factors associated with TDF-to-TAF switching in chronic hepatitis B: A nationwide cohort study in South Korea
  Hyemin Ha, Kwang Il Seo, Nam Kyung Je
  Journal of Infection and Chemotherapy.2025; 31(12): 102860.     CrossRef
• Predicting risk factors for waiting mortality in adult emergent living donor liver transplantation based on Korean national data
  Sang Jin Kim, Jongman Kim, Kyunga Kim, Soon-Young Kim, Jung-Bun Park, Youngwon Hwang, Dong-Hwan Jung
  Annals of Liver Transplantation.2025; 5(2): 107.     CrossRef
• Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
  Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Gwang Hyeon Choi, Yun Bin Lee, Dong Hyun Sinn, Young-Suk Lim
  Gut.2024; 73(4): 649.     CrossRef
• Gray zone of hepatitis B virus infection
  Young-Suk Lim
  Saudi Journal of Gastroenterology.2024; 30(2): 76.     CrossRef
• PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
  Ho Soo Chun, George V. Papatheodoridis, Minjong Lee, Hye Ah Lee, Yeong Hwa Kim, Seo Hyun Kim, Yun-Seo Oh, Su Jin Park, Jihye Kim, Han Ah Lee, Hwi Young Kim, Tae Hun Kim, Eileen L. Yoon, Dae Won Jun, Sang Hoon Ahn, Vana Sypsa, Cihan Yurdaydin, Pietro Lampe
  Journal of Hepatology.2024; 80(1): 20.     CrossRef
• Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment
  Hyeyeon Hong, Minjoo Cho, Chaeyeon Lim, Won‐Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee, Jonggi Choi
  Alimentary Pharmacology & Therapeutics.2024; 59(4): 515.     CrossRef
• Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy
  Liandong Wu, Zhenggang Yang, Min Zheng
  Journal of Viral Hepatitis.2024; 31(5): 255.     CrossRef
• Jaundice That Has Persisted for 5 Days
  Young Chang
  The Korean Journal of Medicine.2024; 99(3): 140.     CrossRef
• Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels
  Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon
  Diagnostics.2024; 14(5): 495.     CrossRef
• Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study
  Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
  OncoTargets and Therapy.2024; Volume 17: 215.     CrossRef
• Linvencovir: Paving the way for functional cure in hepatitis B
  Jiwon Yang, Jonggi Choi
  Clinical and Molecular Hepatology.2024; 30(2): 164.     CrossRef
• Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis
  Hyunjae Shin, Won-Mook Choi, Seung Up Kim, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yun Bin Lee, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Fabien Zoulim
  JHEP Reports.2024; 6(7): 101089.     CrossRef
• Clinical profile and parameters of patients monoinfected with HBV and infected with HDV in Western Amazon
  Eugênia de Castro e Silva, Tárcio Peixoto Roca, Ana Maísa Passos-Silva, Lourdes Maria Pinheiro Borzacov, Adrhyan Araújo da Silva Oliveira, Jackson Alves da Silva Queiroz, Juan Miguel Villalobos Salcedo, Deusilene Vieira
  Heliyon.2024; 10(10): e31065.     CrossRef
• Macrophage-2-Binding Protein Glycosylation Isomer (M2BPGi) and AGAP Score as Markers of Noninvasive Test for Liver Fibrosis versus FibroScan in Chronic Hepatitis B Patients: A Retrospective Observational Study
  Laila Kurnia Pramono, Anna Tjandrawati, Dewi Kartika Turbawaty, Tiene Rostini, Muhammad Begawan Bestari, Haryono, Deny Budiman, Prapanca Nugraha, Dirk Uhlmann
  International Journal of Hepatology.2024; 2024: 1.     CrossRef
• Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis
  Jaejun Lee, Ahlim Lee, Pil Soo Sung, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Hyun Yang
  The Korean Journal of Internal Medicine.2024; 39(4): 577.     CrossRef
• Treatment decisions based on HBV DNA
  Young‐Suk Lim
  Journal of Viral Hepatitis.2024; 31(S2): 36.     CrossRef
• Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
  Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, Chia‐Yen Dai
  Journal of Gastroenterology and Hepatology.2024; 39(11): 2327.     CrossRef
• Differential HBV replicative markers and covalently closed circular DNA transcription in immune‐active chronic hepatitis B with and without HBeAg
  Hye Seon Kim, Jin Seoub Kim, Ji Min Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam, Pil Soo Sung, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
  Liver International.2024; 44(10): 2753.     CrossRef
• Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
  Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon
  Clinical and Molecular Hepatology.2024; 30(3): 500.     CrossRef
• Association of Hepatitis B Surface Antigen Levels With Long‐Term Complications in Chronic Hepatitis B Virus Infection: A Systematic Literature Review
  Anadi Mahajan, Saifuddin Kharawala, Supriya Desai, Stuart Kendrick, Joyeta Das, Vera Gielen
  Journal of Viral Hepatitis.2024; 31(11): 746.     CrossRef
• Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B
  Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Gwang Hyeon Choi, Won-Mook Choi, Jonggi Choi, Dong Hyun Sinn, Yong-Han Paik, Jeong-Hoon Lee, Yun Bin Lee, Ju-Yeon Cho, Nae-Yun Heo, Man-Fung Yuen, Vincent Wai-Sun Wong, Stephen L. Chan, Hwai-I Yang, Chien-Jen Chen
  Annals of Internal Medicine.2024; 177(10): 1308.     CrossRef
• Risk of dyslipidaemia in people living with HIV who are taking tenofovir alafenamide: a systematic review and meta‐analysis
  Jeong‐Ju Yoo, Eun Ae Jung, Sang Gyune Kim, Young Seok Kim, Min Jae Kim
  Journal of the International AIDS Society.2024;[Epub]     CrossRef
• KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
  Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, D
  Clinical and Molecular Hepatology.2024; 30(Suppl): S5.     CrossRef
• Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis
  Young-Joo Jin, Hee Yeon Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun, Miyoung Choi, Seung Up Kim
  Clinical and Molecular Hepatology.2024; 30(Suppl): S159.     CrossRef
• Recent Trends in Noninvasive Tests for Assessing Hepatic Fibrosis in Patients with Chronic Liver Disease
  Jung Hwan Yu
  The Korean Journal of Medicine.2024; 99(5): 232.     CrossRef
• Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on “Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study”
  Yewan Park, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2024; 30(4): 718.     CrossRef
• Liver Fibrosis Assessment in Chronic Liver Diseases Using Elastography: A Comprehensive Review of Vibration-Controlled Transient Elastography and Shear Wave Elastography
  Han Ah Lee
  Clinical Ultrasound.2024; 9(2): 70.     CrossRef
• Effect of renin-angiotensin system inhibitor in incident cancer among chronic hepatitis B patients: An emulated target trial using a nationwide cohort
  Yewan Park, Danbee Kang, Dong Hyun Sinn, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  Journal of the Renin-Angiotensin-Aldosterone System.2024;[Epub]     CrossRef
• Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation
  Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
  Infectious Agents and Cancer.2023;[Epub]     CrossRef
• Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
  Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee
  European Journal of Gastroenterology & Hepatology.2023; 35(4): 431.     CrossRef
• Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues
  Tyng‐Yuan Jang
  Alimentary Pharmacology & Therapeutics.2023; 57(5): 587.     CrossRef
• The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
  Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2023; 38(5): 716.     CrossRef
• Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
  Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
  Frontiers in Oncology.2023;[Epub]     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Journal of Liver Cancer.2023; 23(1): 1.     CrossRef
• Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study
  Moon Haeng Hur, Min Kyung Park, Terry Cheuk-Fung Yip, Chien-Hung Chen, Hyung-Chul Lee, Won-Mook Choi, Seung Up Kim, Young-Suk Lim, Soo Young Park, Grace Lai-Hung Wong, Dong Hyun Sinn, Young-Joo Jin, Sung Eun Kim, Cheng-Yuan Peng, Hyun Phil Shin, Chi-Yi Ch
  American Journal of Gastroenterology.2023; 118(11): 1963.     CrossRef
• Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
  Jeong-Ju Yoo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 513.     CrossRef
• The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
  Moon Haeng Hur, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(2): 363.     CrossRef
• Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
  Joo Hyun Oh, Dong Hyun Sinn
  Clinical and Molecular Hepatology.2023; 29(2): 367.     CrossRef
• Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis
  Eui Gwon Hwang, Eun-Ae Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Hepatology International.2023; 17(4): 860.     CrossRef
• Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
  Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
  Alimentary Pharmacology & Therapeutics.2023; 58(1): 99.     CrossRef
• Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study
  Selena Y. Lin, Dina Halegoua-DeMarzio, Peter Block, Yu-Lan Kao, Jesse Civan, Fwu-Shan Shieh, Wei Song, Hie-Won Hann, Ying-Hsiu Su
  Diagnostics.2023; 13(9): 1537.     CrossRef
• CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B
  Hye Yeon Chon, Han Ah Lee, Soo Young Park, Yeon Seok Seo, Sang Gyune Kim, Chang Hun Lee, Tae Hee Lee, Sang Hoon Ahn, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Lilian Yan Liang, In Hee Kim, Grace Lai‐Hung Wong, Seung Up Kim
  Journal of Digestive Diseases.2023; 24(2): 113.     CrossRef
• Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study
  Jihye Kim, Moon Haeng Hur, Seung Up Kim, Jin-Wook Kim, Dong Hyun Sinn, Hyun Woong Lee, Moon Young Kim, Jae Youn Cheong, Yong Jin Jung, Han Ah Lee, Young-Joo Jin, Jun Sik Yoon, Sung-Jae Park, Chang Hun Lee, In Hee Kim, June Sung Lee, Young Youn Cho, Hyung
  Cancers.2023; 15(11): 2936.     CrossRef
• Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALT
  宇行 刘
  Advances in Clinical Medicine.2023; 13(05): 8702.     CrossRef
• Primary non-response to antiviral therapy affects the prognosis of hepatitis B virus-related hepatocellular carcinoma
  Peng Wang, Xinhui Wang, Xiaoli Liu, Fengna Yan, Huiwen Yan, Dongdong Zhou, Lihua Yu, Xianbo Wang, Zhiyun Yang
  BMC Cancer.2023;[Epub]     CrossRef
• Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
  Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
  BMC Gastroenterology.2023;[Epub]     CrossRef
• A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Hwiyoung Kim, Taeyun Park, Soo Young Park, Young Eun Chon, Yeon Seok Seo, Jae Seung Lee, Jun Yong park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Seung Up Kim
  Liver International.2023; 43(8): 1813.     CrossRef
• Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non‐cirrhotic patients with chronic hepatitis B
  Cheol‐Hyung Lee, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
  Alimentary Pharmacology & Therapeutics.2023; 58(7): 704.     CrossRef
• The efficacy of treatment for hepatocellular carcinoma in elderly patients
  Han Ah Lee, Sangheun Lee, Hae Lim Lee, Jeong Eun Song, Dong Hyeon Lee, Sojung Han, Ju Hyun Shim, Bo Hyun Kim, Jong Young Choi, Hyunchul Rhim, Do Young Kim
  Journal of Liver Cancer.2023; 23(2): 362.     CrossRef
• Current practice and recommendations for management of hepatitis B virus in people living with HIV in Asia
  Grace Chung‐Yan Lui, Grace Lai‐Hung Wong, Hung‐Chih Yang, Wang‐Huei Sheng, Sun Hee Lee
  HIV Medicine.2023; 24(10): 1035.     CrossRef
• Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
  Dong Hyun Sinn, Danbee Kang, Yewan Park, Hyunsoo Kim, Yun Soo Hong, Juhee Cho, Geum-Youn Gwak
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Adult-onset hypophosphatemic osteomalacia as a cause of widespread musculoskeletal pain: A retrospective case series of single center experience
  Sungwon Kim, Sun Woong Kim, Byung Chan Lee, Du Hwan Kim, Duk Hyun Sung
  World Journal of Clinical Cases.2023; 11(32): 7785.     CrossRef
• Hepatocellular carcinoma presenting as organized liver abscess: A case report
  Sung Hyeok Ryou, Hyun Deok Shin, Suk Bae Kim
  World Journal of Clinical Cases.2023; 11(33): 8078.     CrossRef
• The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
  Jung Kim, Sung-Eun Kim, Do Song, Hee Kim, Eileen Yoon, Seong Kang, Young-Kul Jung, Jung Kwon, Sung Lee, Seul Han, Young Chang, Soung Jeong, Jeong Yoo, Young-Joo Jin, Gab Cheon, Byung Kim, Yeon Seo, Hyoungsu Kim, Ji Park, Tae Kim, Dong Sinn, Woo Chung, Hwi
  Diagnostics.2023; 14(1): 14.     CrossRef
• Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
  Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jonggi Choi
  Clinical and Molecular Hepatology.2023; 30(1): 49.     CrossRef
• Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
  Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
  Medicine.2023; 102(43): e34276.     CrossRef
• Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy
  Myung Ji Goh, Wonseok Kang, Woo Kyoung Jeong, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
  Scientific Reports.2022;[Epub]     CrossRef
• Reply to: “A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations”
  Hyun Yang, Si Hyun Bae, Jeong Won Jang
  Journal of Hepatology.2022; 77(6): 1724.     CrossRef
• Viral Hepatitis in Patients with Inflammatory Bowel Disease
  Seung Hwan Shin, Sang Hyoung Park
  The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
  
  Clinical and Molecular Hepatology.2022; 28(4): 583.     CrossRef
• 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
  
  Korean Journal of Radiology.2022; 23(12): 1126.     CrossRef
• Updated Treatment Guidelines for Chronic Hepatitis B
  Jihyun An
  The Korean Journal of Medicine.2022; 97(6): 353.     CrossRef

Citations

Citations to this article as recorded by  

• Mapping Knowledge Landscapes and Emerging Trends in Contrast-Enhanced Ultrasound for Breast Cancer: A Bibliometric and Visualization Analysis
  Chujun Wang, Zhen Hu, Xia Li, Yan Ding, Chunquan Zhang
  Ultrasound in Medicine & Biology.2026; 52(2): 284.     CrossRef
• Stimuli-responsive nanomedicines for hepatic diseases: mechanism, design, recent advances, and clinical translation
  Leyi Wang, Xue Zhang, Yinggang Li, Min Zhao, Gang Xu, Zhenyu Duan, Qiyong Gong, Kui Luo
  Journal of Controlled Release.2026; 390: 114522.     CrossRef
• A preoperative nomogram with MR elastography in identifying cytokeratin 19 status of hepatocellular carcinoma
  Yanan Gu, Kaipu Jin, Shanshan Gao, Wei Sun, Minyan Yin, Jing Han, Yunfei Zhang, Xiaolin Wang, Mengsu Zeng, Ruofan Sheng
  British Journal of Radiology.2025; 98(1166): 210.     CrossRef
• Comparative evaluation of non-contrast MRI versus gadoxetic acid-enhanced abbreviated protocols in detecting colorectal liver metastases
  Haoran Dai, Cheng Yan, Xi Jia, Yuyao Xiao, Xinyue Liang, Chun Yang, Kai Liu, Mengsu Zeng
  Insights into Imaging.2025;[Epub]     CrossRef
• Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
  Yuqi Feng, Letian Fang, Guangwen Cao
  Hepatoma Research.2025;[Epub]     CrossRef
• Radiomics and Deep Learning as Important Techniques of Artificial Intelligence — Diagnosing Perspectives in Cytokeratin 19 Positive Hepatocellular Carcinoma
  Fei Wang, Chunyue Yan, Xinlan Huang, Jiqiang He, Ming Yang, Deqiang Xian
  Journal of Hepatocellular Carcinoma.2025; Volume 12: 1129.     CrossRef
• Application of high-frequency ultrasound in occult focal liver lesions: Does it help?
  Hong Qin, Zheng-biao Ji, Yu-li Zhu, Qian-nan Zhao, Kai Yuan, Dan Zuo, Xiao-long Zhang, Yi Dong, Wen-ping Wang
  Clinical Hemorheology and Microcirculation.2025; 90(2): 84.     CrossRef
• The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
  Stephen Lam Chan, Hui-Chuan Sun, Yang Xu, Hongmei Zeng, Hashem B El-Serag, Jeong Min Lee, Myron E Schwartz, Richard S Finn, Jinsil Seong, Xin Wei Wang, Valérie Paradis, Ghassan K Abou-Alfa, Lorenza Rimassa, Jia-Horng Kao, Bo-Heng Zhang, Josep M Llovet, Jo
  The Lancet.2025; 406(10504): 731.     CrossRef
• Dynamic contrast-enhanced ultrasound perfusion analysis for preoperative prediction of aggressive hepatocellular carcinoma subtypes
  Xin Guan, Xiao Li, Daohui Yang, Chongke Zhao, Dan Lu, Yaqin Zhang, Yikang Sun, Boyang Zhou, Zitong Chen, Xinyuan Hu, Hong Han, Qing Lu, Huixiong Xu, Lifan Wang
  Insights into Imaging.2025;[Epub]     CrossRef
• Integrated multi-task learning framework for hepatocellular carcinoma segmentation and histological grading using fused multi-phase MRI
  Zhihui You, Yuanru Wang, Shili Zhou
  Abdominal Radiology.2025;[Epub]     CrossRef
• Diagnosis of Hepatocellular Carcinoma Using Gadoxetic Acid‐Enhanced MRI Based on LI‐RADS Version 2018 and LI‐RADS Modifications
  Yanjin Qin, Jing Zhang, Danyang Xu, Xiaoqi Zhou, Zhoukun Ling, Lujie Li, Qiaochu Zhao, Zhi Dong, Jifei Wang, Hua‐Song Cai, Hongxiang Li, Lie‐Guang Zhang, Shi‐Ting Feng
  Liver International.2025;[Epub]     CrossRef
• Trends of liver cell carcinoma mortality in the United States by demographics and geography
  Sishir Doddi, Oscar Salichs, Taryn Hibshman, Puneet Bhargava
  Current Problems in Diagnostic Radiology.2024; 53(2): 208.     CrossRef
• Comparative Performance of 2018 LI‐RADS versus Modified LIRADS (mLI‐RADS): An Individual Participant Data Meta‐Analysis
  Stacy M. Goins, Hanyu Jiang, Christian B. van der Pol, Jean‐Paul Salameh, Eric Lam, Robert G. Adamo, Matthew D.F. McInnes, Andreu F. Costa, Christopher Clarke, Sang Hyun Choi, Tyler J. Fraum, Daniel R. Ludwig, Bin Song, Ijin Joo, Andrea S. Kierans, So Yeo
  Journal of Magnetic Resonance Imaging.2024; 60(3): 1082.     CrossRef
• Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria
  Hyo-Jin Kang, Jeong Min Lee, Jeong Hee Yoon, Jeongin Yoo, Jung Hoon Kim, Jiwon Park
  American Journal of Roentgenology.2024;[Epub]     CrossRef
• Recent Hepatocellular Carcinoma Managements in Korea: Focus on the Updated Guidelines in 2022
  Yuri Cho, Bo Hyun Kim, Young-Suk Lim
  Digestive Disease Interventions.2024; 08(03): 169.     CrossRef
• Atypical Presentation of Hepatocellular Carcinoma in a Chronic Alcoholic: Diagnostic Challenges and Therapeutic Approach
  Bhagyasri Nunna, Pratapsingh Parihar, Suhit Naseri, Rishabh Dhabalia, Saraswathula Bharadwaj
  Cureus.2024;[Epub]     CrossRef
• Re-assessing the diagnostic value of the enhancing capsule in hepatocellular carcinoma imaging
  Jae Seok Bae, Jeong Min Lee, Bo Yun Hur, Jeongin Yoo, Sae-Jin Park
  Journal of Liver Cancer.2024; 24(2): 206.     CrossRef
• Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
  Hyo-Jin Kang, Jeong Min Lee, Se Woo Kim
  Ultrasonography.2023; 42(4): 479.     CrossRef
• The clinical effect of antiviral therapy in patients with hepatitis B virus‐related decompensated cirrhosis and undetectable DNA
  Han Ah Lee, Young‐Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyung Joon Yim, Jong Eun Yeon, Yeon Seok Seo, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2023; 38(5): 716.     CrossRef
• Diagnostic efficacy of contrast-enhanced ultrasound, dynamic contrast-enhanced MRI combined with tumor markers AFP and DCP for primary hepatocellular carcinoma
  Xiaohai Guo, Changqing Tian, Gaili Liu, Xiufang Mi, Dezhen Gao
  Biotechnology and Genetic Engineering Reviews.2023; : 1.     CrossRef
• Clinical Encounters with Kupffer Cells While Managing Patients with Liver Diseases
  Vijay Alexander, Kovi Sai Lakshmi, C. E. Eapen
  Gastroenterology, Hepatology and Endoscopy Practice.2023; 3(2): 39.     CrossRef
• Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
  Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
  Clinical and Molecular Hepatology.2023; 29(2): 197.     CrossRef
• Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
  Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
  Clinical and Molecular Hepatology.2023; 29(2): 206.     CrossRef
• Development of a deep-learning model for classification of LI-RADS major features by using subtraction images of MRI: a preliminary study
  Junghoan Park, Jae Seok Bae, Jong-Min Kim, Joseph Nathanael Witanto, Sang Joon Park, Jeong Min Lee
  Abdominal Radiology.2023; 48(8): 2547.     CrossRef
• Ultrasound radiomics in the prediction of microvascular invasion in hepatocellular carcinoma: A systematic review and meta-analysis
  Qinyu Xiao, Wenjun Zhu, Huanliang Tang, Lijie Zhou
  Heliyon.2023; 9(6): e16997.     CrossRef
• Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation – Real-world data from the prospective multicentre DEGUM study
  Barbara Meitner-Schellhaas, Daniel Jesper, Rüdiger Stephan Goertz, Sebastian Zundler, Deike Strobel
  Clinical Hemorheology and Microcirculation.2023; 84(4): 413.     CrossRef
• Perfluorobutane-Enhanced Ultrasound for Characterization of Hepatocellular Carcinoma From Non-hepatocellular Malignancies or Benignancy: Comparison of Imaging Acquisition Methods
  Seungchul Han, Se Woo Kim, Sungeun Park, Jeong Hee Yoon, Hyo-Jin Kang, Jeongin Yoo, Ijin Joo, Jae Seok Bae, Jeong Min Lee
  Ultrasound in Medicine & Biology.2023; 49(10): 2256.     CrossRef
• Suboptimal performance of LI-RADS v2018 on gadoxetic acid–enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates
  Na Eun Oh, Sang Hyun Choi, Sehee Kim, Habeen Lee, Hyeon Ji Jang, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin
  European Radiology.2023; 34(1): 465.     CrossRef
• Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
  Sung Won Lee, Min Kyu Kang, Xiang Zhang
  Journal of Liver Cancer.2023; 23(2): 238.     CrossRef
• Does threshold growth benefit imaging criteria when used as a major diagnostic imaging feature for hepatocellular carcinoma?
  Ji Young Choi, Rohee Park, Sang Hyun Choi, Hyeon Ji Jang, Se Jin Choi, Subin Heo
  European Journal of Radiology.2023; 169: 111188.     CrossRef
• Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis
  Stacy M. Goins, Hanyu Jiang, Christian B. van der Pol, Jean-Paul Salameh, Eric Lam, Robert G. Adamo, Matthew D. F. McInnes, Andreu F. Costa, An Tang, Ayman S. Alhasan, Brian C. Allen, Caecilia S. Reiner, Christopher Clarke, Milena Cerny, Jin Wang, Sang Hy
  Radiology.2023;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Quinoa bran terpenoids ameliorates metabolic dysfunction-associated steatotic liver disease by enriching of L. murinus LQ719
  Qinqin Qiao, Shuhua Shan, Huiqin Guo, Ning An, Jiangying Shi, Zhuoyu Li
  Food Research International.2026; 225: 118084.     CrossRef
• Effects of Intermittent Calorie Restriction in Nondiabetic Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
  Han Ah Lee, Hyeyoung Moon, Yuri Kim, Jeong Kyong Lee, Hye Ah Lee, Hwi Young Kim
  Clinical Gastroenterology and Hepatology.2025; 23(1): 114.     CrossRef
• Serum Ferritin Levels and Liver‐Related Events in Individuals With Steatotic Liver Disease: A Longitudinal Cohort Study
  Byeong Geun Song, Myung Ji Goh, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
  Alimentary Pharmacology & Therapeutics.2025; 61(3): 491.     CrossRef
• Differential Exercise Requirements for Nonalcoholic Fatty Liver Disease Resolution Across Age Groups: A Longitudinal Study of Korean Military Officers
  Jaejun Lee, Dong Yeup Lee, Jae Hyeop Jung, Eunkyoung Bae, Jeong A. Yu, Hyun Yang
  Journal of Physical Activity and Health.2025; 22(3): 323.     CrossRef
• The Role of microRNA-22 in Metabolism
  Simone Tomasini, Paolo Vigo, Francesco Margiotta, Ulrik Søberg Scheele, Riccardo Panella, Sakari Kauppinen
  International Journal of Molecular Sciences.2025; 26(2): 782.     CrossRef
• Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults
  Jaejun Lee, Chang In Han, Dong Yeup Lee, Pil Soo Sung, Si Hyun Bae, Hyun Yang
  Gut and Liver.2025; 19(1): 116.     CrossRef
• Evidence summary of lifestyle interventions in adults with metabolic dysfunction-associated steatotic liver disease
  Mei-jing Chen, Ying Chen, Jin-qing Lin, Rong Hu, Dun Liu, Jing-yi Chen, Ka Li, Xiao-ying Jiang
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• Diagnostic Accuracy of Non-Invasive Diagnostic Tests for Nonalcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
  Yuxin Sun, Die Hu, Mingkun Yu, Shi-Bing Liang, Youyou Zheng, Xin Wang, Guangdong Tong
  Clinical Epidemiology.2025; Volume 17: 53.     CrossRef
• Cardiovascular Risk From Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiometabolic Risk Factor Count, and Their Longitudinal Changes: A Nationwide Cohort Study
  Hyeok-Hee Lee, Han Ah Lee, Eun-Jin Kim, Hwi Young Kim, Hyeon Chang Kim, Sang Hoon Ahn, Hokyou Lee, Seung Up Kim
  American Journal of Gastroenterology.2025; 120(10): 2321.     CrossRef
• Comparing non-alcoholic fatty liver disease indices in predicting the prevalence and incidence of metabolic syndrome in middle-aged adults
  Byung Sik Kim, Hyun-Jin Kim, Seong Won Jeon, Kyung Hwan Kim, Dong Wook Kim, Jeong-Hun Shin
  Heliyon.2025; 11(7): e43073.     CrossRef
• Impact of cardiometabolic risk factors on hepatic fibrosis and clinical outcomes in MASLD: A population-based multi-cohort study
  Huiyul Park, Terry Cheuk-Fung Yip, Eileen L. Yoon, Grace Lai-Hung Wong, Hye Sun Lee, Vincent Wai-Sun Wong, Jimmy Che-To Lai, Dae Won Jun
  JHEP Reports.2025; 7(6): 101388.     CrossRef
• KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
  Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang
  Clinical and Molecular Hepatology.2025; 31(Suppl): S1.     CrossRef
• The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study
  Yanjun Guo, Wei Su, Lulong Tao, Guoxin Zhang, Kun Wang
  BMC Gastroenterology.2025;[Epub]     CrossRef
• Sex differences in the mediation of the MASLD - Depression association by fat distribution in U.S. adults
  Changhuai He, Liuxin Zhou, Tianming Gao, Runmin Cao, Chuanqi Cai, Guoqing Jiang
  Acta Psychologica.2025; 256: 105041.     CrossRef
• Association Between Perfluoroalkyl Substance (PFAS) Exposure and Nonalcoholic Fatty Liver Disease in Korean Adults: Results From the KoNEHS 2018–2020: A Cross‐Sectional Study
  Jisuk Yun, Young‐Sun Min
  American Journal of Industrial Medicine.2025; 68(7): 588.     CrossRef
• Valorization of grape pomace by microbial fermentation: Composition, biological activities and potential applications for the food industry
  Kavindya Samarakoon, H.P. Vasantha Rupasinghe
  Journal of Food Composition and Analysis.2025; 144: 107656.     CrossRef
• Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A Review
  Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya
  Preventive Medicine: Research & Reviews.2025; 2(4): 183.     CrossRef
• Cost-effectiveness analysis of MASLD screening using FIB-4 based two-step algorithm in the medical check-up
  Mimi Kim, Huiyul Park, Eileen L. Yoon, Ramsey Cheung, Donghee Kim, Hye-Lin Kim, Dae Won Jun
  Scientific Reports.2025;[Epub]     CrossRef
• Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease?
  Milton Artur Ruiz, Roberto Luiz R Kaiser Junior, Gabriel Piron-Ruiz, Luiz Gustavo de Quadros
  World Journal of Stem Cells.2025;[Epub]     CrossRef
• The ameliorative effect of C-Kit+ hepatic endothelial cells with Mertk deficiency on nonalcoholic steatohepatitis
  Seng-Wang Fu, Yu-Xuan Gao, Hui-Yi Li, Jun-Cheng Wu, Zheng-Hong Li, Ming-Yi Xu
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(7): 167964.     CrossRef
• Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease
  Eiji Kakazu, Masaaki Mino, Tatsuya Kanto
  Clinical and Molecular Hepatology.2025; 31(3): 771.     CrossRef
• Chemical profile of Ficus lyrata bark extract and its therapeutic effect on non-alcoholic fatty liver disease via regulating oxidative stress, inflammation and hepatic lipogenesis
  Amria Mamdouh Mousa, Rehab Fikry Taher, Nermin Mohamed El-Sammad, Esraa Aly Balabel, Elham Mohamed Youssef, Ahmed Hassan Afifi, Sahar Samir Abdel-Rahman, Nayera Anwar, Sherien Kamal Hassan
  BMC Complementary Medicine and Therapies.2025;[Epub]     CrossRef
• Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
  Minkwan Kim, Minkook Son, Sang Yi Moon, Yang Hyun Baek
  Journal of the American Heart Association.2025;[Epub]     CrossRef
• Comparison of sarcopenia screening indices using serum creatinine and cystatin C in metabolic dysfunction-associated steatotic liver disease
  Inyoung Hwang, Shi-Ra Lee, Yun Kim, Sang Won Lee
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Exercise training improves metabolic and circulatory function in COPD patients with NAFLD: evidence from clinical and molecular profiling
  Yi-cai Qian, Xiaoxiang Liu, Panpan Liu, ShuYing Jia, Yi Ding, Cuiling Zhu, Jing He
  Frontiers in Medicine.2025;[Epub]     CrossRef
• Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver Disease
  Yunmi Ko, Moon Haeng Hur, Youngsu Park, Jeayeon Park, Hyunjae Shin, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
  Gut and Liver.2025; 19(5): 758.     CrossRef
• Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review
  Muhammad Y. Sheikh, Muhammad F. Younus, Annie Shergill, Muhammad N. Hasan
  International Journal of Molecular Sciences.2025; 26(19): 9625.     CrossRef
• Association of Rapid Early Weight Loss with One-Year Hepatic Steatosis Improvement After Sleeve Gastrectomy: A Retrospective Cohort Study
  Min Kyoung Jang, Si Yeol Yoon, Jin A. An, Ji Soo Kim, Min-Seon Kim, Jung Ah Lee, Chang Seok Ko, Se Hee Min
  Journal of Clinical Medicine.2025; 14(20): 7284.     CrossRef
• Metabolic dysfunction-associated steatotic liver disease in Egypt: Epidemiology, risk factors and management challenges
  Walaa Abdelhamed, Mona Amin, Imam Waked, Mohamed El-Kassas
  World Journal of Gastroenterology.2025;[Epub]     CrossRef
• Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
  Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
  The Journal of Infectious Diseases.2024; 229(1): 108.     CrossRef
• A Comparison of the Prognostic Value of Liver Fibrosis Scores in Acute Myocardial Infarction Patients With and Without Type 2 Diabetes
  Hao-ming He, Shu-wen Zheng, Yi-nong Chen, Long-yang Zhu, Zhe Wang, Si-qi Jiao, Fu-rong Yang, Yi-hong Sun
  Angiology.2024; 75(3): 219.     CrossRef
• Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style
  Qianying Zuo, Nicole Hwajin Park, Jenna Kathryn Lee, Ashlie Santaliz-Casiano, Zeynep Madak-Erdogan
  Steroids.2024; 203: 109330.     CrossRef
• Association between plant-based diets and risk of metabolic dysfunction–associated steatotic liver disease in Korean adults: A prospective cohort study
  Bayarmaa Nasan Ulzii, Kyungjoon Lim, Sangah Shin
  Nutrition.2024; 128: 112579.     CrossRef
• Extrahepatic malignancies in metabolic dysfunction‐associated fatty liver disease: A nationwide cohort study
  Min Kyung Park, Moon Haeng Hur, Hye‐Sung Moon, Hyunjae Shin, Sung Won Chung, Sungho Won, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim
  Liver International.2024; 44(3): 799.     CrossRef
• Performance Evaluation of a Novel Non-Invasive Test for the Detection of Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
  Anna Stefanska, Katarzyna Bergmann, Szymon Suwała, Aneta Mankowska-Cyl, Marek Kozinski, Roman Junik, Magdalena Krintus, Mauro Panteghini
  Metabolites.2024; 14(1): 52.     CrossRef
• Very low-carbohydrate diet with higher protein ratio improves lipid metabolism and inflammation in rats with diet-induced nonalcoholic fatty liver disease
  I-Ting Wu, Wan-Ju Yeh, Wen-Chih Huang, Hsin-Yi Yang
  The Journal of Nutritional Biochemistry.2024; 126: 109583.     CrossRef
• Quality Evaluation of Metabolic-Associated Fatty Liver Disease Guidelines and Expert Consensus
  Meijing Chen, Ying Chen, Dun Liu, Ka Li, Rong Hu, Jingyi Chen, Xiaoying Jiang, Jinqing Lin
  Hormone and Metabolic Research.2024; 56(07): 509.     CrossRef
• Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
  Xin Ding, Xu He, Bulang Tang, Tian Lan
  Chinese Medicine.2024;[Epub]     CrossRef
• Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease
  Heejoon Jang, Yeonjin Kim, Dong Hyeon Lee, Sae Kyung Joo, Bo Kyung Koo, Soo Lim, Woojoo Lee, Won Kim
  JAMA Internal Medicine.2024; 184(4): 375.     CrossRef
• Mobile App–Based Lifestyle Coaching Intervention for Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial
  Oh Young Kwon, Mi Kyung Lee, Hye Won Lee, Hyerang Kim, Jae Seung Lee, Yeonsoo Jang
  Journal of Medical Internet Research.2024; 26: e49839.     CrossRef
• Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective
  Jia-Lan Wang, Su-Wen Jiang, Ai-Rong Hu, Ai-Wu Zhou, Ting Hu, Hong-Shan Li, Ying Fan, Ken Lin
  Heliyon.2024; 10(5): e27325.     CrossRef
• Assessment of Hepatic Steatosis Using Ultrasound-Based Techniques: Focus on Fat Quantification
  Woo Sun Rou
  Clinical Ultrasound.2024; 9(1): 1.     CrossRef
• Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
  Hye Kyung Hyun, Hye Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
  Gut and Liver.2024; 18(2): 294.     CrossRef
• The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease
  Hye Won Lee, Kun Hee Kim, Sang Hoon Ahn, Han Chu Lee, Jonggi Choi
  Liver International.2024; 44(6): 1448.     CrossRef
• Independent and joint association of physical activity and adequate weekday sleep duration with metabolic dysfunction-associated steatotic liver disease
  Yaxin Li, Yitian Guo, Shiyun Tan
  Clinics and Research in Hepatology and Gastroenterology.2024; 48(4): 102320.     CrossRef
• Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
  Byeong Geun Song, Aryoung Kim, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
  Liver Cancer.2024; 13(5): 561.     CrossRef
• Sleep factors were associated with a higher risk of MAFLD and significant fibrosis
  Yaxin Li, Shiyun Tan
  Sleep and Breathing.2024; 28(3): 1381.     CrossRef
• Puerarin Induces Macrophage M2 Polarization to Exert Antinonalcoholic Steatohepatitis Pharmacological Activity via the Activation of Autophagy
  Xiaoxue Fang, Xintian Lan, Ming Zhu, Min He, Mengmeng Sun, Yiming Cao, Difu Zhu, Dean Guo, Haoming Luo
  Journal of Agricultural and Food Chemistry.2024; 72(13): 7187.     CrossRef
• Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score
  Aryoung Kim, Danbee Kang, Sung Chul Choi, Juhee Cho, Dong Hyun Sinn, Geum-Youn Gwak, Ashraf Elbahrawy
  PLOS ONE.2024; 19(3): e0301126.     CrossRef
• Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
  Hong Jun Lee, Jae Seung Lee, Hyesung So, Ja Kyung Yoon, Jin-Young Choi, Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim
  Yonsei Medical Journal.2024; 65(7): 371.     CrossRef
• Diagnostic performances of Fibrosis‐4 index and nonalcoholic fatty liver disease fibrosis score in metabolic dysfunction‐associated steatotic liver disease in Asian primary care clinics
  Huiyul Park, Mimi Kim, Hye‐Lin Kim, Seon Cho, Eileen L. Yoon, Dae Won Jun
  Hepatology Research.2024; 54(11): 1027.     CrossRef
• Harnessing Metabolic Indices as a Predictive Tool for Cardiovascular Disease in a Korean Population without Known Major Cardiovascular Event
  Hyun-Jin Kim, Byung Sik Kim, Yonggu Lee, Sang Bong Ahn, Dong Wook Kim, Jeong-Hun Shin
  Diabetes & Metabolism Journal.2024; 48(3): 449.     CrossRef
• An Exploration of the Treatment of Non-Alcoholic Fatty Liver Disease Based on Dietary Factors
  Wanzhou Yang, Y.-T. Yu, P.P. Piccaluga, S. Xie
  BIO Web of Conferences.2024; 111: 03024.     CrossRef
• Assessing the Utility of Acoustic Radiation Force Impulse in the Evaluation of Non-Alcoholic Fatty Liver Disease with Severe Obesity or Steatosis
  Yeo Wool Kang, Yang Hyun Baek, Jong Hoon Lee, Young Hoon Roh, Hee Jin Kwon, Sang Yi Moon, Min Kook Son, Jin Sook Jeong
  Diagnostics.2024; 14(11): 1083.     CrossRef
• Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort
  Joo Hyun Oh, Sang Bong Ahn, Seon Cho, Eun-Hee Nah, Eileen L. Yoon, Dae Won Jun
  Journal of Hepatology.2024; 81(5): 772.     CrossRef
• A Novel Antioxidant, Hydrogen-Rich Coral Calcium Alters Gut Microbiome and Bile Acid Synthesis to Improve Methionine-and-Choline-Deficient Diet-Induced Non-Alcoholic Fatty Liver Disease
  Hung-Tsung Wu, Chin-Shiang Tsai, Ting-Hsing Chao, Horng-Yih Ou, Liang-Miin Tsai
  Antioxidants.2024; 13(6): 746.     CrossRef
• Emerging mRNA Technology for Liver Disease Therapy
  Ji Wang, Yile Fang, Zhiqiang Luo, Jinglin Wang, Yuanjin Zhao
  ACS Nano.2024; 18(27): 17378.     CrossRef
• Evaluation of pancreatic iodine uptake and related influential factors in multiphase dual-energy CT
  Chen Pan, Tao Yu, Heng Zhao, Jiani He, Xiaomei Lu, Haiyan Tang, Yang Hong, Chao Shang, Qijun Wu, Aoran Yang, Chunli Li, Minghui Zhou, Yu Shi
  European Radiology.2024; 34(12): 7609.     CrossRef
• Comparative effects of lifelong moderate-intensity continuous training and high-intensity interval training on blood lipid levels and mental well-being in naturally ageing mice
  Ling Yang, Wentao Lin, Xu Yan, Zhishang Zhang
  Experimental Gerontology.2024; 194: 112519.     CrossRef
• The Effect of Mobile Lifestyle Intervention Combined with High-Protein Meal Replacement on Liver Function in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Randomized Controlled Trial
  Eunbyul Cho, Sunwoo Kim, Soonkyu Kim, Ju Young Kim, Hwa Jung Kim, Yumi Go, Yu Jung Lee, Haesol Lee, Siye Gil, Sung Kwon Yoon, Keonho Chu
  Nutrients.2024; 16(14): 2254.     CrossRef
• Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients
  Maria Eva Argenziano, Mi Na Kim, Michele Montori, Alessandro Di Bucchianico, Daniele Balducci, Sang Hoon Ahn, Gianluca Svegliati Baroni
  Hepatology International.2024; 18(S2): 922.     CrossRef
• A New Korean Nomenclature for Steatotic Liver Disease
  
  The Korean Journal of Gastroenterology.2024; 84(1): 1.     CrossRef
• Barriers to care linkage and educational impact on unnecessary MASLD referrals
  Jun-Hyuk Lee, Eileen Laurel Yoon, Ju Hyun Oh, Kyunam Kim, Sang Bong Ahn, Dae Won Jun
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes
  Merve Cebi, Yusuf Yilmaz
  Frontiers in Immunology.2024;[Epub]     CrossRef
• A New Korean Nomenclature for Steatotic Liver Disease
  
  The Korean Journal of Medicine.2024; 99(4): 189.     CrossRef
• Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction‐associated steatotic liver disease
  Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
  Alimentary Pharmacology & Therapeutics.2024; 60(8): 1051.     CrossRef
• A New Korean Nomenclature for Steatotic Liver Disease
  
  Gut and Liver.2024; 18(5): 924.     CrossRef
• A new Korean nomenclature for steatotic liver disease
  
  Clinical and Molecular Hepatology.2024; 30(Suppl): S214.     CrossRef
• Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
  Yewan Park, Jooyi Jung, Seungbong Han, Gi‐Ae Kim
  Alimentary Pharmacology & Therapeutics.2024; 60(11-12): 1599.     CrossRef
• Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification
  Min Kyu Kang, Jeong Eun Song, Rohit Loomba, Soo Young Park, Won Young Tak, Young Oh Kweon, Yu Rim Lee, Jung Gil Park
  Scientific Reports.2024;[Epub]     CrossRef
• A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease
  Dana Ivancovsky Wajcman, Christopher J. Byrne, John F. Dillon, Paul N. Brennan, Marcela Villota-Rivas, Zobair M. Younossi, Alina M. Allen, Javier Crespo, Lynn H. Gerber, Jeffrey V. Lazarus
  Hepatology.2024;[Epub]     CrossRef
• Visceral Obesity and Its Association with Severe Coronary Artery Calcification in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
  Min Kyu Kang, Jeung Eun Song, Young Oh Kweon, Won Young Tak, Soo Young Park, Yu Rim Lee, Jung Gil Park
  Diagnostics.2024; 14(20): 2305.     CrossRef
• Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
  Han Ah Lee
  The Ewha Medical Journal.2024;[Epub]     CrossRef
• Evaluation of hepatoprotective and nephroprotective activities of Castanopsis costata extract in rats
  Maulana Alkandahri, Asman Sadino, Ermi Abriyani, Faizal Hermanto, Zulpakor Oktoba, Muhammad Sayoeti, Putu Sangging, Diah Wardani, Nahrul Hasan, Suci Sari, Nurul Safitri, Windi Ikhtianingsih, Safitri Safitri
  Biomedical Reports.2024;[Epub]     CrossRef
• Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  Yuan Yao, Yunfeng Shen
  Open Life Sciences.2023;[Epub]     CrossRef
• Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease
  Ho Soo Chun, Minjong Lee, Hye Ah Lee, Seo Yeong Oh, Hyo Jeong Baek, Jae Won Moon, Yeon Jeong Kim, Jinha Lee, Hyoeun Kim, Hwi Young Kim, Kwon Yoo, Tae Hun Kim, Seung Up Kim
  Clinical Gastroenterology and Hepatology.2023; 21(2): 358.     CrossRef
• Non-Invasive Liver Fibrosis Scores Are Associated With Contrast-Associated Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention
  Hao-Ming He, Chen He, Zhe-Bin You, Si-Cheng Zhang, Xue-Qin Lin, Man-Qing Luo, Mao-Qing Lin, Li-Wei Zhang, Kai-Yang Lin, Yan-Song Guo
  Angiology.2023; 74(4): 333.     CrossRef
• Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
  Dong Hyun Sinn, Danbee Kang, Sung Chul Choi, Yun Soo Hong, Di Zhao, Eliseo Guallar, Yewan Park, Juhee Cho, Geum-Youn Gwak
  Clinical Gastroenterology and Hepatology.2023; 21(7): 1873.     CrossRef
• The association of non‐alcoholic fatty liver disease between parents and adolescent children
  Yewan Park, Dong Hyun Sinn, Kyunga Kim, Geum‐Youn Gwak
  Alimentary Pharmacology & Therapeutics.2023; 57(2): 245.     CrossRef
• Statin use is associated with better post‐operative prognosis among patients with hepatitis B virus‐related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
  European Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Reply
  Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
  Clinical Gastroenterology and Hepatology.2023; 21(9): 2435.     CrossRef
• Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
  Yoon-a Hwang, Hye Won Lee, Sang Hoon Ahn, Eun Jig Lee, Cheol Ryong Ku, Seung Up Kim
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Ideal cardiovascular health metrics and the risk of nonalcoholic fatty liver disease in Korean adults
  Sun Young Shim, Sun Jae Jung, Seung Up Kim, Hyeon Chang Kim
  Clinical Hypertension.2023;[Epub]     CrossRef
• Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
  Won Sohn, Yong-Han Paik
  Clinical and Molecular Hepatology.2023; 29(1): 182.     CrossRef
• Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
  Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
  Clinical and Molecular Hepatology.2023; 29(1): 185.     CrossRef
• Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
  Seung Min Lee, Dae Won Jun
  Clinical and Molecular Hepatology.2023; 29(1): 171.     CrossRef
• Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
  Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
  Clinical and Molecular Hepatology.2023; 29(1): 179.     CrossRef
• Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection
  Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee
  European Journal of Gastroenterology & Hepatology.2023; 35(4): 431.     CrossRef
• Comparison of Guidelines for the Screening, Diagnosis, and Noninvasive Assessment of Nonalcoholic Fatty Liver Disease
  Kenneth W. Chow, Pragyat Futela, Aryan Saharan, Sammy Saab
  Journal of Clinical and Experimental Hepatology.2023; 13(5): 783.     CrossRef
• Clinical Implications of Cardiac Symptoms and Electrocardiographic Abnormalities for Advanced Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
  Min-Kyu Kang, Min-Cheol Kim
  Medicina.2023; 59(2): 375.     CrossRef
• The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
  George Chen, Bubu Banini, Albert Do, Joseph K. Lim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S319.     CrossRef
• Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
  Yuri Cho, Bo Hyun Kim, Joong-Won Park
  Clinical and Molecular Hepatology.2023; 29(Suppl): S220.     CrossRef
• Global incidence and prevalence of nonalcoholic fatty liver disease
  Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
  Clinical and Molecular Hepatology.2023; 29(Suppl): S32.     CrossRef
• Non-alcoholic fatty liver disease: the pathologist’s perspective
  Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S302.     CrossRef
• Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models
  Dong Yun Kim, Kyu Sik Chung, Jun Yong Park, Heon Yung Gee
  Biomedicine & Pharmacotherapy.2023; 161: 114445.     CrossRef
• Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease
  Goh Eun Chung, Sohee Oh, Dong-Won Ahn, Su Hwan Kim, Yong Jin Jung, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee, Ji Bong Jeong
  Scientific Reports.2023;[Epub]     CrossRef
• Screening strategy for non-alcoholic fatty liver disease
  Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
  Clinical and Molecular Hepatology.2023; 29(Suppl): S103.     CrossRef
• Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
  Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
  Clinical and Molecular Hepatology.2023; 29(Suppl): S157.     CrossRef
• Baseline Tyrosine Level Is Associated with Dynamic Changes in FAST Score in NAFLD Patients under Lifestyle Modification
  Hwi Young Kim, Da Jung Kim, Hye Ah Lee, Joo-Youn Cho, Won Kim
  Metabolites.2023; 13(3): 444.     CrossRef
• Nonalcoholic fatty liver disease and non-liver comorbidities
  Richie Manikat, Mindie H. Nguyen
  Clinical and Molecular Hepatology.2023; 29(Suppl): s86.     CrossRef
• Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
  Peter Konyn, Aijaz Ahmed, Donghee Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S43.     CrossRef
• Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
  Jihyun An, Joo Hyun Sohn
  Clinical and Molecular Hepatology.2023; 29(Suppl): S268.     CrossRef
• Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
  Sang Bong Ahn
  Clinical and Molecular Hepatology.2023; 29(Suppl): S150.     CrossRef
• Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
  Asako Nogami, Masato Yoneda, Michihiro Iwaki, Takashi Kobayashi, Yasushi Honda, Yuji Ogawa, Kento Imajo, Satoru Saito, Atsushi Nakajima
  Clinical and Molecular Hepatology.2023; 29(Suppl): S123.     CrossRef
• Comparison between obese and non-obese nonalcoholic fatty liver disease
  Wah-Kheong Chan
  Clinical and Molecular Hepatology.2023; 29(Suppl): S58.     CrossRef
• Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
  Jung Hwan Yu, Han Ah Lee, Seung Up Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S136.     CrossRef
• Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
  Georg Semmler, Christian Datz, Michael Trauner
  Clinical and Molecular Hepatology.2023; 29(Suppl): S244.     CrossRef
• Non-alcoholic fatty liver disease: Definition and subtypes
  Seul Ki Han, Soon Koo Baik, Moon Young Kim
  Clinical and Molecular Hepatology.2023; 29(Suppl): S5.     CrossRef
• The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
  Hyunwoo Oh, Won Sohn, Yong Kyun Cho
  Clinical and Molecular Hepatology.2023; 29(Suppl): S261.     CrossRef
• Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
  Yi-wen Shi, Jian-Gao Fan
  Clinical and Molecular Hepatology.2023; 29(Suppl): S228.     CrossRef
• Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
  Anja Geerts, Sander Lefere
  Clinical and Molecular Hepatology.2023; 29(Suppl): S276.     CrossRef
• Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
  Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
  Clinical and Molecular Hepatology.2023; 29(Suppl): S286.     CrossRef
• CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
  Ha Neul Kim, Hong Jae Jeon, Hei Gwon Choi, In Sun Kwon, Woo Sun Rou, Jeong Eun Lee, Tae Hee Lee, Seok Hyun Kim, Byung Seok Lee, Kyung Sook Shin, Hyun Jung Lee, Hyuk Soo Eun
  BMC Gastroenterology.2023;[Epub]     CrossRef
• How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
  Duck Min Seo, Sang Min Lee, Ji Won Park, Min-Jeong Kim, Hong Il Ha, Sun-Young Park, Kwanseop Lee
  Ultrasonography.2023; 42(2): 227.     CrossRef
• The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
  Young-Joo Jin
  Clinical and Molecular Hepatology.2023; 29(2): 414.     CrossRef
• Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
  Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
  Clinical and Molecular Hepatology.2023; 29(2): 404.     CrossRef
• The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
  Ji-Won Park, Ki Tae Suk
  Clinical and Molecular Hepatology.2023; 29(2): 408.     CrossRef
• Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
  Philipp Kasper, Münevver Demir, Hans-Michael Steffen
  Clinical and Molecular Hepatology.2023; 29(2): 390.     CrossRef
• Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
  Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
  Clinical and Molecular Hepatology.2023; 29(2): 433.     CrossRef
• The growing burden of non-alcoholic fatty liver disease on mortality
  Ju-Yeon Cho, Won Sohn
  Clinical and Molecular Hepatology.2023; 29(2): 374.     CrossRef
• Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
  Min Kyu Kang, Yu Rim Lee, Se Young Jang, Won Young Tak, Young Oh Kweon, Jeong Eun Song, Rohit Loomba, Soo Young Park, Jung Gil Park
  Hepatology International.2023; 17(3): 626.     CrossRef
• Genetic association study identifies genetic variants for non-alcoholic fatty liver without comorbidities in the Korean population
  Yeon Jun Kim, Yoon Shin Cho
  Genes & Genomics.2023; 45(7): 847.     CrossRef
• Association between the fatty liver index and the risk of fracture among individuals over the age of 50 years: a nationwide population-based study
  Goh Eun Chung, Eun Ju Cho, Min Joo Kim, Jeong-Ju Yoo, Yuri Cho, Kyu-na Lee, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease
  Han Ah Lee, Hwi Young Kim
  International Journal of Molecular Sciences.2023; 24(11): 9324.     CrossRef
• Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD
  Yun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jee Won Chai, Myoung Seok Lee, Si Won Jang, Young Ho So, Jeong Hwan Park, Mee Soo Chang, Won Kim
  Alimentary Pharmacology & Therapeutics.2023; 58(3): 322.     CrossRef
• Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI‐PDFF in NAFLD
  Beom K. Kim, Nicole Bernstein, Daniel Q. Huang, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajim
  Alimentary Pharmacology & Therapeutics.2023; 58(2): 229.     CrossRef
• Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
  Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
  Byeong Geun Song, Sung Chul Choi, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
  JHEP Reports.2023; 5(9): 100810.     CrossRef
• Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
  Jung Wook Seo, Youe Ree Kim, Jong Keon Jang, So Yeon Kim, Young Youn Cho, Eun Sun Lee, Dong Ho Lee
  Ultrasonography.2023; 42(3): 421.     CrossRef
• Serum resistin and the risk for hepatocellular carcinoma in diabetic patients
  Mona Mohamed Ibrahim Abdalla
  World Journal of Gastroenterology.2023; 29(27): 4271.     CrossRef
• Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
  Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim, Jae Youn Cheong
  Gut and Liver.2023; 17(4): 610.     CrossRef
• The correlation between NAFLD and serum uric acid to serum creatinine ratio
  Jangwon Choi, Hyun Joe, Jung-Eun Oh, Yong-Jin Cho, Hwang-Sik Shin, Nam Hun Heo, Gulali Aktas
  PLOS ONE.2023; 18(7): e0288666.     CrossRef
• Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non‐cirrhotic patients with chronic hepatitis B
  Cheol‐Hyung Lee, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
  Alimentary Pharmacology & Therapeutics.2023; 58(7): 704.     CrossRef
• Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease
  Ho Soo Chun
  Gut and Liver.2023; 17(4): 485.     CrossRef
• KASL clinical practice guidelines for management of autoimmune hepatitis 2022
  
  Clinical and Molecular Hepatology.2023; 29(3): 542.     CrossRef
• Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply
  Min-Ji Kim, Jae-Hyung Roh, Jae-Han Jeon
  Gut and Liver.2023; 17(4): 663.     CrossRef
• Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study
  Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Sung Chul Choi, Yun Soo Hong, Yewan Park, Juhee Cho, Geum-Youn Gwak, Ahmed Mustafa Rashid
  PLOS ONE.2023; 18(7): e0288820.     CrossRef
• Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial
  Han Ah Lee, Hyeyoung Moon, Yuri Kim, Hye Ah Lee, Hwi Young Kim
  Trials.2023;[Epub]     CrossRef
• Associations of Serum Uric Acid Level With Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Liver Fibrosis in Korean Men and Women: A Cross-Sectional Study Using Nationally Representative Data
  Jun Myong Lee, Hye Won Kim, So Young Heo, Kyung Yi Do, Jun Deok Lee, Seul Ki Han, Soon Koo Baik, Moon Young Kim, Sei-Jin Chang
  Journal of Korean Medical Science.2023;[Epub]     CrossRef
• Statins for treatment of fatty liver disease: Recent advances
  Xiao-Hui Fang, Cai-E Wang, Jiao Deng, Xing-Shun Qi
  World Chinese Journal of Digestology.2023; 31(16): 659.     CrossRef
• MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
  Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim
  Journal of Gastroenterology and Hepatology.2023; 38(9): 1598.     CrossRef
• The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients
  Magdi A. Ali, Eman El-Abd, Mohamed Morsi, Mohamed M. El Safwany, Mohamed Z. El-Sayed
  European Journal of Hybrid Imaging.2023;[Epub]     CrossRef
• Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
  Gi-Ae Kim, Joon Ho Moon, Won Kim
  Clinical and Molecular Hepatology.2023; 29(4): 831.     CrossRef
• Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea
  Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han
  Infectious Diseases and Therapy.2023; 12(10): 2387.     CrossRef
• Association between waist circumference trajectories and incident non-alcoholic fatty liver disease
  Jun-Hyuk Lee, Soyoung Jeon, Hye Sun Lee, Yu-Jin Kwon
  Obesity Research & Clinical Practice.2023; 17(5): 398.     CrossRef
• Overview and prospect of NAFLD: Significant roles of nutrients and dietary patterns in its progression or prevention
  Tianyu Mao, Yiwen Sun, Xinyi Xu, Kang He
  Hepatology Communications.2023;[Epub]     CrossRef
• Approach to Fatty Liver Disease in Patients with Type 2 Diabetes
  Ji Cheol Bae
  The Journal of Korean Diabetes.2023; 24(3): 107.     CrossRef
• Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production
  Dong Yun Kim, Jun Yong Park, Heon Yung Gee
  Experimental & Molecular Medicine.2023; 55(11): 2332.     CrossRef
• Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study
  Beom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem K. Oz, Ayse Erden, Emily Truong, Ju Dong Yang, Mazen Noureddin, Alina M. Allen, Rohit Loomba, Veeral Ajmera
  Hepatology.2023; 78(6): 1858.     CrossRef
• Association between total body muscle percentage and prevalence of non-alcoholic fatty liver disease in Korean adults findings from an 18-year follow-up: a prospective cohort study
  Byoung Chan Ahn, Chul Yong Park, Jung Hee Hong, Ki Ook Baek
  Journal of Yeungnam Medical Science.2023; 40(Suppl): S47.     CrossRef
• The Association of Perfluoroalkyl Substance Exposure and a Serum Liver Function Marker in Korean Adults
  Jisuk Yun, Soon-Chan Kwon
  Toxics.2023; 11(12): 965.     CrossRef
• Alcohol consumption and the risk of liver disease: a nationwide, population-based study
  Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek
  Frontiers in Medicine.2023;[Epub]     CrossRef
• Lifestyle of patients with non-alcoholic fatty liver disease: assessment of dietary habits and physical activity
  T.S. Krolevets, M.I. Syrovenko, M.A. Livzan
  Russian Journal of Evidence-Based Gastroenterology.2023; 12(4): 43.     CrossRef
• Association of Hepatic Fat Deposition and Severity of Acanthosis Nigricans in Children and Adolescents with Obesity
  Junhyung Lee, Hye-ji An, Young-Gyun Seo, Hong Ji Song, Hye-Mi Noh, Yu-Jin Paek, Kyung Hee Park
  Korean Journal of Family Practice.2023; 13(4): 240.     CrossRef
• Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease
  Chan-Young Jung, Geun Woo Ryu, Hyung Woo Kim, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
  Diabetologia.2022; 65(3): 518.     CrossRef
• Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study
  Seung Min Chung, Min Kyu Kang, Jinho Jung, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee, Rohit Loomba, Jung Gil Park, Jun Sung Moon
  Diabetes Research and Clinical Practice.2022; 184: 109208.     CrossRef
• Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious
  Suprabhat Giri, Harish Darak, Sunil Kasturi
  Digestive Diseases and Sciences.2022; 67(10): 4962.     CrossRef
• Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
  Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Do
  Biomedicines.2022; 10(3): 550.     CrossRef
• Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis
  Heejoon Jang, Yun Bin Lee, Hyemi Moon, Jong‐Won Chung, Joon Yeul Nam, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Juneyoung Lee, Jung‐Hwan Yoon
  Hepatology.2022; 76(2): 492.     CrossRef
• The Phase 2 Study to Evaluate Efficacy and Safety of Lanifibranor in Patients with Nonalcoholic Steatohepatitis: Back in the Spotlight?
  Sae Hwan Lee
  The Korean Journal of Gastroenterology.2022; 79(3): 138.     CrossRef
• Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study
  Chan-Young Jung, Hee Byung Koh, Keun Hyung Park, Young Su Joo, Hyung Woo Kim, Sang Hoon Ahn, Jung Tak Park, Seung Up Kim
  Diabetes & Metabolism.2022; 48(4): 101344.     CrossRef
• MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
  Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
  Clinical and Molecular Hepatology.2022; 28(2): 150.     CrossRef
• PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients
  Naomi F. Lange, Vanessa Graf, Cyrielle Caussy, Jean-François Dufour
  International Journal of Molecular Sciences.2022; 23(8): 4305.     CrossRef
• Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
  Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae
  Clinical and Molecular Hepatology.2022; 28(2): 196.     CrossRef
• Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
  Youn Huh, Yoon Jeong Cho, Ga Eun Nam
  Journal of Obesity & Metabolic Syndrome.2022; 31(1): 17.     CrossRef
• Gamma‐glutamyl transpeptidase dynamics as a biomarker for advanced fibrosis in non‐alcoholic fatty liver disease
  Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Seong Gyu Hwang
  Journal of Gastroenterology and Hepatology.2022; 37(8): 1624.     CrossRef
• The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study
  Yuri Cho, Eun Ju Cho, Jeong-Ju Yoo, Young Chang, Goh Eun Chung, In Young Choi, Sang-Hyun Park, Kyungdo Han, Yoon Jun Kim, Jung-Hwan Yoon, Dong Wook Shin, Su Jong Yu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
  Jun-Hyeon Byeon, Min-Kyu Kang, Min-Cheol Kim
  Healthcare.2022; 10(5): 850.     CrossRef
• Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease
  Kwang Seob Lee, Yongin Cho, Hongkyung Kim, Hyunkyeong Hwang, Jin Won Cho, Yong-ho Lee, Sang-Guk Lee
  Biomedicines.2022; 10(6): 1216.     CrossRef
• Risk of liver fibrosis in patients with prediabetes and diabetes mellitus
  Jongsin Park, Heon-Ju Kwon, Won Sohn, Ju-Yeon Cho, Soo Jin Park, Yoosoo Chang, Seungho Ryu, Byung Ik Kim, Yong Kyun Cho, Chen-Hua Liu
  PLOS ONE.2022; 17(6): e0269070.     CrossRef
• Exercise reduces the risk of chronic kidney disease in individuals with nonalcoholic fatty liver disease: A nationwide cohort study
  Chan-Young Jung, Ho Soo Chun, Minjong Lee, Hee Byung Koh, Keun Hyung Park, Young Su Joo, Hyung Woo Kim, Sang Hoon Ahn, Jung Tak Park, Seung Up Kim
  Diabetes & Metabolism.2022; 48(5): 101362.     CrossRef
• Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study
  Dong Hyun Sinn, Danbee Kang, Mira Kang, Eliseo Guallar, Yun Soo Hong, Kyung Hyun Lee, Jiyeon Park, Juhee Cho, Geum‐Youn Gwak
  Hepatology.2022; 76(6): 1746.     CrossRef
• Short-term outcome of bariatric surgery on nonalcoholic fatty liver disease: a Korean perspective
  Ki Hyun Kim, Yoonhong Kim, Kwang Il Seo, Kyung Won Seo
  Annals of Surgical Treatment and Research.2022; 102(6): 353.     CrossRef
• A Case Report of Nonalcoholic Fatty Liver Disease with Obesity and Dyslipidemia
  Eujin Kim, Cho-Hyun Hwang, Juyoung Lee, Eungyeong Jang, Youngchul Kim, Jang-Hoon Lee
  The Journal of Internal Korean Medicine.2022; 43(2): 184.     CrossRef
• Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study
  Wenting Wang, Jianping Ren, Wenzhao Zhou, Jinyu Huang, Guomin Wu, Fenfang Yang, Shuang Yuan, Juan Fang, Jing Liu, Yao Jin, Haiyang Qi, Yuyang Miao, Yanna Le, Cenhong Ge, Xiantao Qiu, JinJing Wang, Ping Huang, Zixin Liu, Sheng Wang
  Scientific Reports.2022;[Epub]     CrossRef
• Obstructive Sleep Apnea and Nonalcoholic Fatty Liver Disease in the General Population: A Cross-Sectional Study Using Nationally Representative Data
  Taeyun Kim, Hyunji Choi, Jaejun Lee, Jehun Kim
  International Journal of Environmental Research and Public Health.2022; 19(14): 8398.     CrossRef
• Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
  Jung Il Lee
  Gut and Liver.2022; 16(4): 497.     CrossRef
• Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
  Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
  Clinical and Molecular Hepatology.2022; 28(3): 425.     CrossRef
• Real‐world clinical features, health‐care utilization, and economic burden in decompensated cirrhosis patients: A national database
  Hankil Lee, Beom Kyung Kim
  Journal of Gastroenterology and Hepatology.2022; 37(11): 2154.     CrossRef
• Reply
  Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak
  Hepatology.2022; 76(6): E121.     CrossRef
• Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
  Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Tuo Lin, Xin M. Tu, Jaclyn Bergstrom, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi N
  Journal of Hepatology.2022; 77(6): 1482.     CrossRef
• Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
  Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
  Abdominal Radiology.2022; 47(11): 3733.     CrossRef
• Fatty Liver Change in Korean Adults in a Systematic Social Distancing System Amid the COVID-19 Pandemic: A Multicenter Analysis
  Ji-Hee Haam, Yang-Im Hur, Young-Sang Kim, Kyoung-Kon Kim, Jee-Hyun Kang, Hae-Jin Ko, Yoon Jeong Cho, Hye-In Choi, Kyu Rae Lee, Jung Ha Park, Soo Hyun Cho, Jong-Koo Kim, Taesic Lee, Myung-Jae Seo, Yeong Sook Yoon, Yoobin Seo, Ga Eun Nam, Sun Hyun Kim
  International Journal of Environmental Research and Public Health.2022; 19(16): 10444.     CrossRef
• Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis
  Liu Han, Shifeng Fu, Jianglei Li, Deliang Liu, Yuyong Tan
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Correlation between shift work and non-alcoholic fatty liver disease among male workers in the steel manufacturing company of Korea: a cross-sectional study
  Kiseok Kim, Yong-Jin Lee, Soon-Chan Kwon, Young-Sun Min, Hyun Kyo Lee, Gwangin Baek, Sang Hyeon Kim, Eun-Chul Jang
  Annals of Occupational and Environmental Medicine.2022;[Epub]     CrossRef
• Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease
  Ki Choon Sim, Min Ju Kim, Yongwon Cho, Hyun Jin Kim, Beom Jin Park, Deuk Jae Sung, Na Yeon Han, Yeo Eun Han, Tae Hyung Kim, Yoo Jin Lee
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• Bioelectrical Impedance Analysis Can Be an Effective Tool for Screening Fatty Liver in Patients with Suspected Liver Disease
  Jin Wook Choi, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
  Healthcare.2022; 10(11): 2268.     CrossRef
• Tenofovir alafenamide alleviates nonalcoholic steatohepatitis in mice by blocking the phosphorylation of AKT in intrahepatic mononuclear phagocytes
  Pu Reun Roh, Sung Min Kim, Byung-Yoon Kang, Kyoung Do Mun, Jong Geun Park, Min Woo Kang, Wonhee Hur, Ji Won Han, Heechul Nam, Seung Kew Yoon, Pil Soo Sung
  Biomedicine & Pharmacotherapy.2022; 156: 113952.     CrossRef
• Accuracy of Noninvasive Scoring Systems in Assessing Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
  Sangsoo Han, Miyoung Choi, Bora Lee, Hye-Won Lee, Seong Hee Kang, Yuri Cho, Sang Bong Ahn, Do Seon Song, Dae Won Jun, Jieun Lee, Jeong-Ju Yoo
  Gut and Liver.2022; 16(6): 952.     CrossRef
• The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults
  Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
  Clinical and Molecular Hepatology.2022; 28(4): 814.     CrossRef
• Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
  Soon Sun Kim, Jae Youn Cheong
  Clinical and Molecular Hepatology.2022; 28(4): 802.     CrossRef
• Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
  Sun Young Kim, Subin Mun, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Sang-Heon Cho, Jin-Woo Lee
  Medicine.2022; 101(37): e30527.     CrossRef
• A Review of Research Trends in Traditional Korean Medicine for Nonalcoholic Fatty Liver Disease
  Na-yeon Kim, Mi-jung Yoon, Hong-sik Choi, Seung-mo Kim, Sang-chan Kim, Kyung-soon Kim
  The Journal of Internal Korean Medicine.2022; 43(4): 680.     CrossRef
• Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
  Seogsong Jeong, Won Kim, Sang Min Park
  Clinical and Molecular Hepatology.2022; 28(4): 933.     CrossRef
• Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
  Jae Lee, Tae Lim, Hye Lee, Seung Kim, Jun Park, Do Kim, Sang Ahn, Hyun Lee, Jung Lee, Ja Kim, In Min, Beom Kim
  Diagnostics.2022; 13(1): 3.     CrossRef
• Terpenoids: Natural Compounds for Non-Alcoholic Fatty Liver Disease (NAFLD) Therapy
  Pengyu Yao, Yajuan Liu
  Molecules.2022; 28(1): 272.     CrossRef
• The Evidence Surrounding Non-Alcoholic Fatty Liver Disease in Individuals with Cancer: A Systematic Literature Review
  Elena S. George, Surbhi Sood, Nicole Kiss, Robin M. Daly, Amanda J. Nicoll, Stuart K. Roberts, Brenton J. Baguley
  Current Oncology.2022; 30(1): 48.     CrossRef
• Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Korean Patients Undergoing Bariatric Surgery
  Ki Hyun Kim, Yoonhong Kim, Kwang Il Seo, Kyung Won Seo
  Journal of Metabolic and Bariatric Surgery.2022; 11(2): 63.     CrossRef
• Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
  Eun-Ju Cho, Gu-Cheol Jung, Min-Sun Kwak, Jong-In Yang, Jeong-Yoon Yim, Su-Jong Yu, Goh-Eun Chung
  Diagnostics.2021; 11(12): 2233.     CrossRef
• Association between Fasting Ketonuria and Advanced Liver Fibrosis in Non-Alcoholic Fatty Liver Disease Patients without Prediabetes and Diabetes Mellitus
  Kiyoung Lim, Minkyu Kang, Junggil Park
  Nutrients.2021; 13(10): 3400.     CrossRef
• Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression
  Jeong-An Gim, Soo Min Bang, Young-Sun Lee, Yoonseok Lee, Sun Young Yim, Young Kul Jung, Hayeon Kim, Baek-Hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun, Matias A. Avila
  PLOS ONE.2021; 16(8): e0255822.     CrossRef
• Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
  Yuan Zhu, Jiao Xu, Dong Zhang, Xingyu Mu, Yi Shi, Shangtao Chen, Zengxiang Wu, Shuangqing Li
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Effect of Nutrition Education in NAFLD Patients Undergoing Simultaneous Hyperlipidemia Pharmacotherapy: A Randomized Controlled Trial
  Won Myung Lee, Jea Hurn Bae, Young Chang, Sae Hwan Lee, Ji Eun Moon, Soung Won Jeong, Jae Young Jang, Sang Gyune Kim, Hong Soo Kim, Jeong-Ju Yoo, Young Seok Kim
  Nutrients.2021; 13(12): 4453.     CrossRef
• Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
  Jae Seung Lee, Dong Hyun Sinn, Soo Young Park, Hye Jung Shin, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Joo Hyun Oh, Jung Il Lee, Seung Up Kim
  Cancers.2021; 13(18): 4567.     CrossRef

Citations

Citations to this article as recorded by  

• Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B
  David Z Pan, Cameron M Soulette, Abhishek Aggarwal, Dong Han, Nicholas van Buuren, Peiwen Wu, Becket Feierbach, Jaw-Town Lin, Cheng-Hao Tseng, Chi-Yi Chen, Bryan Downie, Hongmei Mo, Lauri Diehl, Li Li, Simon P Fletcher, Scott Balsitis, Ricardo Ramirez, Vi
  Gut.2025; 74(4): 628.     CrossRef
• Limited Value of HBV‐RNA for Relapse Prediction After Nucleos(t)ide Analogue Withdrawal in HBeAg‐negative Hepatitis B Patients
  Valerie Ohlendorf, Maximilian Wübbolding, Christoph Höner zu Siederdissen, Birgit Bremer, Katja Deterding, Heiner Wedemeyer, Markus Cornberg, Benjamin Maasoumy
  Journal of Viral Hepatitis.2025;[Epub]     CrossRef
• Overview of chronic hepatitis B management
  Angela Jun, Sherona Bau, John S. Kim, Susanne J. Phillips
  The Nurse Practitioner.2025; 50(1): 7.     CrossRef
• Effectiveness and safety of tenofovir amibufenamide and tenofovir alafenamide in treating elderly patients diagnosed with decompensated hepatitis B cirrhosis: a retrospective cohort study
  Xinye Qiu, Yue Yin, Shibin Zhang, Wei Liu
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Decreased incidence of hepatocellular carcinoma in non‐cirrhotic and low‐viral‐load chronic hepatitis B patients treated with nucleotide/nucleoside analogs
  Tyng‐Yuan Jang, Chia‐Yen Dai
  Advances in Digestive Medicine.2025;[Epub]     CrossRef
• Global burden of HBV-related liver disease: Primary liver cancer due to chronic HBV infection increased in over one-third of countries globally from 2000 to 2021
  Pojsakorn Danpanichkul, Kwanjit Duangsonk, Vincent L. Chen, Preenapun Saokhieo, Disatorn Dejvajara, Banthoon Sukphutanan, Majd B. Aboona, Chawin Lopimpisuth, Yanfang Pang, Andrew F. Ibrahim, Michael B. Fallon, Daniel Q. Huang, Donghee Kim, Amit G. Singal,
  Hepatology.2025; 82(5): 1274.     CrossRef
• Tenofovir alafenamide-related hyperlipidemia and cardiovascular risk
  Ankur Jindal, Manoj Kumar
  Hepatology International.2025; 19(4): 701.     CrossRef
• Comparison of bone mineral density changes between denosumab and bisphosphonates in tenofovir-exposed chronic hepatitis B patients with osteoporosis
  Yunmi Ko, Byeong Geun Song, Hyunjae Shin, Youngsu Park, Jeayeon Park, Min Kyung Park, Yun Bin Lee, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Jung-Hwan Yoon, Seung Shin Park, Moon Haeng Hur, Jeong-Hoon Lee
  Osteoporosis International.2025; 36(8): 1391.     CrossRef
• Besifovir dipivoxil maleate versus other antivirals in reducing hepatocellular carcinoma in chronic hepatitis B
  Jae Seung Lee, Sung Won Lee, Hae Lim Lee, Jeong-Ju Yoo, Yeon Seok Seo, Su Jong Yu, Hyung Joon Yim, Young Kul Jung, Jisu Moon, Hye Won Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Sang Gyune Kim, Seung Up Kim
  Scientific Reports.2025;[Epub]     CrossRef
• Time for a globally unified chronic HBV terminology?
  Su Wang, Catherine Freeland, Seng Gee Lim, Hailemichael Desalegn, Chari Cohen, Harry L.A. Janssen
  JHEP Reports.2025; 7(12): 101570.     CrossRef
• Chronic hepatitis B: Is it time for expanded antiviral treatment?
  Manish Manrai, Atul A Jha, Aditya V Pachisia, Saurabh Dawra
  World Journal of Virology.2025;[Epub]     CrossRef
• Modeling the Impact of Treatment on Hepatitis B Burden: Mathematical Analysis and Simulation
  Jean Pierre II Kouenkam, Joseph Mbang, Gilbert Chendjou, Herieth Rwezaura, Jean Tchuenche
  Operations Research Forum.2025;[Epub]     CrossRef
• Efficacy and safety of PEG-IFN α-2b and tenofovir amibufenamide in combination therapy for chronic hepatitis B
  Wen Zhao, Longcan Li, Shihui Liu, Wenjie Zhang, Yufeng Gao, Zonghao Zhao, Xiaojun Liu, Yi Luo, Dongdong Li, Chuanmiao Liu
  BMC Infectious Diseases.2025;[Epub]     CrossRef
• Precision Management of Patients with HBV Infection
  Chih-Lin Lin, Jia-Horng Kao
  Current Hepatology Reports.2024; 23(1): 22.     CrossRef
• Management of Hepatitis B in Pregnancy
  Jeanette Rios, Lital Aliasi-Sinai, Natalia Schmidt, Tatyana Kushner
  Current Hepatology Reports.2024; 23(2): 278.     CrossRef
• Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
  Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, Yeon Seok Seo, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
  Gut and Liver.2024; 18(2): 305.     CrossRef
• Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
  Heechul Nam, Ji Won Han, Soon Kyu Lee, Hyun Yang, Hae Lim Lee, Pil Soo Sung, Myeong Jun Song, Jung Hyun Kwon, Jeong Won Jang, U‐Im Chang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jin Mo Yang, Hee Yeon Kim
  Journal of Gastroenterology and Hepatology.2024; 39(8): 1673.     CrossRef
• Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
  Tyng‐Yuan Jang, Batbold Batsaikhan, Yo‐Chia Chen, Chia‐Yen Dai
  Journal of Gastroenterology and Hepatology.2024; 39(11): 2327.     CrossRef
• Modern etiotropic therapy of chronic viral hepatitis B
  E. B. Bun'kova, N. A. Bileva, A. E. Bilev, M. I. Sinel'nikov
  Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2024; 14(4): 76.     CrossRef
• Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
  Wei-Chun Lin, Ke Lin, Ming-Kai Li, Xiao Liu, Yi-Fei Huang, Xing Wang, Bin Wu
  World Journal of Hepatology.2024; 16(11): 1321.     CrossRef
• Safety and efficacy of 48-week pegylated interferon-α-2b therapy in patients with hepatitis B virus-related compensated liver cirrhosis: a pilot observational study
  Zehong Wang, Xuanxuan Wang, Li Zhou, Shaoyuan Shi, Yongli Hua, Yinong Feng
  Frontiers in Medicine.2024;[Epub]     CrossRef
• Limited stability of Hepatitis B virus RNA in plasma and serum
  Valerie Ohlendorf, Birgit Bremer, Lisa Sandmann, Carola Mix, Tammo Tergast, Markus Cornberg, Heiner Wedemeyer, Katja Deterding, Benjamin Maasoumy
  Scientific Reports.2024;[Epub]     CrossRef
• Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate
  Shenglong Lin, Wanlong Huang, Ziyuan Liao, Huaxi Ma, Wenjun Wu, Minghua Lin, Defu Huang, Haibing Gao
  Scientific Reports.2024;[Epub]     CrossRef
• Post-operative recurrence of liver cancer according to antiviral therapy for detectable hepatitis B viremia: A nationwide study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2023; 107: 66.     CrossRef
• Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study
  Byungyoon Yun, Juyeon Oh, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
  American Journal of Gastroenterology.2023; 118(6): 1001.     CrossRef
• Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
  Won Sohn, Yong-Han Paik
  Clinical and Molecular Hepatology.2023; 29(1): 182.     CrossRef
• Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
  Yoonseok Lee, Seryun Bae, Ji Hoon Kim, Minjung Kwak, So Yeon Jeon, Taehyung Kim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
  Journal of Clinical Medicine.2023; 12(2): 712.     CrossRef
• Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
  Han Ah Lee, Seung Up Kim, Yeon Seok Seo, Sang Hoon Ahn, Chai Hong Rim
  Hepatology Communications.2023; 7(2): e0011.     CrossRef
• miR-548c-3p targets TRIM22 to attenuate the Peg–IFN–α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B
  Ni Lin, Long Wang, Zhaopei Guo, Shaoying Guo, Can Liu, Jinpiao Lin, Songhang Wu, Siyi Xu, Hongyan Guo, Fenglin Fang, Ya Fu, Qishui Ou
  Antiviral Research.2023; 213: 105584.     CrossRef
• Pre-S1 Mutations as Indicated by Serum Pre-S1 Antigen Negative is Associated with an Increased Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
  Xingxin Zhang, Chenjian Gu, Qian Wei, Yirong Cao, Weimin She, Hong Shi, Youhua Xie, Jinsheng Guo
  Journal of Hepatocellular Carcinoma.2023; Volume 10: 599.     CrossRef
• Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
  Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
  Clinical and Molecular Hepatology.2023; 29(2): 482.     CrossRef
• Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis
  Daniel Q. Huang, Nobuharu Tamaki, Hyung Woong Lee, Soo Young Park, Yu Rim Lee, Hye Won Lee, Seng Gee Lim, Tae Seop Lim, Masayuki Kurosaki, Hiroyuki Marusawa, Toshie Mashiba, Masahiko Kondo, Yasushi Uchida, Haruhiko Kobashi, Koichiro Furuta, Namiki Izumi,
  Hepatology.2023; 77(5): 1746.     CrossRef
• Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy
  Jae Seung Lee, Chan‐Young Jung, Jung Il Lee, Sang Hoon Ahn, Beom Seok Kim, Seung Up Kim
  Alimentary Pharmacology & Therapeutics.2023; 58(1): 99.     CrossRef
• The urgency to expand the antiviral indications of general chronic hepatitis B patients
  Ping Fan, Lan-Qing Li, En-Qiang Chen
  Frontiers in Medicine.2023;[Epub]     CrossRef
• Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
  Lanqing Li, Jing Zhou, Yujing Li, Fada Wang, Dongmei Zhang, Menglan Wang, Yachao Tao, Enqiang Chen
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
  Heejoon Jang, Su Jong Yu, Hong Ghi Lee, Tae Min Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim
  Journal of Korean Medical Science.2023;[Epub]     CrossRef
• Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
  Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
  BMC Gastroenterology.2023;[Epub]     CrossRef
• Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
  Beom Kyung Kim, Sang Hoon Ahn
  Journal of the Formosan Medical Association.2023; 122(12): 1238.     CrossRef
• Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
  Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee
  Clinical and Molecular Hepatology.2023; 29(3): 794.     CrossRef
• Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
  Soo Ryang Kim, Soo Ki Kim
  Diagnostics.2023; 13(20): 3212.     CrossRef
• The Connection between MiR-122 and Lymphocytes in Patients Receiving Treatment for Chronic Hepatitis B Virus Infection
  Marina Manea, Dimitri Apostol, Ileana Constantinescu
  Microorganisms.2023; 11(11): 2731.     CrossRef
• Patient Preferences and Their Influence on Chronic Hepatitis B-A Review
  Lin Zhang, Yunyue Liu, Jinping Tian
  Patient Preference and Adherence.2023; Volume 17: 3119.     CrossRef
• Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR‐122
  Yuh‐Jin Liang, Yu‐Wei Chiou, Abby Pei‐Ting Chiu, Ming‐Shi Shiao, Wei Teng, Chin‐Wei Lin, Mei‐Ling Cheng, Yen‐Hua Huang, Kung‐Hao Liang, Chien‐Wei Su, Chi‐Yu Lai, Chih‐Li Chen, Jaw‐Ching Wu
  Journal of Medical Virology.2023;[Epub]     CrossRef
• Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues
  Tyng-Yuan Jang, Chi-Chang Ho, Chih-Da Wu, Chia-Yen Dai, Pau-Chung Chen
  Medicine.2023; 102(43): e34276.     CrossRef
• Effectiveness and Safety of Tenofovir Alafenamide in Treatment-Naïve and Treatment-Experienced Patients with Chronic Hepatitis B: Results of a Real-World Study from China
  Lan-Qing Li, Fa-Da Wang, Jing Zhou, Meng-Lan Wang, Yachao Tao, En-Qiang Chen
  Hepatitis Monthly.2023;[Epub]     CrossRef
• Influence of Renal Function on the Single‐Dose Pharmacokinetics of Besifovir, a Novel Antiviral Agent for theTreatment of Hepatitis B Virus Infection
  Jun Gi Hwang, Yu Kyong Kim, Young‐sim Choi, Soon Kil Kwon, Joung‐Ho Han, Min Kyu Park
  The Journal of Clinical Pharmacology.2022; 62(1): 46.     CrossRef
• Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
  Zhenyu Zhong, Weiting Liao, Lingyu Dai, Xiaojie Feng, Guannan Su, Yu Gao, Qiuying Wu, Peizeng Yang
  Annals of the Rheumatic Diseases.2022; 81(4): 584.     CrossRef
• Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
  Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  American Journal of Gastroenterology.2022; 117(2): 288.     CrossRef
• Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
  Anil Alpsoy, Haydar Adanir, Zeynep Bayramoglu, Gulsum Ozlem Elpek
  World Journal of Hepatology.2022; 14(1): 260.     CrossRef
• External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2022; 14(3): 711.     CrossRef
• Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries
  Ben Kang, Dae Yong Yi, Byung-Ho Choe
  Frontiers in Pediatrics.2022;[Epub]     CrossRef
• Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
  Seunghwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Diagnostics.2022; 12(2): 441.     CrossRef
• Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study
  Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Viral Hepatitis.2022; 29(4): 289.     CrossRef
• A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
  Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon, Yeon Seok Seo, Jeong Won Jang, Yong Kyun Cho, Byoung Kuk Jang, Byung Hoon Han, Changhyeong Lee, Joon Hyeok Lee, Jung-Hwan Yoon, Kang Mo Kim, Moon Young Kim, Do Young Kim, Neung Hwa Park, Eun Young Cho, June Sung
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
  Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim, Yeon Seok Seo
  Journal of Clinical Medicine.2022; 11(6): 1729.     CrossRef
• Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
  Hankil Lee, Sungin Jang, Sang Hoon Ahn, Beom Kyung Kim
  Hepatology International.2022; 16(2): 294.     CrossRef
• KASL clinical practice guidelines for management of chronic hepatitis B
  
  Clinical and Molecular Hepatology.2022; 28(2): 276.     CrossRef
• Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study
  Byungyoon Yun, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
  American Journal of Gastroenterology.2022; 117(5): 758.     CrossRef
• Fibrotic burden during antiviral therapy for chronic hepatitis B, not ALT level, independently predicts liver cancer risk
  David Sooik Kim, Beom Kyung Kim, Yeon Seok Seo, Byung Seok Kim, Byoung Kuk Jang, Sang Gyune Kim, Ki Tae Suk, Jin‐Woo Lee, Soung Won Jeong, Seung Up Kim
  Liver International.2022; 42(8): 1902.     CrossRef
• Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study
  Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
  Journal of Viral Hepatitis.2022; 29(9): 756.     CrossRef
• Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study
  Byungyoon Yun, Sang Hoon Ahn, Jin‐Ha Yoon, Beom Kyung Kim
  Hepatology Communications.2022; 6(9): 2455.     CrossRef
• Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  European Journal of Internal Medicine.2022; 103: 122.     CrossRef
• [Retracted] Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment
  Haixia Sun, Yinhui Liu, Yufeng Zhang, Yusheng Jie, Yuankai Wu, Zhanyi Li, Xuxia Wei, Xiangyong Li, Bing Niu
  BioMed Research International.2022;[Epub]     CrossRef
• Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
  Ran Cheng, Xiaoyuan Xu
  Journal of Hepatocellular Carcinoma.2022; Volume 9: 987.     CrossRef
• Response to Liao et al.
  Byungyoon Yun, Jin-Ha Yoon, Beom Kyung Kim
  American Journal of Gastroenterology.2022; 117(10): 1718.     CrossRef
• Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
  Hyung Joon Yim, Ji Hoon Kim, Yong Kyun Cho, Young Oh Kweon, Hyun Chin Cho, Jae Seok Hwang, Changhyeong Lee, Moon Soo Koh, Yang-Hyun Baek, Young-Min Park, Jeong-Hoon Lee, Seung Up Kim, Min-Kyu Kang, Neung Hwa Park, June Sung Lee, Young Eun Chon, Gab Jin Ch
  Drug Design, Development and Therapy.2022; Volume 16: 3263.     CrossRef
• Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
  Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
  Cancers.2022; 14(20): 5002.     CrossRef
• Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients
  Ji Hun Lee, Seung Kak Shin, Seong Hee Kang, Tae Hyung Kim, Hyung Joon Yim, Sun Young Yim, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Oh Sang Kwon, Soon Ho Um, Kwan Soo Byun
  Journal of Clinical Medicine.2022; 11(22): 6613.     CrossRef
• Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis
  Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
  Clinical and Molecular Hepatology.2022; 28(4): 876.     CrossRef
• Secondary prevention of hepatitis B virus‐related hepatocellular carcinoma with current antiviral therapies
  Jonggi Choi, Young‐Suk Lim
  The Kaohsiung Journal of Medical Sciences.2021; 37(4): 262.     CrossRef
• External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
  Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Viral Hepatitis.2021; 28(6): 951.     CrossRef
• Association of Physical Activity with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
  Ho Soo Chun, Sojeong Park, Minjong Lee, Yuri Cho, Ha Sung Kim, A Reum Choe, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
  Cancers.2021; 13(14): 3424.     CrossRef
• No Uniformity in the References of Clinical Practice Guidelines for Bariatric Surgery: a Review of 3 Similar Guidelines Published in 2020.
  Mark J. R. Smeets, Ronald S. L. Liem
  Obesity Surgery.2021; 31(12): 5427.     CrossRef
• Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
  Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
  Hepatology International.2021; 15(5): 1083.     CrossRef
• Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
  Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
  Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123.     CrossRef
• The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
  Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Journal of Hepatocellular Carcinoma.2021; Volume 8: 467.     CrossRef
• Critical Updates on Chronic Hepatitis B Virus Infection in 2021
  Cyriac A Philips, Rizwan Ahamed, Jinsha K Abduljaleel, Sasidharan Rajesh, Philip Augustine
  Cureus.2021;[Epub]     CrossRef
• Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
  David Sooik Kim, Soo Young Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang-Hyub Han, Yu Rim Lee, Won Young Tak, Young Oh Kweon, Inkyung Jung, Minkyung Han, Eun Hwa Kim, Sang Hoon Ahn, Seung Up Kim
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Novel Therapies of Hepatitis B and D
  Iman Waheed Khan, Mati Ullah Dad Ullah, Mina Choudhry, Mukarram Jamat Ali, Muhammad Ashar Ali, Sam L. K. Lam, Pir Ahmad Shah, Satinder Pal Kaur, Daryl T. Y. Lau
  Microorganisms.2021; 9(12): 2607.     CrossRef
• Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
  Yoon Seok Lee, Soo Min Bang, Young-Sun Lee
  Journal of Clinical Medicine.2021; 10(11): 2320.     CrossRef
• Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
  Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
  Journal of Viral Hepatitis.2021; 28(11): 1570.     CrossRef
• Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
  Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee, Dong Hyun Sinn, Seung Up Kim
  Hepatology International.2021; 15(6): 1328.     CrossRef
• Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination
  Fátima Higuera-de la Tijera, Alfredo Servín-Caamaño, Luis Servín-Abad
  World Journal of Gastroenterology.2021; 27(26): 4004.     CrossRef
• Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
  Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
  Cancers.2021; 13(23): 5892.     CrossRef